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ABSTRACT
In Fenton-like reactions, Cu+ localized on DNA reduces hydrogen peroxide to form
hydroxyl radical (•OH), resulting in oxidative DNA damage. This DNA damage causes
mutation and cell death, which can lead to diseases such as cancer, Alzheimer’s, and
arteriosclerosis. Sulfur and selenium antioxidants have been investigated for the
prevention and treatment of these diseases, and studies have shown that sulfur- and
selenium-containing antioxidants prevent DNA damage from copper-generated hydroxyl
radical and that metal coordination is required for the observed antioxidant activity.
To determine how copper coordination results in DNA damage inhibition, Cu+
complexes with selone and thione ligands were synthesized with the aim of studying their
electrochemistry and reactivity with H2O2. Tris(pyrazolyl)methane and -borate ligands
are used to synthesize the target metal complexes, since they mimic metal coordination
environments in biological systems. N,N’-1,3-dimethyl-imidazole thione (dmit), and
selone (dmise) ligands are used since they resemble ergothioneine and selenoneine, sulfur
and selenium-containing antioxidants naturally found in plants and animals. Selone
coordination to Cu+ significantly stabilizes Cu2+ more effectively than thione
coordination by an average of 224 mV. The copper-selone complexes of the formula
[TpmRCu(dmise)]+ and Tp*Cu(dmise) (TpmR = tris(pyrazolyl)methane, R = H; Tpm, R =
Me; Tpm*, R = iPr; TpmiPr; Tp* = tris(1,3-dimethylpyrazolyl)borate) have potentials
from -283 mV to -390 mV, while the analogous thione complexes ([TpmRCu(dmit)]+ and
Tp*Cu(dmit)) have potentials ranging from 70 mV to -232 mV. If similar Cu-Se
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complexes are formed in vivo, these potentials may be low enough to inhibit Cu2+
reduction by NADH and prevent copper redox cycling.
The reactivity of dmise, dmit, and their tris(3,5-dimethylpyrazolyl)methane
copper complexes [Tpm*Cu(L) (L = dmise or dmit) with H2O2 was explored. Dmise and
dmit are both reactive towards H2O2 and may be effective scavengers of H2O2. Treatment
of [Tpm*Cu(dmise/dmit)]+ with H2O2 showed sacrificial oxidation of the chalcogenone
without oxidation of the Cu+ metal center, and if similar copper-selenium or –sulfur
complexes form in vivo, these complexes may scavenge H2O2 and inhibit coppermediated oxidative damage.
A comparative coordination chemistry and density functional theory study of
selone and thione with cuprous halides was also performed, and the resulting complexes
have varied geometries and stochiometries depending on the type of halide and
chalcogenone ligand used, intramolecular π-π interactions, and degree of short contact
interactions between X-H (X = I, Br, Cl, Se or S) atoms in the solid state structures. Cu+
complexes

of

the

bidentate

thio-

and

seleno-imidazolyl

ligands

bis(thioimidazolyl)methane, bis(selenoimidazolyl)methane, bis(thioimidazolyl)ethane,
and bis(selenoimidazolyl)ethane were synthesized, and these complexes preferentially
formed dinuclear, three- and four-coordinate Cu+ complexes. The Cu2+/+ reduction
potentials of these copper complexes with bidentate chalcogenone ligands vary within a
range of 471 mV, a difference that would have significant effects in redox-mediated
reactions. The results presented give more insight on the antioxidant activity of selone
and thione compounds in the prevention of copper-mediated oxidative damage. These
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results also reveal the diverse coordination chemistry of Cu+ with selone and thione and
elucidates the effects of this coordination on Cu2+/+ reduction potentials.
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CHAPTER ONE
ANTIOXIDANT AND METAL COORDINATION PROPERTIES OF BIOLOGICAL
CHALCOGENONES
Antioxidant and biological effects of selenium and sulfur.
Selenium is an essential micronutrient for both humans and animals with a RDA
(recommended dietary allowance) ranging from 55-350

g/day for humans.1 It is

incorporated as selenocysteine in the active site of many antioxidant proteins, including
glutathione peroxidases, thioredoxin reductases, and thyroid hormone deiodinases.2-3 In
humans, selenium deficiency can lead to Keshan, Kashin-Beck, and neurodegenerative
diseases, whereas selenium overload may lead to garlic breath, poisoning, and selenosis.4
Selenocysteine coordinates nickel in Ni-Fe-Se hydrogenase, a microbial enzyme that
catalyze the reversible and selective interconversion of H2 and 2H+/2e-.5 Selenocysteine
also coordinates molybdenum and tungsten in the formate dehydrogenases of E. coli6,7
and Clostridium thermoaceticum,8 respectively. Metal coordination of selenium
antioxidant compounds prevents Fe2+- and Cu+-mediated oxidative DNA damage,9-11 and
selenium antioxidants play protective roles against heart disease, as well as prostate, lung,
and colon cancer.12,13 Recently, the selenium containing compound selenoneine (Figure
1.1) was isolated from the blood of blue tuna and was shown to be a very potent
antioxidant.14
Sulfur is found in numerous proteins and low molecular weight compounds in
plants and animals and plays a major role in redox processes, metal binding, and catalytic
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reactions.15 Major sulfur-containing compounds in the body include methioneine,
cysteine, taurine, glutathione, N-acetylcysteine, and ergothioneine, and these compounds
are involved in protein synthesis and antioxidant defense mechanisms. In biological
systems, sulfur coordination to metals is found in
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Figure 1.1. Thione and selone ligands described in this
chapter.
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ferrodoxins,21,22 Rieske proteins,23 and zinc fingers.24 Sulfur antioxidants also prevent
Fe2+- and Cu+-mediated DNA oxidative damage through metal coordination.25,26 Sulfurcontaining compounds such as N-acetyl-L-cysteine and D-penicillamine are used to treat
heavy metal poisoning, whereas allicin and other sulfur containing compounds from
garlic exhibit antimicrobial, antibacterial and antifungal properties.27-30 The thione
compound ergothioneine (Figure 1.1) is a biological antioxidant capable of binding
divalent metal ions.31-33
2

Antioxidant and metal binding properties of biological chalcogenones.
Selenoneine (2-selenohistidine trimethylbetaine or 2-selenyl-Nα,Nα,Nα-trimethyl-Lhistidine) is a seleno-histidine first identified by Yamashita and Yamashita in 2010 after
isolation from the blood of blue tuna, Thunnus orientalis.14 Selenoneine is also the
primary source of selenium in chicken gizzard, liver, and heart as well as in squid
hepatopancreas. The highest concentration of selenoneine (430-437 nmol of selenium/g)
are found in tuna and mackerel blood.14 Selenoneine was first isolated in its oxidized
diselenide form that was then reduced to the monomeric selone form by treatment with
dithiothreitol or glutathione. In solution, selenoneine exhibits selenol-selone tautomerism
and exists primarily in the selone form under physiological conditions.14
As an antioxidant, selenoneine is a potent radical scavenger and has shown
greater antioxidant activity than the analogous sulfur antioxidant ergothioneine in
scavenging the 1-diphenyl-2-picrylhydrazyl (DPPH) radical in vitro.14 The high
concentrations of selenoneine found in animal tissues suggest that this molecule may play
an important role in physiological redox and antioxidant processes.14 Because selenium
antioxidants can inhibit oxidative damage by binding to Cu+ and Fe2+,9-11 and because
selenoneine likely coordinates metal ions through the selenium and nitrogen atoms of the
five-membered ring, the coordination chemistry of selenoneine may contribute to its
antioxidant behavior. Thus, understanding the binding properties of similar selone
compounds will provide insight into metal binding as a novel antioxidant mechanism for
selenoneine.
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Ergothioneine (2-mecarptohistidine trimethylbetaine) is a thiohistidine first
isolated in 1909 from ergot, and it is also found in plants, animals, and humans.34 Similar
to selenoneine, ergothioneine exhibits thione-thiol tautomerism, but exists primarily in
the thione form under physiological conditions.27 Ergothioneine binds divalent metals
ions such as Cu2+ without undergoing autooxidation to the disulfide dimer due to its more
negative reduction potential relative to other thiols.27
The antioxidant abilities of ergothioneine inhibition of peroxynitrite-dependent
nitration of nitrotyrosine,35 and prevention of xanthine and hypoxanthine formation,
compounds implicated in inflammatory conditions such as gout.36 Similar to selenoneine,
ergothioneine also scavenges DPPH radical but it is less potent compared to
selenoneine.14 Several studies have shown that ergothioneine can neutralize reactive
oxygen species such as hydroxyl radical and peroxynitrite,37,38 and that ergothioneine
protects rat kidneys and livers from oxidative damage by Fe/H2O2,34 despite studies
showing that the reaction of ergothioneine with H2O2 is very sluggish.39,40
In addition, ergothioneine coordinates redox-active metals such as Cu2+, Cu+,
Hg2+, and Fe2+, by binding through sulfur or nitrogen atoms. To determine how this metal
coordination ability may be related to its observed antioxidant activity, it is necessary to
investigate the coordination chemistry of ergothioneine analogs.
The thione methimazole is the most common drug used in the treatment of
hyperthyroidism.41 The mechanism of inhibition of hyperthyroidism using thiourea drugs
such as methimazole is not fully understood, but these compounds are proposed to block
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thyroid hormone biosynthesis by inhibiting thyroid peroxidases catalyzed iodination of
tyrosine residues in thyroglobulin.41,42 Numerous studies have also shown that
methimazole is a potent scavenger of hydroxyl radical and peroxynitrite and that it
prevents thyroperoxidase and DNA damage.43-45 Medicinal studies of methimazole have
shown its ability to prevent oxidative stress and chemical-induced gastropathy in rats,46 to
inhibit melanin synthesis in cultured B16 melanocytes,47 and to upregulate T-cell-derived
cytokines.48
The rich coordination chemistry of transition metals with methimazole has
previously been investigated in detail.49-52 The coordination of methimazole to Cu+
results in diverse architectures ranging from mononuclear complexes to polynuclear
networks with several methimazole binding modes, including monodentate and bridging
via coordination of the sulfur and non-alkylated nitrogen atom.53-55
The research presented in this dissertation involves understanding the antioxidant
mechanisms of chalcogenone compounds similar to selenoneine, ergothioneine, and
methimazole. The selone and thione ligands used throughout these chapters resemble
selenoneine,14 ergothioneine,56 and methimazole (Figure 1.1).41 The work presented in
Chapter 2 investigates the effects of N,N’-1,3-dimethylimidazole selone (dmise) and
thione (dmit; Figure 1.1) ligand coordination on the redox properties of Cu+.57
Tris(pyrazolyl)methane and -borate ligands are used to synthesize the target Cu+
complexes, since they mimic metal coordination environments in biological systems.58
Research described in Chapter 3 focuses on the reactivity of dmise, dmit, and their
tris(pyrazolyl)methane Cu+ complexes with H2O2. Work outlined in Chapter 4
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investigates the ability of dmise and dmit to reduce Cu2+ to Cu+ as well as the
coordination and electrochemistry of bis(1-methylimidazolyl) diselenide with Cu2+. The
work presented in Chapters 2, 3, and 4 enhances further understanding of selenium and
sulfur antioxidant activity through their ability to alter Cu2+/+ reduction potential upon
coordination to Cu+ or through the ability of selenium and sulfur antioxidant compounds
to scavenge reactive oxygen species such as H2O2.
Work described in Chapter 5 investigates the comparative coordination chemistry
of dmise and dmit with Cu+ halides, resulting in complexes with varied geometries and
stochiometries. Tetrameric and monomeric copper complexes were synthesized and
compared using density functional theory calculations to determine ligand effects as well
as the effects of inter- and intramolecular forces on solid state geometries of the
complexes.59 The research described in Chapter 6 focuses on the coordination and
electrochemistry studies of the bidentate thio- and seleno-imidazolyl ligands
bis(thioimidazolyl)methane, bis(selenoimidazolyl)methane, bis(thioimidazolyl)ethane,
and bis(selenoimidazolyl)ethane ligands with Cu+. Overall the work presented in this
dissertation reveals the diverse coordination chemistry of Cu+ with selone and thione
ligands and elucidates the effect of this coordination on Cu2+/+ reduction potentials and
reactivity with H2O2. It also sheds light on the mechanisms of antioxidant activity of
selone and thione compounds in the prevention of copper-mediated oxidative damage.
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CHAPTER TWO
PROBING THE ANTIOXIDANT ACTION OF SELENIUM AND SULFUR USING
Cu(I)-CHALCOGENONE TRIS(PYRAZOLYL) METHANE AND -BORATE
COMPLEXES
Introduction
Reactive oxygen species, (ROS) which include superoxide (O2•-), hydrogen
peroxide (H2O2), hydroxyl radical (•OH), singlet oxygen (1O2•) and peroxyl radical
(RO2•), are involved in oxidative damage to lipids, proteins and DNA.1 Copper(I)
participates in the Fenton-like reaction (reaction 1) in which hydroxyl radical is generated
from the reduction of less-damaging hydrogen peroxide.2 This copper-mediated hydroxyl
radical generation is catalytic in vivo if cellular reductants, such as NADH are available
to reduce Cu2+ to Cu+. Numerous studies have linked damage from copper-generated
hydroxyl radical to Alzheimer’s disease, cardiovascular diseases, and cancer.3,4
Cu+ + H2O2 → Cu2+ + HO∙ + OH- (1)
Selenium- and sulfur-containing compounds have been widely studied as
potential antioxidants for the prevention or reduction of oxidative DNA damage.5
Selenium is an essential micronutrient for both humans and animals, with a
recommended dietary allowance ranging from 55-350

g/day.6 Organoselenium

compounds are of particular interest because they appear to be more bioavailable relative
to inorganic selenium compounds.7
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Using copper-mediated DNA damage studies and UV-vis spectroscopy, our group
has identified copper coordination as an explanation for selenium and sulfur antioxidant
activity.5,8-10 This novel metal binding antioxidant hypothesis is separate from the
traditional explanation that focuses on the ability of selenium compounds to decompose
hydrogen peroxide in a manner similar to glutathione peroxidase (GPx).11

Figure 2.1. A) Tris(pyrazolyl) and heterocyclic thione and selone
ligands used in this study. Numbering scheme is shown for dmit. B)
Structures of naturally-occurring selone and thione antioxidants and the
drug methimazole.
As part of our efforts to understand the role of Se/S-Cu coordination in the
prevention of metal-mediated DNA damage, biologically relevant Cu+ selone and thione
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complexes with tris(pyrazolyl)methane or tris(pyrazolyl)borate ligands have been
synthesized, with the aim of studying their copper coordination and electrochemistry.
Scorpionate nitrogen donor ligands first introduced by Trofimenko12 (Figure 2.1A) were
employed, since they mimic biological coordination.13 The heterocyclic selones and
thiones used in this study (Figure 2.1A) resemble methimazole, a drug currently used in
the treatment of hyperthyroidism (Figure 2.1B).14 Dmit and dmise are also structurally
similar to ergothioneine,15 and selenoneine,16 respectively, antioxidant compounds widely
found in plant and animal tissues (Figure 2.1B).
The heterocyclic chalcogenones used in this study are good σ- and π-donors, and
similar compounds, such as imidazoline-2-thiones, display a diversity of bonding
modes.17 The coordination chemistry of selones and thiones with transition metals and
halogens has been previously reviewed by Raper,18 Akrivos,19 Spicer, et al.,20 and
Pettinari,21 as well as studied by Devillanova, et al.,22 Williams, et al.,23-27 Rabinovich, et
al.,28,29 and Parkin, et al.30,31 Many reports describe the coordination chemistry of thiones
with Cu+,17,32-34 but reports of analogous selone complexes are few.35-37 Herein, we report
the synthesis and characterization of mononuclear, four coordinate-copper(I) complexes:
Tp*Cu(L) and [TpmRCu(L)]+ where (L = N,N’-dimethylimidazole selone, dmise; N,N’dimethylimidazole thione, dmit; Tp* = hydrotris(3,5-dimethylpyrazolyl)borate; TpmR =
tris(pyrazolyl)methane, R = H; Tpm, R = Me; Tpm*, R = iPr; TpmiPr). Brumaghim, et
al.,8,10,38 and others39 have determined that the antioxidant activities of analogous
selenium and sulfur compounds can be very distinct. Thus, we have investigated the
geometries and spectroscopic properties of both copper-selone and -thione complexes.
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Because selenium and sulfur coordination to copper is necessary for prevention of copper
mediated DNA damage, comparative electrochemical studies of selone and thione
complexes will help determine changes in the reduction potentials of Cu2+/+ upon
coordination. These comparative studies will provide insights into the effects of selenium
and sulfur coordination and antioxidant activity in vivo. "This work is reproduced from
Kimani, et al. Inorg. Chem. 2010, 49, 9200-9211. Copyright 2010 American Chemical
Society." The copyright permission is in Appendix A, page 221.

Results and Discussion
Synthesis of Cu(I) selone and thione complexes. The target copper(I) complexes
with the BF4- counterion were synthesized using two different routes. Method 1 involves
a two-step, one-pot procedure via the treatment of equimolar amounts of
[Cu(NCCH3)4][BF4]

and

N,N’-dimethylimidazole

selone

(dmise)

or

N,N’-

dimethylimidazole thione (dmit) in acetonitrile followed by cannula addition of the
desired

tripodal

ligand

in

acetonitrile.

Method

2

involves

treating

[TpmRCu(NCCH3][BF4] with one molar equivalent of dmise or dmit in dichloromethane
(Scheme 2.1). Compared to method 1, method 2 generally results in slightly higher yields
with shorter reaction times. Copper complexes with the chloride counterion were
synthesized by reaction of equimolar amounts of CuCl and the chalcogenone in a mixed
solvent system of methanol and acetonitrile, followed by cannula addition of the tripodal
ligand in acetonitrile (Scheme 2.1).
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The neutral copper complexes were synthesized by combining CuCl and
dmise/dmit in methanol and acetonitrile, respectively, followed by cannula addition of
tris(3,5-dimethylpyrazolyl)borate (Tp*) in acetonitrile (Scheme 2.1). These neutral
complexes can also be synthesized by reaction of Tp*Cu(NCCH3) with molar equivalent
of dmit or dmise in dichloromethane (Scheme 2.1). All of the target metal complexes are
fairly stable to air for about 5-10 h as solids but are easily oxidized from Cu+ to Cu2+ in
solution.
Scheme 2.1
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NMR spectroscopy of copper thione and selone complexes. In the 1H NMR spectra
of [TpmRCu(L)][X] (R = H; Tpm, R = Me; Tpm*, R = iPr; TpmiPr; L = NCCH3, dmise, or
dmit; X = BF4- or Cl-), the apical CH proton resonance of the tris(pyrazolyl)methane
ligand bound to copper is shifted upfield by

0.1 to 0.5 from its position in the free

ligand. This same upfield shift was observed by Fujisawa and co-workers for the
[TpmiPrCu(NCCH3)]+ complex.40 All other proton signals of both the tripodal ligand
(TpmR) and the chalcogenone (dmise and dmit) are shifted downfield upon Cu+
complexation. This downfield shift of the ligand resonance upon copper coordination is a
result of increased deshielding effects on the protons upon metal binding. For copper
complexes with tris(pyrazolyl)borate ligands, the resonance for the BH proton is not
observed, as is common.40
1

H and
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C{1H} NMR spectroscopy data for the complexed and uncomplexed

selone and thione ligands are given in Table 2.1 (ligand numbering scheme in Figure
2.1A). A substantial shift of the C-2 resonance of the dmise and dmit ligands, are
observed upon complexation to copper. Shifts of

3 to 8 for both the C=Se and C=S

carbons are also observed upon copper binding, attributed to the shift of the electron
density from the selenocarbonyl or thiocarbonyl group to the neighboring N-C bond. This
electron density shift reduces the double bond character of the C=Se or C=S bond while
increasing that of the C-N single bond, resulting in an upfield shift for the C-2
resonance.32,41-43 This upfield shift is characteristic of selone or thione bound to copper
via the selenium and sulfur atoms. The increased electron density of the C-N bond upon
copper complexation results in a minor increases in deshielding effects on C-4 and C-5,
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as supported by observed downfield shifts of the C-4 and C-5 resonances. In the 1H and
13

C{1H} NMR spectra, H-4/5 and are shifted downfield and C-2 resonances are shifted

upfield for the selone copper complexes (δ 6.93 - 7.18 and δ 120.3 - 122.2, respectively)
and thione copper complexes (δ 6.82 - 7.04 and δ 118.6 - 119.9, respectively) relative to
the free selone (δ 6.77 and δ 119.7) and thione (δ 6.64 and δ 117.6) compounds (Table
2.1). These NMR shifts upon selone and thione complexation are consistent with copper
binding stabilizing the resonance form that places the positive charge into the
heterocyclic ring (Figure 2.2).

Se

Se
N

N

N

N

Figure 2.2. Resonance structures for the selone.
ligand.
The 77Se{1H} NMR resonances for the tris(pyrazolyl) copper selone complexes 1,
3, 6, and 8 are shifted upfield (δ -31.5 to -95.6) upon selone coordination to copper
relative to the free dmise ligand (δ -6). The charge of the ligand of the tri(pyrazolyl)
ligand has the most profound effect on the shift of the
coordination of dmise to copper. The

77

77

Se{1H} NMR resonance upon

Se{1H} NMR resonance in the neutral

Tp*Cu(dmise) (8) complex resulted in an upfield shift of δ 25.5 while the charged
complexes [TpmRCu(dmise)]+ (R = H; Tpm; 3, R = Me; Tpm*; 1, R = iPr; 6) show an
average upfield shift of δ 86.8.
Notably, the copper complexes with Cl- counterions have smaller downfield shift
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on the methyl and olefinic protons and smaller upfield C-2 resonance shifts of the
heterocyclic chalcogenones relative to analogous complexes with BF4- counterions.
Because Cl- is significantly more coordinating than BF4-, the Cl- counterion may compete
slightly with the selone ligand for binding to labile Cu+.44,45 The presence of mononuclear
copper complexes with dmise and dmit ligands can be clearly seen from their ESI-mass
spectra. The fragmentation patterns found for all the complexes are consistent with their
calculated isotopic distribution.

Table 2.1. 13C{1H}, 1H and 77Se{1H} NMR chemical shifts of selone and thione
ligands before and after copper complexation.
13

C{1H} shift (
Ligand or Cu(I) complex C-2
Dmise
155.57
[TpmCu(dmise)][BF4] (3) 148.90
[Tpm*Cu(dmise)][BF4] (1) 147.61
[TpmiPrCu(dmise)][BF4] (6) 148.12
[Tpm*Cu(dmise)][Cl] (9) 153.22
[TpmiPrCu(dmise)][Cl]
152.03
Tp*Cu(dmise)
151.63
(12)
dmit
162.42
(8)
[TpmCu(dmit)][BF4]
(4) 154.66
[Tpm*Cu(dmit)][BF4] (2) 155.96
[TpmiPrCu(dmit)][BF4] (5) 155.49
[Tpm*Cu(dmit)][Cl]
156.54
iPr
[Tpm
159.52
(10) Cu(dmit)][Cl]
Tp*Cu(dmit)
(7)
157.45
(11)

)
C-4/5
119.71
122.24
121.60
121.47
119.98
120.54
120.27
117.60
119.90
119.70
119.80
119.42
118.58
119.33

1

H shift (
CH3
3.53
3.73
3.88
3.85
3.75
3.79
3.75
3.53
3.82
3.80
3.77
3.73
3.70
3.68

)
H-4/5
6.77
7.15
7.17
7.18
6.97
6.98
6.93
6.64
7.04
7.00
7.03
6.86
6.82
6.83

77

Se{1H} shift (δ)
-6
-95.6
-87.5
-95.6

-31.5

Molar conductivities of the neutral complexes TpmiPrCuCl and Tpm*CuCl are
low (18.4 and 19.2 S cm2 mol-1, respectively), indicating chloride coordination. In
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contrast, molar conductivities of the cationic complexes 1, 2, 5, and 6 with noncoordinating BF4- anions are significantly higher (89.7 – 118.4 S cm2 mol-1), indicating
1:1 ionic complexes. Conductivities of compounds with Cl- anions (9, 10, 11, and 12)
range from 23.3 to 30.7 S cm2 mol-1, indicating that the Cl- anions compete with thione
and selone for copper binding. The 1H NMR resonances for the H-4/5 protons of the
copper chloride complexes 9, 10, 11, and 12 (δ 6.82 - 6.98) are closer to the unbound
ligands compared to complexes 1, 2, 5, and 6 with non-coordinating BF4- counterions (δ
7.00 – 7.18), corroborating the conductivity measurements.
IR Spectroscopy. The acetonitrile copper complexes used as starting materials,
[Tpm*Cu(NCCH3)][BF4]

and

[TpmiPrCu(NCCH3)][BF4]

have

N≡C

stretching

frequencies of 2272 and 2275 cm-1 respectively, comparable to literature reports.46 The
N≡C stretches in these copper acetonitrile complexes are shifted to higher wavenumbers
relative to free acetonitrile (2250 cm-1), indicating an increased N≡C bond strength due to
donor bond formation upon Cu+ complexation.47 The IR spectrum of dmit shows a C=S
stretching vibration at ~ 1181 cm-1, whereas dmise has a C=Se stretching vibration at
~1148 cm-1, consistent with previous reports for dmit, 1-mesitylimidazole selone, mbit =
1,1'-methylenebis(1,3-dihydro-3-methyl-2H-imidazole-2-thione),
methylene-bis(1,3-dihydro-3-methyl-2H-imidazole-2-selone).48-50

and

mbis

Upon

=

1,1'-

copper-dmit

binding in complexes 2, 4, 5, and 7 this C=S stretch shifts to lower energy, 1172-1178
cm-1, indicative of weak backbonding to the thione ligand. Coordination of dmise to
copper in TpmR complexes 1, 3, and 6 results in a slight shift of C=Se stretch to higher
energy, 1150-1151 cm-1, indicating that backbonding interactions with this ligand are not
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significant. In contrast, the IR spectrum of Tp*Cu(dmise) (8) shows a slight shift to lower
energy region for C=Se stretch (1145 cm-1) upon coordination of dmise to copper.
Structural analysis of copper selone and thione complexes. Single crystal X-ray
diffraction data were collected for [Tpm*Cu(dmise)][BF4] (1), [Tpm*Cu(dmit)][BF4] (2),
[TpmCu(dmit)][BF4]

(4),

[TpmiPrCu(dmise)][BF4]

(6),

Tp*Cu(dmit)

(7)

and

Tp*Cu(dmise) (8) which crystallized as colorless prisms, and for [TpmCu(dmise)][BF4]
(3), which crystallized as colorless rods. Their structural parameters are summarized in
Tables 2.5 to 2.11, and their structures are shown in Figures 2.3 to 2.5 and 2.7 to 2.10
while their packing diagrams are depicted in Figures 2.6, and 2.14 to 2.19. All the Cu+
centers adopt distorted tetrahedral coordination geometry, bound to three nitrogen atoms
from the tridentate ligand in a κ3-fashion, and terminally bound to the heterocyclic
chalcogenones. The distorted tetrahedral geometries can be seen in the N-Cu-N angles,
ranging from 84.6 to 92.1º and arise from pinning back of TpmR and KTp* nitrogen
atoms due to the small bite angles of these ligands.51
The crystal structure of [TpmCu(dmise)][BF4] (3) is composed of two
crystallographically-independent molecules in the same unit cell (Figure 2.3; Table 2.5).
Each copper atom adopts a distorted tetrahedral coordination environment with average
Cu-N distances of 2.12 Å for Cu(1)-N and 2.13 Å for Cu(1A)-N(A). Mean N-Cu-N
angles are 87.2º for N-Cu(1)-N and 86.9º for N(A)-Cu(1A)-N(A), respectively. The CuSe bond lengths and Cu-Se-C bond angles are the major differences between the
molecular geometry of these independent molecules, with the Cu(1A) molecule
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exhibiting a bond length of 2.314 Å and an angle of 110.3º and the Cu(1) molecule a
slightly shorter bond length of 2.294 Å and a much smaller angle of 100.4º.
Structures of the Tpm, Tpm*, TpmiPr, and Tp* copper selone complexes (1, 3, 6
and 8; (Figures 2.3, 2.4, 2.5, and 2 7; Table 2.2, 2.3, 2.4 and 2.5) are very similar despite
the differences in steric bulk of their tris(pyrazolyl)methane ligands and overall charge of
the ligands. In 1, 3, 6, and 8 the dmise ligand is bound to the copper center with an
average angle of 105.2º due to the presence of the lone pairs on the selenium atom. The
Cu-Se bond lengths for 1 (2.30 Å), 3 (2.29 Å and 2.31 Å), and 6 (2.31 Å) are comparable,
whereas the Cu-Se bond in 8 (2.33 Å) is slightly longer. The Cu-Se bond distances in 1,
3, 6, and 8 are comparable to the Cu-Se bond distance of

2.30 Å in the

CuIII-bis-diselenolene complex reported by Ribas et al.,52 but shorter than most reported
copper-selenium complexes such as the selone [Cu(1,10-phen)2(C5H10N2Se)][2ClO4]
(2.49 Å);36 the selenolate [CuSe(2,4,6-iPr3C6H2)]2[bipy]2 (2.45 Å);53 the selenoether
[Cu(o-

C6H4(SeMe)2)2][PF6]

(2.42

Å);54and

the

selenium

macrocycle

[Cu(C11H14Se2)2][BF4] (avg. 2.41 Å).55 Short Cu-Se bond distances for 1, 3, 6, and 8
imply stronger donor interactions between the soft selenium ligand and the soft copper
metal ion, but only a limited number of non-bridging copper selone complexes are
available for structural comparison.
Short interactions of 3.59 Å between selenium atoms are found within the unit
cell of [TpmiPrCu(dmise)][BF4] (6), and these interactions are shorter than the sum of
Se-Se van der Waals radii (3.80 Å).
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Figure 2.3. Crystal structure diagram (50% probability ellipsoids) of
[TpmCu(dmise)][BF4] (3) showing the two crystallographically independent
molecules. Counterion and hydrogen atoms are omitted for clarity.

Table 2.2. Selected bond lengths (Å) and angles (°) for the two
crystallographically independent molecules in complex 3.
Cu(1)-N(3)
Cu(1)-N(4)
Cu(1)-N(5)
Cu(1)-Se(1)
C(1)-Se(1)

2.188(6)
2.111(6)
2.053(6)
2.2941(13)

Cu(1A)-N(3A)
Cu(1A)-N(4A)
Cu(1A)-N(5A)
Cu(1A)-Se(1A)
C(1A)-Se(1A)

2.111(6)
2.094(7)
2.184(7)
2.3120(13)

N(4)-Cu(1)-N(5)
N(4)-Cu(1)-N(3)
N(5)-Cu(1)-N(3)
N(3)-Cu(1)-Se(1)
N(4)-Cu(1)-Se(1)
N(5)-Cu(1)-Se(1)
N(4A)-Cu(1A)-N(5A)
N(4A)-Cu(1A)-N(3A)
N(5A)-Cu(1A)-N(3A)
N(3A)-Cu(1A)-Se(1A)
N(4A)-Cu(1A)-Se(1A)
N(5A)-Cu(1A)-Se(1A)
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88.8(2)
86.6(2)
86.1(2)
122.35(17)
132.94(17)
125.80(17)
86.20(3)
87.4(3)
87.0(3)
114.74(17)
145.41(18)
119.49(18)

Figure 2.4. Crystal structure diagram of [Tpm*Cu(dmise)][BF4] (1) displaying
50% probability density ellipsoids. Hydrogen atoms and counterion are
omitted for clarity.

Table 2.3. Selected bond lengths (Å) and angles (°) for complex 1.
Cu(1)-N(3)
Cu(1)-N(4)
Cu(1)-N(5)
Cu(1)-Se(1)
Se(1)-C(1)

2.126(2)
2.063(3)
2.089(2)
2.2981(6)
1.868(3)

N(4)-Cu(1)N(4)-Cu(1)N(5)
N(5)-Cu(1)N(3)
N(3)-Cu(1)N(3)
N(4)-Cu(1)Se(1)
N(5)-Cu(1)Se(1)
C(1)-Se(1)Se(1)
Cu(1)
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88.66(10)
87.66(10)
85.67(9)
125.46(7)
132.37(7)
123.04(7)
108.24(10)

Figure 2.5. Crystal structure diagram of [TpmiPrCu(dmise)][BF4] (6)
displaying 50% probability density ellipsoids. Hydrogen atoms and counterion
are omitted for clarity.

Table 2.4. Selected bond lengths (Å) and angles (°) for complex 6.
Cu(1)-N(3)
Cu(1)-N(4)
Cu(1)-N(5)
Cu(1)-Se(1)
Se(1)-C(1)

2.058(4)
2.095(4)
2.189(4)
2.3126(8)
1.858(5)

N(4)-Cu(1)-N(5)
N(4)-Cu(1)-N(3)
N(5)-Cu(1)-N(3)
N(3)-Cu(1)-Se(1)
N(4)-Cu(1)-Se(1)
N(5)-Cu(1)-Se(1)
C(1)-Se(1)-Cu(1)
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84.62(16)
88.44(16)
85.43(16)
130.52(11)
124.40(11)
128.71(10)
104.62(13)

Figure 2.6. Crystal packing diagram of [TpmiPrCu(dmise)][BF4] (6) at 50%
probability density ellipsoids displaying short Se-Se interactiona along the aaxis. Hydrogen atoms and counterion omitted for clarity.

The copper(I) thione complexes 2, 4, and 7 are tetrahedrally coordinated via the
three nitrogen atoms of the Tpm* (2), Tpm (4), or Tp* (7), ligands and the sulfur atom of
dmit (Figures 2.9, 2.10, and 2.11; Tables 2.8, 2.9, and 2.10). The average Cu-N distance
of 2.10 Å in complex 7 is similar to complex 2, but shorter compared to Cu-N distances
of 2.12 Å in complex 4.
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Figure 2.7. Crystal structure diagram of Tp*Cu(dmise) (8) displaying 50%
probability density ellipsoids. Hydrogen atoms are omitted for clarity.

Table 2.5. Selected bond lengths (Å) and angles (°) for complex 8.
Cu(1)-N(2)
Cu(1)-N(3)
Cu(1)-N(3A)
Cu(1)-Se(1)
Se(1)-C(1)

2.033(4)
2.120(2)
2.120(2)
2.3299(9)
1.864(4)

N(2)-Cu(1)-N(3)
N(2)-Cu(1)-N(3A )
N(3)-Cu(1)-N(3A)
N(2)-Cu(1)-Se(1)
N(3)-Cu(1)-Se(1)
N(3A)-Cu(1)-Se(1)
C(1)-Se(1)-Cu(1)
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92.05(10)
92.05(10)
87.53(13)
135.23(10)
118.86(7)
118.86(7)
103.63(13)

The thione ligand is bound to the copper ion at almost identical C-S-Cu angles in
complexes 4 (106.9º) and 7 (105.6º), but the angle increases to 111.3º in complex 2.
Complex 7 has a Cu-S bond distance of 2.22 Å, slightly longer than the observed bond
length of 2.19 Å for complex 2 and 2.20 Å for complex 4. The Cu-S bond lengths of
complexes 2, 4, and 7 are shorter than previously-reported copper thione complexes such
as [Cu(PPh3)2(bzimH2)Cl] (2.38 Å),34 [Cu(diditme)2Cl] (2.23 Å),56 [CuCl(1κSimzSH)(PPh3)2] (2.36 Å),57 and [Cu(HB(3,5-iPrPz)3(SMeIm)] (2.45 Å);58 however, the
Cu-S bond lengths of complexes 2, 4, and 7 are longer than those copper thiolate
complexes such as [Cu(SC6F5)(HB(3,5-iPrPz)3)] (2.18 Å),59 and [Cu(SCPh3)(HB(3,5iPrPz)3)] (2.12 Å).59
Changing the alkyl substituents on the 3 and 5 positions of the pyrazole ring has
minor effects on Cu-Se/S bond distances and Cu-Se/S-C(1) bond angles. In addition, the
overall charge of the tris(pyrazolyl) ligand has very little effect on the structure of copper
thione complexes. Complex 7 with the negatively charged Tp* ligand has slightly larger
N-Cu-N angles (avg. 90.5º) compared to the neutral Tpm and Tpm* ligands (avg. 87.2º).
The Cu-S bond distance of 2.19 Å in [Tpm*Cu(dmit)][BF4] (2) is slightly shorter relative
to 2.22 Å in the neutral complex Tp*Cu(dmit) (7).
The average Cu-N bond lengths and N-Cu-N angles in complexes 1, 2, 3, 4, and 6
are comparable to other tris(pyrazolyl)methane copper(I) complexes such as
[TpmCu(NCCH3)][BF4]

(2.05-2.14

Å,

87.8º),60

[Tpm*Cu(1,4-CNC6H4NC)][BF4]

(2.06-2.09 Å, 87.2º),60 [Tpm3-tBuCu(NCCH3)][PF6] (2.06-2.14 Å, 89.2º),51 and
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Figure 2.8. Crystal structure diagram of [Tpm*Cu(dmit)][BF4] (2)
showing 50% probability density ellipsoids. Hydrogen atoms and
counterion are omitted for clarity.

Table 2.6. Selected bond lengths (Å) and angles (°) for complex 2.
Cu-N(3)
Cu-N(4)
Cu-N(5)
Cu-S
S-C(1)

2.095(2)
2.077(2)
2.1334(19)
2.191(8)
1.709(3)

N(3)-Cu-N(4)
N(3)-Cu-N(5)
N(4)-Cu-N(5)
N(3)-Cu-S
N(4)-Cu-S
N(5)-Cu-S
C(1)-S-Cu
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88.49(8)
85.23(8)
87.40(8)
125.20(6)
130.45(6)
126.07(6)
111.30(9)

Figure 2.9. Crystal structure diagram of [TpmCu(dmit)][BF4] (4)
showing 50% probability density ellipsoids. Hydrogen atoms and
counterion are omitted for clarity.

Table 2.7. Selected bond lengths (Å) and angles (°) for complex 4.
Cu-N(3)
Cu-N(4)
Cu-N(5)
Cu-S
S-C(1)

2.128(2)
2.121(2)
2.117(2)
2.202(7)
1.711(3)

N(3)-Cu-N(4)
N(3)-Cu-N(5)
N(4)-Cu-N(5)
N(3)-Cu-S
N(4)-Cu-S
N(5)-Cu-S
C(1)-S-Cu
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88.73(9)
87.82(9)
85.5(10)
111.8(6)
133.15
134.51
106.8(9)

Figure 2.10. Crystal structure diagram of Tp*Cu(dmit) (7) showing 50%
probability density ellipsoids. Hydrogen atoms are omitted for clarity.

Table 2.8. Selected bond lengths (Å) and angles (°) for complex 7.
Cu-N(3)
Cu-N(3A)
Cu-N(4)
Cu-S
S-C(1)

2.1248(16)
2.1248(16)
2.039(2)
2.219(9)
1.708(3)

N(3)-Cu-N(4)
N(3A)-Cu-N(5)
N(4)-Cu-N(5)
N(3)-Cu-S
N(3A)-Cu-S
N(4)-Cu-S
C(1)-S-Cu
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92.09(7)
92.09(7)
87.23(9)
119.14(5)
119.14(5)
134.84(7)
105.62(10)

[TpmiPrCu(CO)][PF6] (avg. 2.05 Å,88.1º).40 The neutral Tp* complexes 7 and 8 have
average N-Cu-N bond angles of 90.5º, larger than those of complexes 1 (87.3º), 2 (87.1º),
3 (87.3º and 86.9º), 4 (87.4º), 6 (86.2°) and K[Tp*Cu(SC6H4NO2)]·2C3H6O (88.9º),61 but
similar to or slightly smaller than the previously reported TpiPrCu(CO) (90.9º) and
TpiPrCu(SMeIm) (90.6º)58 complexes.
Coordination of the dmise ligand to copper results in slightly shorter Se-C(1)
bond lengths of 1.87 Å in complex 1 and 1.86 Å in complexes 6 and 8 relative to that of
the uncoordinated ligand (1.89 Å),27 whereas for complex 3, this bond length is relatively
unchanged compared to unbound dmise (1.89, Se(1)-C(1A) and 1.87 Å, Se(1A)-C(1A)).
This slight shortening of the C=Se bond may be a result of donor bond formation
between dmise and copper. Coordination of the thione ligand to copper in complexes 2,
4, and 7 results in almost identical S-C(1) bond distances (1.71 Å), longer than the S-C(1)
bond distance (1.68 Å) in the free thione ligand.62 Thus, the C=S bond is weakened due
to back bonding from the copper. Based upon IR data and C=S/Se bond distances of the
ligands before and after coordination, dmit is a better pi-acceptor than dmise but is a
weak pi-acceptor relative to ligands such as CO that show slight elongation of the CO
bond distance and a large shift of the C-O bond stretch to lower wavenumbers (~50 cm-1)
in the IR spectrum upon copper coordination.40
It has been reported that the strength of the metal-chalcogenone bond can be
correlated to the degree of

13

C{1H} NMR shift difference for the C-2 resonance upon

complexation of selone or thione ligands.42,63,64 Popovic, et al.,42 showed a correlation
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between C-2 13C{1H} NMR resonance shifts vs. Hg-S bond lengths for three complexes,
but this reported trend does not correlate with a shift of ν(C=S) to lower energies in the
reported IR spectra. Isab and coworkers,63,64 make this claim based solely on

13

C{1H}

NMR data with no corresponding structural data. To determine whether our data
suggested such a trend, we compared the

13

C{1H} NMR C-2 resonance shifts for our

complexes (Table 4) with their Cu-S/Se bond lengths from the X-ray crystallographic
data. For the copper selone complexes, the largest C-2 resonance shift of

8 compared to

unbound dmise was found for [Tpm*Cu(dmise)][BF4] (1), but its Cu-Se bond length of
2.298 Å is not statistically different from the average bond length of 2.303 Å for
[TpmCu(dmise)][BF4] (3) with a C-2 resonance shift of

6. [TpmiPrCu(dmise)][BF4] (6)

and Tp*Cu(dmise) (8) have C-2 resonance shifts of δ 7 and δ 4, respectively, compared
to unbound dmise and slightly longer Cu-Se bond lengths of 2.313 Å and 2.330 Å,
respectively. For the copper thione complexes, the largest C-2 resonance shift of

8

relative to the unbound dmit was found for [TpmCu(dmit)][BF4] (4) with the
second-shortest Cu-S bond distance of 2.20 Å. [Tpm*Cu(dmit)][BF4] (2) has the shortest
Cu-S bond distance of 2.19 Å and a C-2 resonance shift of
Tp*Cu(dmit) (7) has a C-2 resonance shift of

7. The neutral complex

5 compared to the unbound dmit and a

slightly longer Cu-S bond distance of 2.22 Å. Thus, although we observed consistent
upfield shifts of the C-2 resonance in the

13

C{1H} NMR spectra of complexes 1 to 12

upon dmise and dmit coordination to copper, no specific correlation is observed between
Cu-S/Se bond distances determined from the X-ray structures and C-2 NMR resonance
shifts.
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Electrochemical studies of selone and thione ligands and their copper complexes.
The electrochemical behavior of the chalcogenone ligands and their copper(I) complexes
were examined by cyclic voltammetry to determine the difference in redox potentials
between dmise and dmit as well as the change in the Cu2+/+ redox potential upon Cuselone or Cu-thione coordination. The free selone has a more negative reduction potential
(E ) compared to the thione: E1/2 = -367 mV and -169 mV, respectively, versus normal
hydrogen electrode (NHE), and both ligands exhibit quasi-reversible electrochemical
behavior (Figure 2.11). The lower reduction potential of the selone relative to that of the
thione implies that selone is a better reducing agent, thus it may possess greater
antioxidant ability to neutralize reactive oxygen species.65,66

Figure 2.11. Cyclic voltammetry (CV) scans for dmise (A) and dmit (B). All
data collected with 1 mM complex in acetonitrile. Potentials are reported
versus NHE.

The Cu2+/+ redox potentials of the copper selone and thione complexes versus
NHE are given in Table 2.12. The cyclic voltammograms (CV) of these complexes
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exhibit two one-electron, chemically reversible potential waves belonging to the Cu2+/+
and Cu+/0 reduction and oxidation processes, as shown in Figure 2.12 (CV spectra for all
complexes are provided in Figures 2.13). At negative potentials, a peak corresponding to
the Cu+/0 reduction commences at potentials more negative than -1242 mV. After
switching the scan direction, the Cu0 is then stripped off the electrode at a potential close
to -742 mV.67,68
The acetonitrile complexes [TpmiPrCu(NCCH3)][BF4], [Tpm*Cu(NCCH3)][BF4],
and [TpmCu(NCCH3)][BF4] show large peak separations between the cathodic and
anodic waves for the Cu2+/+ oxidation and reduction potentials compared to the copper
selone and thione complexes, suggesting quasi-reversible electrochemical behavior. This
large separation may indicate that the oxidized or reduced products are not stable enough
to remain intact, due to slow electron transfer kinetics during the voltammetry sweep,69 or
may indicate a large reorganization energy upon shifting from a distorted tetrahedral Cu+
complex to a five-coordinate Cu2+ complex.70
The redox potentials of the copper selone complexes decrease significantly
compared to those of the thione copper complexes. Complexation of selone and thione
ligand to [Tpm*Cu(NCCH3)][BF4] lowers the Cu2+/+ redox potential by 635 mV and 374
mV, respectively, whereas upon complexation to [TpmiPrCu(NCCH3)][BF4] the Cu2+/+
redox potential is reduced by 847 mV and 617 mV, respectively. Thus, dmise
coordination stabilizes the Cu2+ metal center more effectively than dmit coordination by
an average of 224 mV.
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Figure 2.12. Cyclic voltammetry (CV) scan for Tp*Cu(dmise) (dashed line)
and Tp*Cu(dmit) (solid line) in acetonitrile.

Effect of ligands and counterions on the Cu+/2 redox potential. For the copper
selone and thione complexes (1, 2, 3, 4, 5, and 6) the bulkier the tris(pyrazolyl)methane
ligand on the 3 and 5 positions of the pyrazole rings, the more negative the Cu 2+/+ redox
potentials. The electron donating ability of the alkyl substituents is: iPr > Me > H. For the
copper selone complexes, the redox potentials are shifted to lower voltages in the
following order: [TpmCu(dmise)][BF4] (3) (-283 mV) > [Tpm*Cu(dmise)][BF4] (1) (366 mV) > [TpmiPrCu(dmise)][BF4] (6) (-0.390 mV). Despite the analogous copper
thione complexes having higher positive potentials, the same trend is observed:
[TpmCu(dmit)][BF4] (4) (70 mV) > [Tpm*Cu(dmit)BF4] (2) (-105 mV) >
[TpmiPrCu(dmit)][BF4] (5) (-160 mV). The partially-negatively-charged chalcogenone
species coupled with its σ and π donation abilities, stabilizes Cu2+ relative to Cu+ and
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results in a more negative Cu2+/+ redox potential. In contrast, for the acetonitrile
complexes [TpmRCu(NCCH3)][BF4] (R = H, Me, iPr), increased steric bulk of the alkyl
substituents on the 3 and 5 position of the pyrazole rings results in a more positive Cu2+/+
potential: [TpmCu(NCCH3)][BF4] (-219 mV) < [Tpm*Cu(NCCH3)][BF4] (269 mV) <
[TpmiPrCu(NCCH3)][BF4] (457 mV). Thus, increasing the steric bulk on the 3 and 5
positions of the pyrazole rings results in increased thermodynamic stability of the
copper(I) acetonitrile complexes, due to increased electron donating ability of the alkyl
groups on the 3 and 5 positions of the pyrazole ring. The same increase to more positive
Cu2+/+ potentials with increased steric bulk and electron donating ability on the 3 position
of the pyrazole ring in copper acetonitrile complexes with tris(pyrazolyl)methane type
ligands was observed by Fujisawa et al.40
The selone compound 1 with the neutral Tpm* ligand has slightly more negative
Cu2+/+ potentials (-366 mV) relative to the complex 8 with anionic Tp* ligand (-346 mV).
For the copper thione complexes, complex 7 with the anionic Tp* ligand has significantly
more negative potential (-232 vs. -105 mV) compared to complex 2 with the neutral
Tpm* ligand, an effect similarly observed for Tp*Cu(NCCH3) (-349 mV) vs.
[Tpm*Cu(NCCH3)][BF4] (269 mV). Fujisawa et al. also observed more negative
potentials for TpiPrCu(NCCH3) relative to [TpmiPrCu(NCCH3)][PF6] and determined that
the borate ligands are more electron donating than the methane ligands.40 It is expected
that the negatively-charged borate ligands coupled with the partially-negatively-charged
chalcogenone will stabilize Cu2+ relative to Cu+ vs. the neutral Tpm* ligand, resulting in
a more negative reduction potential.
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Table 2.9. Redox potentials of selone and thione ligands and Cu2+/+ and Cu+/0 potentials of synthesized
copper complexes vs. NHE.
Cu2+/+
Complex or ligand
[TpmCu(dmise)][BF4]
[Tpm*Cu(dmise)][BF4]
[TpmiPrCu(dmise)][BF4]
Tp*Cu(dmise)
[Tpm*Cu(dmise)][Cl]
[TpmiPrCu(dmise)][Cl]
[TpmCu(NCCH3)][BF4]
[Tpm*Cu(NCCH3)][BF4]
Tp*Cu(NCCH3)
Tpm*CuCl
dmisea
[TpmCu(dmit)][BF4]
[Tpm*Cu(dmit)][BF4]
[TpmiPrCu(dmit)][ BF4]
Tp*Cu(dmit)
[Tpm*Cu(dmit)][Cl]
[TpmiPrCu(dmit)][Cl]
[TpmiPrCu(NCCH3)][BF4]
TpmiPrCuCl
dmita

(3)
(1)
(6)
(8)
(9)
(12)

(4)
(2)
(5)
(7)
(10)
(11)

Cu+/0

Epa

Epc

ΔE

E1/2

Epa

Epc

ΔE

E1/2

-30
-88
(mV)
-49
-122
-30
11
203
1158
-51
46
39
392
307
187
147
-15
9
1254
280
424

-536
-644
(mV)
-729
-570
-752
-643
-641
-620
-647
-450
-773
-252
-518
-507
-611
-341
-291
-340
-18
-761

506
556
(mV)
680
448
722
654
844
1778
596
496
812
644
825
694
758
326
300
1594
298
1158

-283
(mV)
-366
-390
-346
-376
-316
-219
269
-349
-202
-367
70
-105
-160
-232
-163
-141
457
131
-167

-915
-905
(mV)
-888
-1072
-803
-920
-598
-363
-824
-723

-1303
-1494
(mV)
1257
-1444
-1305
-1448
-922
-1297
-1247
-1645

324
(mV)
589
370
372
502
525
324
934
423
922

-760
-1199
(mV)
-1070
-1258
-1053
-1184
-760
-830
-1036
-1184

-932
-789
-967
-980
-785
-908
-332
-467

-1295
-1371
-1181
-1566
-1349
-1442
-1248
-1370

363
582
214
586
564
534
916
903

-1113
-1080
-1074
-1273
-1067
-1175
-790
-918

a

Reported redox potentials are for the uncomplexed ligand.

Biological significance of selenium coordination. Although dmit and dmise are
not found in vivo, they are structurally similar to ergothioneine15 and selenoneine,16
respectively, which are sulfur and selenium containing antioxidants found in plants and
animals. Yamashita, et al.16 found that selenoneine is the major selenium compound
found in tuna and mackerel blood (~0.45 M concentration) and is a very potent radical
scavenger. Dmit is also structurally similar to methimazole,14 a thione drug currently used
for treatment of hyperthyrodism. Mugesh, et al. has demonstrated the abilities of dmit
and dmise to protect against peroxynitrite-mediated protein tyrosine nitration71 and
similar compounds such as selenoneine have been shown to be very potent radical
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scavengers.16 Dmise and dmit also prevent copper-mediated DNA damage.72 The
electrochemical data obtained from the target metal complexes provides insight as to
whether similar Se-Cu complexes formed in vivo could cycle between the Cu2+/+ forms.
Complexes with reduction potentials lower than -324 mV (versus NHE) cannot be
reduced by cellular reductants such as NADH.73 The copper selone complexes have a
reduction potential range of -283 to -390 mV, whereas copper thione complex potentials
range from 70 to -232 mV versus NHE. Thus, copper selenium complexes have
significantly lower potentials than analogous copper-sulfur complexes, and most are
more negative than that of NADH. Therefore, if similar complexes are formed in vivo,
these potentials may be low enough to prevent Cu2+ reduction by NADH, making the
Fenton-like reaction of copper non-catalytic, and inhibiting generation of hydroxyl
radical (reaction 1).

Conclusions
Biologically

relevant

Cu+

selone

and

thione

complexes

with

tris(pyrazolyl)methane and tris(pyrazolyl)borate ligands have been synthesized and
characterized, and their electrochemistry has been investigated and compared. The
copper-selone complexes [Tpm*Cu(dmise)][BF4] (1), [TpmCu(dmise)][BF4] (3),
[TpmiPrCu(dmise)][BF4] (6), and Tp*Cu(dmise) (8) possess the shortest copper-selone
bond distances reported. The copper-thione complexes [Tpm*Cu(dmit)][BF4] (2),
[TpmCu(dmit)][BF4] (4), and Tp*Cu(dmit) (7) have Cu-S bond lengths ranging from
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2.19 - 2.22 Å. Changing the alkyl groups on the 3 and 5 positions of the pyrazole ring has
little effect on the Cu-Se or Cu-S bond lengths, but has dramatic effects on the Cu2+/+
redox potentials of complexes. The 13C{1H} NMR data predicts stronger Cu-Se bonding
in

[Tpm*Cu(dmise)][BF4]

(1)

relative

to

[TpmCu(dmise)][BF4]

(3)

and

[TpmiPrCu(dmise)][BF4] (6), although little variation is observed in the Cu-Se bond
distances. The dmise ligand coordination stabilizes the Cu2+ center more effectively than
dmit coordination by an average of 224 mV. The results obtained in this study give us
insight into possible alternative explanation about the antioxidant abilities of selenium
and sulfur compounds. Since reduction potentials of the copper selone complexes are
more negative than the copper thione complexes, if similar complexes are formed in vivo,
these potentials may be low enough to inhibit Cu2+ reduction by NADH and prevent
copper redox cycling.

Experimental section
Materials. The synthesis and manipulation of all copper complexes was
performed under an inert atmosphere of argon or nitrogen using standard Schlenk
techniques. Acetonitrile, methanol, and ether were purified using standard procedures and
freshly distilled under argon atmosphere prior to use. The following compounds were
synthesized according to published procedures: 3,5-diisopropyl pyrazole,59 hydrotris(3,5diisopropyl-1-pyrazoyl)methane

(TpmiPr),40

potassium

hydro-tris(3,5-

dimethylpyrazolyl)borate (Tp*),74 N,N’-dimethylimidazole selone (dmise), N,N’-
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dimethylimidazole

thione

[Tpm*Cu(NCCH3)]+,51

(dmit),75

[Cu(NCCH3)4][BF4],76

hydrotris(3,5-dimethyl-1-pyrazoyl)methane

Tpm*CuCl,
(Tpm*),77

TpmiPrCuCl and [TpmiPrCu(NCCH3)]+.40 The following reagents were used as received:
cuprous chloride (Aldrich), 3,5-dimethyl-1-pyrazole (Aldrich), tetra-n-butylammonium
bromide (Aldrich), sodium carbonate (VWR), selenium powder, sulfur powder, cuprous
oxide (stabilized; Aldrich), diisobutyrylmethane (VWR), hydrazine monohydrate (VWR),
1-methylimidazole (VWR), and methyliodide (VWR).
Instrumentation. 1H, 13C{1H}, 77Se{1H}, and 19F{1H} NMR spectra were obtained
on Bruker-AVANCE 300 and 500 MHz NMR spectrometers.

11

were obtained on a Joel 300 MHz NMR spectrometer. 1H and

C{1H} NMR chemical

shifts are reported in
19

F{1H} NMR and

11

and neat BF3·OEt2 (

13

B{1H} NMR spectra

relative to tetramethylsilane (TMS) and referenced to solvent.
B{1H} NMR spectra were externally referenced to CCl3F ( 0)78
-19.4),79 respectively.

77

Se{1H} NMR chemical shifts were

externally referenced to diphenyl diselenide (δ 461),80 and reported relative to dimethyl
selenide (δ 0).
Electrochemical experiments were performed with a BAS 100B potentiostat. A
three compartment cell was used with an Ag/AgCl reference electrode, Pt counter
electrode, and a glassy carbon working electrode. Freshly-distilled acetonitrile was used
as the solvent with tetra-n-butylammonium phosphate as the supporting electrolyte (0.1
M). Solutions containing 1 mmol analyte were deaerated for 2 min by vigorous nitrogen
purge. The measured potentials were corrected for junction potentials relative to
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ferrocenium/ferrocene (0.543 mV vs. Ag/AgCl).81 All E1/2 values were calculated from
(Epa + Epc)/2 at a scan rate of 100 mV/s, and ΔE = Epa - Epc. Cyclic voltammograms of
selone and thione ligands (Figure 11) and their copper complexes showing the Cu+/2+
potentials are given in Figures 13-15. Resistivity for each complex was measured in DMF
solution (0.1 mM) at 25°C using a GDT-11 multimeter and converted to molar electrical
conductivity.
Infrared spectra were obtained using Nujol mulls on KBr salt plates with a Magna
550 IR spectrometer. Abbreviations used in the description of vibrational data are as
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a
Turbo Ionspray ionization source. Samples were run under positive mode, with ionspray
voltage of 5500 V, and TOF scan mode. Melting points were determined using a
Barnstead Electrothermal 9100 apparatus in silicon-grease-sealed glass capillary tubes.
Absorption spectra were collected using a Varian Cary-50 Bio spectrophotometer in
quartz cuvettes with a path length of 1 cm. Elemental analysis was performed by Atlantic
Microlabs, Inc.Preparation of complexes. [Tpm*Cu(dmise)][BF4] (1) Method 1: The
dmise ligand (176 mg, 1 mmol) was dissolved in acetonitrile (20 mL) and was cannula
transferred into a solution of [Cu(CNCH3)4][BF4] (312 mg, 1 mmol) in acetonitrile (20
mL). The reaction mixture was stirred at room temperature for 3 h until it was clear and
colorless. An equimolar amount of Tpm* (298 mg, 1 mmol) was then dissolved in
acetonitrile (10 mL) and cannula transferred into the reaction mixture and stirred for an
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additional 18 h. The solvent volume in the reaction mixture was reduced to about 4 mL
and the product was precipitated with diethyl ether to afford an off-white solid that was
dried in vacuo and analyzed. Yield 78% (486 mg, 0.78 mmol).
Method 2: [Tpm*Cu(NCCH3)][BF4]51 (250 mg, 0.5 mmol) was dissolved in
dichloromethane (10 mL) and into this was cannula transferred dmise (90 mg, 0.5 mmol)
in dichloromethane (10 mL). The reaction mixture was stirred for 3 h, and the solvent
volume reduced to about 3 mL. The product was precipitated with diethyl ether to afford
an off-white solid that was dried in vacuo and analyzed. Single crystals for X-ray analysis
were grown from slow vapor diffusion of ether into acetonitrile solution. Yield: 89% (277
mg, 0.445 mmol). 1H NMR (CD2Cl2): 2.18 (s, 9H, 3CH3), 2.541 (s, 9H, 3CH3), 3.88 (s,
6H, 2CH3 [dmise]), 5.99 (s, 3H, 3CH [Pz]), 7.17 ( s, 2H, 2CH [dmise]), 7.77 (s, 1H, CH).
13

C{1H} NMR (CD2Cl2): 10.72 (CH3), 13.16 (CH3), 37.58 (CH3 [dmise], 67.86 (CH),

106.76 (C-4 [Pz]), 121.60 (2CH [dmise]), 139.60 (C-3 [Pz]), 147.61 (C=Se), 150.79 (C-5
[Pz]).
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-1.397.

F{1H} NMR: -152.46, -152.52 (s,

77

10

BF4,

11

BF4).

11

B{1H} NMR (CD3CN):

Se{1H} NMR (CD2Cl2): -87.5. IR (cm-1): 481 s, 520 vs, 582 s, 610 s, 630 vs,

661 vs, 703 s, 739 vs, 793 vs, 815 s, 853 w, 900 vs, 980 s, 1031 b, 1150 vs, 1239 b, 1306
w, 1454 w, 1569 s, 1688 s, 2362 s, 2722 s, 3141 s, 3171 s, 3423 b. UV-vis (CH3CN): 273
nm. Mp: 169-172◦C. Mass spectrum (ESI-MS): m/z 537.1 [Tpm*Cu(dmise)]+, 361.1
[Tpm*Cu]+. Molar conductivity: 90.42 S cm2 mol-1. Anal. Calc. for C21H30BCuF4N8Se:
C, 40.43; N, 17.96; H, 4.86. Found: C, 40.19; N, 17.74; H, 4.84.
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[Tpm*Cu(dmit)][BF4] (2). Complex 2 was prepared following the procedure for 1
using both methods except that dmit (1 mmol, 129 mg) was used in place of dmise.
Yield: method 1, 64% (368 mg, 0.640 mmol); method 2, 78% (451 mg, 0.780 mmol).
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into
acetonitrile solution. 1H NMR (CD2Cl2): 2.18 (s, 9H, 3CH3), 2.53 (s, 9H, 3CH3), 3.80 (s,
6H, 2CH3 [dmit]), 6.00 (s, 3H, 3CH [Pz]), 7.00 (s, 2H, 2CH [dmit]), 7.76 (s, 1H, CH).
13

C{1H} NMR: 10.72 (CH3), 13.11 (CH3), 35.82 (CH3 [dmit]), 67.79 (CH), 106.74 (C-4

[Pz]), 119.70 (2CH [dmit]), 139.58 (C-3 [Pz]), 150.78 (C-5 [Pz]), 155.96 (C=S). 19F{1H}
NMR: -152.56, 152.61 (s,

10

BF4, 11BF4).

11

B{1H} NMR (CD3CN): -1.43. IR (cm-1): 481

s, 520 s, 582 s, 611 m, 630 vs, 672 vs, 703 s, 734 vs, 751 vs, 795 m, 816 s, 854 m, 900 vs,
976 s, 1058 b, 1149 vs, 1171 vs, 1239 m, 1306 s, 1393 b, 1570 s, 1676 s, 2723 s, 3141 vs,
3171 vs, 3351 w. UV-vis (CH3CN): 273 nm. Mp: 167-170◦C. Mass spectrum (ESI-MS):
m/z 489.1 [Tpm*Cu(dmit)]+, 361.1 [Tpm*Cu]+, 319.0 [Cu-(dmit)2]+, 191.0 [Cu-dmit]+.
Molar conductivity: 89.74 S cm2 mol-1. Anal. Calc. for C21H30BCuF4N8S: C, 43.72; N,
19.42; H, 5.24. Found: C, 43.78; N, 19.36; H, 5.27.
[TpmCu(dmise)][BF4] (3). Complex 3 was prepared following the procedure for 1
using both methods except that Tpm (214 mg, 1 mmol) was used in place of Tpm*.
Yield: method 1, 83% (447 mg, 0.83 mmol); method 2, 87% (471 mg, 0.87 mmol).
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into a
methanol solution. 1H NMR (CD3CN): 3.73 (s, 6H, CH3 [dmise]), 6.45 (b, 3H, CH [Pz]),
7.15 (s, 2H, CH [dmise]), 7.70 (b, 3H, CH [Pz]), 7.82 (b, 3H, CH [Pz]), 8.66 (s, H, CH).
13

C{1H} NMR (CD3CN): 38.02 (CH3 [dmise]), 81.9 (CH), 107.87 (4-CH [Pz]), 122.24
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(2CH [dmise]), 131.71 (3-CH [Pz]), 142.68 (5-CH [Pz]), 148.9 (C=Se). 19F{1H} NMR
(CD3CN): -149.557, -149.610 (s,
1

10

BF4,

11

BF4). 77Se{1H} NMR (CDCl3): -95.6. IR (cm-

): 521 w, 603 w, 611 w, 656 w, 723 s, 761 vs, 799 vs, 815 vs, 917 w, 961 w, 978 w,

1093 b, 1208 w, 1233 s, 1275 s, 1307 vs, 1351 s, 1379 vs, 1396 s, 1458 vs, 1507 s, 1522
s, 1540 w, 1570 w, 1652 w, 1700 w, 2337 w, 2361 w, 2724 w, 2920 b, 3133 b. Mp: 204206. UV-vis (CH3CN): 275 nm. Mass spectrum (ESI-MS): m/z 452.9 [TpmCu(dmise)]+,
277.0 [TpmCu]+. Anal. Calc. for C15H18BCuF4N8Se: C, 33.38; N, 20.76; H, 3.36. Found:
C, 33.17; N, 20.55; H, 3.34
[TpmCu(dmit)][BF4] (4). Complex 4 was prepared following the procedure for 1
using both methods except that Tpm (214 mg, 1 mmol) and dmit (129 mg, 1 mmol) were
used in place of Tpm* and dmise. Yield: method 1, 79% (389 mg, 0.791 mmol); method
2, 75% (368 mg, 0.749 mmol). Single crystals for X-ray analysis were grown from slow
vapor diffusion of ether into a methanol solution. 1H NMR (CD2Cl2): 3.82 (s, 6H, CH3
[dmit]), 6.35 (t, JHH = 2 Hz, 3H, CH [Pz]), 7.04 (s, 2H, CH [dmit]), 7.53 (d, JHH = 2 Hz,
3H, CH [Pz]), 8.26 (d, JHH = 2.5 Hz, 3H, CH [Pz]), 9.14 (s, H, CH).

13

C{1H} NMR

(CD2Cl2): 35.93 (CH3 [dmit]), 76.08 (CH), 106.65 (4-CH [Pz]), 119.90 (2CH [dmit]),
132.07 (3-CH [Pz]), 141.64 (5-CH [Pz]), 154.66 (C=S).

19

F{1H} NMR (CD2Cl2): -

149.557, -149.610 (s, 10BF4, 11BF4). IR (cm-1): 520 w, 613 vs, 661 w, 671 s, 719 vs, 750
vs, 772 vs, 794 vs, 851 vs, 921 w, 970 s, 1020 b, 1092 b, 1174 s, 1232 s, 1242 vs, 1258
w, 1288 vs, 1307 w, 1377 s, 1400 vs, 1464 vs, 1512 s, 1542 w, 1571 s, 2361 w, 2727 w,
2925 b, 3016 w, 3107 w, 3137 w, 3173 w. Mp: 205-207ºC. UV-vis (CH3CN): 273 nm.
Mass spectrum (ESI-MS): m/z 405.0 [TpmCu(dmit)]+, 277.0 [TpmCu]+, 191.0
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[Cu-dmit]+. Anal. Calc. for C15H18BCuF4N8S: C, 36.56; N, 22.74; H, 3.68. Found: C,
36.61; N, 22.77; H, 3.63.
[TpmiPrCu(dmit)][BF4] (5). Complex 5 was prepared following the procedure for
1 using both methods except that TpmiPr ( 466 mg, 1 mmol) and dmit (129 mg, 1 mmol)
were used in place of Tpm* and dmise, respectively. Yield: method 1, 83% (617 mg,
0.83 mmol).
Synthesis of complex 5 by method 2 was conducted following procedure for 1,
but with slight modifications. [TpmiPrCu(NCCH3)][BF4]40 (660 mg, 1 mmol) was
dissolved in dichloromethane (10 mL) and into this was cannula transferred dmit (128
mg, 1 mmol) in dichloromethane (10 mL). The reaction mixture was stirred for 3 h, and
the solvent volume reduced to about 3 mL. The product was extracted with diethyl ether
to afford a yellowish solution that was dried in vacuo and analyzed. Yield: 87% (648 mg,
0.872 mmol). Single crystals for X-ray analysis were grown via slow vapor diffusion of
ether into dichloromethane solution. 1H NMR (CD2Cl2) : 1.19 (d, JHH = 7 Hz, 18H,
3(CH3)2) , 1.33 (d, JHH = 7 Hz, 18H, 3(CH3)2) , 2.96 (sept, JHH = 7 Hz, 3H, 3CH), 3.12
(sept, JHH = 6.75 Hz, 3H, 3CH), 3.77 (s, 6H, 2CH3 [dmit]), 6.05 (s, 3H, 3CH [Pz]), 7.03(s,
2H, 2CH [dmit]), 8.00 (s, 1H, CH).

13

C{1H} NMR (CD2Cl2): 22.31 (CH(CH3)2), 22.88

(CH(CH3)2), 26.18 (CH(CH3)2), 27.84 (CH(CH3)2), 35.81 (CH3 [dmit]), 67.28 (CH),
99.71 (4-CH [Pz]), 119.80 (2CH [dmit]), 150.85 (3-CH [Pz]), 155.49 (C=S), 160.99 (5CH [Pz]).
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F{1H} NMR (CD2Cl2): -152.844, -152.896 (s,

10

BF4,

11

BF4).

11

B NMR

(CD2Cl2): -4.69. IR (cm-1): 520 s, 582 s, 633 s, 669 vs, 695 s, 723 s,743 s, 799 s, 821
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vs,879 s, 902 s, 914 s, 1005 s, 1053 b, 1180 vs, 1235 vs, 1289 s, 1366 s, 1394 m, 1464 w,
1556 vs, 1569 s,1682 b, 1737 s, 2126 b, 2359 b, 2727 b, 3139 s, 3167 s, 3364 b. Mp:
232◦C.

UV-vis

(CH3CN):

261

nm.

Mass

spectrum

(ESI-MS):

m/z

657.2

[TpmiPrCu(dmit)]+, 529.2 [TpmiPrCu]+, 319.0 [Cu-(dmit)2]+, 191.0 [dmit-Cu]+. Molar
conductivity: 95.61 S cm2 mol-1. Anal. Calc. for C33H54BCuF4N8S: C, 53.23; N, 15.15; H,
7.26. Found: C, 53.44; N, 14.92; H, 7.42.
[TpmiPrCu(dmise)][BF4] (6). Complex 6 was prepared following the procedure
for 1 using both methods except that TpmiPr (466 mg, 1 mmol) was used in place of
Tpm*. Yield: method 1, 62% (491 mg, 0.619 mmol). Method 2 was modified as stated in
procedure for 5. Yield: 67% (530 mg, 0.67 mmol). Single crystals for X-ray analysis
were grown via slow vapor diffusion of ether into dichloromethane solution. 1H NMR
(CD2Cl2): 1.17 (d, JHH = 7 Hz, 18H, 3(CH3)2), 1.32 (d, JHH = 7 Hz, 18H, 3(CH3)2), 2.98
(sept, JHH = 6 Hz, 3H, 3CH), 3.11 (sept, JHH = 6.75 Hz, 3H, 3CH), 3.85 (s, 6H, 2CH3
[dmise]), 6.04 (s, 3H, 3CH [Pz]), 7.18 (s, 2H, 2CH [dmise]), 8.01 (s, 1H, CH).
NMR (CD2Cl2): 22.40 (CH(CH3)2),

13

C{1H}

22.87 (CH(CH3)2), 26.19 (CH(CH3)2), 27.82

(CH(CH3)2), 37.57 (CH3 [dmise]), 67.50 (CH), 99.64 (4-CH [Pz]), 121.47 (2CH [dmise]),
148.12 (C=Se), 150.81(3-CH [Pz]), 161.04(5-CH [Pz]).
-152.932, -152.984 (s,

10

BF4,

11

BF4).

11
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F{1H} NMR (CD2Cl2):

B{1H} NMR [(CD3CN) ]: -1.39.

77

Se{1H} NMR

(CDCl3): -95.6. IR (cm-1): 520 s, 583 s, 669 vs, 694 s, 723 s, 746 vs, 797 vs, 821 b, 878 s,
902 s, 914 vs, 928 s, 964 s, 1004 s, 1044 b, 1150 s, 1182 s, 1234 b, 1289 b, 1383 b, 1458
b, 1556 s, 1679 s, 2125 s, 2359 s, 2728 s, 3139 s, 3165 s, 3357 b. Mp: 234◦C. UV-vis
(CH3CN): 273 nm. Mass spectrum (ESI-MS): m/z 705.2 [TpmiPrCu(dmise)]+, 529.2
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[TpmiPrCu]+. Molar conductivity: 118.4 S cm2 mol-1. Anal. Calc. for C33H54CuN8SeBF4:
C, 50.04; N, 14.15; H, 6.87. Found: C, 49.92; N, 14.23; H, 6.99.
Tp*Cu(dmit) (7). Method 1: The dmit ligand (134 mg, 1 mmol) was dissolved in
acetonitrile (20 mL) and was cannula transferred into a solution of CuCl (99 mg, 1 mmol)
in methanol (20 mL). The reaction mixture was stirred at room temperature for 3 h, and
an equimolar amount of KTp* (330 mg, 1 mmol) dissolved in acetonitrile was cannula
transferred into the reaction mixture, stirred for 18 h and dried in vacuo. The target
product was extracted using dichloromethane and the filtrate was dried in vacuo and
analyzed. Single crystals suitable for X-ray structure determination were grown by slow
diffusion of ether into methanol/dichloromethane solution. Yield 75% (365 mg, 0.75
mmol).
Method 2: [Tp*Cu(NCCH3)] (200 mg, 0.5 mmol) was dissolved in
dichloromethane (10 mL) and dmit (90 mg, 0.5 mmol) in dichloromethane (10 mL) was
added. The reaction mixture was stirred for 3 h, dried in vacuo and the solid product
washed with hexane to afford a white precipitate which was filtered, dried in vacuo, and
analyzed. Yield 89% (217 mg, 0.445 mmol). 1H NMR (CDCl3): 1.70 (s, 9H, 3(CH3)),
2.44 (s, 9H, 3(CH3), 3.68 (s, 6H, 2CH3 [dmit]), 5.73 (s, 3H, 3CH [Pz]), 6.83 (s, 2H, 2CH
[dmit]). 13C{1H} NMR (CDCl3): 13.25 (CH3), 13.64 (CH3), 36.08 (CH3 [dmit]), 104.79
(C-4 [Pz]), 119.33 (2CH [dmit]), 144.60 (C-3 [Pz]), 148.31 (C-5 [Pz]), 157.45 (C=S). IR
(cm-1): 502 s, 516 s, 634 s, 656 s, 664 s, 679 s, 699 s, 743 s, 784 s, 813 s, 842 s, 979 s,
1036 s, 1059 s, 1082 s, 1175 b, 1235 s, 1262 s, 1386 b, 1542 s, 1571 s, 1653 s, 1673 s,
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1695 s, 1734 s, 2341 s, 2362 s, 2509 s, 2735 s, 2853 b, 3034 s, 3118 s, 3155 s. Mp: 223227◦C. UV-vis (CH3CN): 267 nm. Mass spectrum (ESI-MS): m/z 488.1 [Tp*Cu(dmit)]+,
360.1 [Tp*Cu]+, 318.9 [Cu(dmit)2]+, 190.9 [Cu-dmit]+. Anal. Calc. for CuC20BH30N8S:
C, 49.13; N, 22.92; H, 6.20. Found: C, 48.83; N, 22.45; H, 6.18.
Tp*Cu(dmise) (8). Complex 8 was prepared following the procedure for 7 using
both methods except that dmise (175 mg, 1 mmol) was used in place of dmit. Single
crystals suitable for X-ray analysis were grown by slow vapor diffusion of ether into
dichloromethane and methanol solution. Yield: method 1, 59% (316 mg, 0.59 mmol);
method 2, 74% (397 mg, 0.74 mmol). 1H NMR (CDCl3): 1.70 (s, 9H, 3(CH3)), 2.44 (s,
9H, 3(CH3), 3.75 (s, 6H, 2CH3 [dmise]), 5.73 (s, 3H, 3CH [Pz]), 6.93 (s, 2H, 2CH
[dmise]).

13

C{1H} NMR (CDCl3): ): 13.25 (CH3), 13.64 (CH3), 37.45 (CH3 [dmise]),

104.79 (C-4 [Pz]), 120.27 (2CH [dmise]), 144.60 (C-3 [Pz]), 148.30 (C-5 [Pz]), 151.63
(C=Se). 77Se{1H} NMR (CDCl3): -31.5. IR (cm-1): 599 s, 635 s, 655 s, 666 s, 699 s, 723
s, 748 s, 811 w, 839 s, 980 s, 1036 s, 1059 s, 1081 s, 1146 s, 1176 b, 1232 s, 1262 s, 1378
b, 1443 b, 1541 s, 1569 s, 1594 s, 1699 s, 2508 s, 2734 s, 2851 s, 3116 s, 3152 s. Mp:
223-227◦C. UV-vis (CH3CN): 270 nm. Mass spectrum (ESI-MS): m/z 536.1
[Tp*Cu(dmise)]+, 414.9 [Cu(dmise)2]+, 360.1 [Tp*Cu]+, 175.9 [dmise]+. Anal. Calc. for
CuC20BH30N8Se: C, 46.04; N, 20.45; H, 5.52. Found: C, 45.05; N, 20.89; H, 5.69.
[Tpm*Cu(dmise)][Cl] (9). The dmise ligand (176 mg, 1 mmol) was dissolved in
acetonitrile (20 mL) and was cannula transferred to a solution of CuCl (99 mg, 1 mmol)
in methanol (20 mL). The reaction mixture was stirred for 3 h at room temperature and an
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equimolar amount of Tpm* (298 mg, 1 mmol) was dissolved in acetonitrile and cannula
transferred into the reaction mixture and stirred for 18 h. The reaction mixture was
pumped down to ~5 mL and the target product was precipitated using ether. The
precipitate was dried in vacuo to yield a white powder. Yield 52% (297 mg, 0.52 mmol).
1

H NMR (CD2Cl2): 2.26 (s, 9H, 3CH3), 2.32 (s, 9H, 3CH3), 3.75 (s, 6H, 2CH3 [dmise]),

5.97 (s, 3H, 3CH [Pz]), 6.97 (s, 2H, 2CH [dmise]), 7.87 (s, 1H, CH).

13

C{1H} NMR

(CD2Cl2): 10.70 (CH3), 13.37 (CH3), 37.22 (CH3 [dmise]), 106.99 (C-4 [Pz]), 119.98
(2CH [dmise]), 139.69 (C-3 [Pz]), 149.95 (C-5 [Pz]), 153.22 (C=Se). Mp: 256-258◦C. IR
(cm-1): 628 s, 652 s, 700 vs, 705 vs, 738 s, 799 vs, 813 s, 850 vs, 900 vs, 975 vs, 1035 vs,
1098 w, 1150 s, 1240 vs, 1305 s, 1382 s, 1412 s, 1464 s, 1522 w, 1540 w, 1560 vs, 1653
s, 1733 s, 2338 w, 2361 w, 2936 b. UV-vis (CH3CN): 273 nm. Mass spectrum (ESI-MS):
m/z 537.1 [Tpm*Cu(dmise)]+, 402.1 [Tpm*Cu + MeOH]+, 361.1[Tpm*Cu]+. Molar
conductivity: 30.71 S cm2 mol-1. Anal. Calc. for C21H30CuN8SeCl: C, 44.06; N, 19.57; H,
5.28. Found: C, 43.35; N, 19.43; H, 5.19.
[Tpm*Cu(dmit)][Cl] (10). Complex 10 was prepared following the procedure for
9 except that dmit (129 mg, 1mmol) was used in place of dmise. Yield: 60% (315 mg,
0.60 mmol). 1H NMR (CD2Cl2): 2.16 (s, 9H, 3CH3), 2.55 (s, 9H, 3CH3), 3.73 (s, 6H,
2CH3 [dmit]), 6.06 (s, 3H, 3CH [Pz]), 6.86 (s, 2H, 2CH [dmit]), 7.912 (s, 1H, CH).
13

C{1H} NMR (CD2Cl2): 9.43 (CH3), 12.04 (CH3), 34.63 (CH3 [dmit]), 68.59 (CH),

106.40 (C-4 [Pz]), 119.42 (CH [dmit]), 140.38 (C-3 [Pz]), 150.61 (C-5 [Pz]), 156.54
(C=S). IR (cm-1): 630 s, 664 s, 670 s, 699 s, 706 s, 734 s, 749 s, 763 s, 817 s, 849 vs, 898
s, 977 s, 1035 s, 1087 s, 1181 b, 1240 s, 1306 s, 1387 b, 1465 b, 1521 s, 1567 s, 1623 b,
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1653 b, 2915 b, 3074 b, 3105 b. Mp: 275-277ºC. UV-vis (CH3CN): 273 nm. Mass
spectrum (ESI-MS): m/z 489.1 [Tpm*Cu(dmit)]+, 402.1 [Tpm*Cu + MeOH]+, 361.1
[Tpm*Cu]+. Molar conductivity: 25.10 S cm2 mol-1. Anal. Calc. for C21H30CuN8SCl: C,
47.91; N, 21.29; H, 5.71. Found: C, 47.65; N, 21.05; H, 5.69.
[TpmiPrCu(dmit)][Cl] (11). Complex 11 was prepared following the procedure for
9 except that dmit (129 mg, 1 mmol) and TpmiPr (466 mg, 1 mmol) were used in place of
dmise and Tpm*. Yield: 62% (430 mg, 0.62 mmol). 1H NMR (CDCl3): 1.22 (d, JHH = 6
Hz, 36H, 6(CH3)2), 3.11 (sept, JHH = 8.25 Hz, 3H, 3CH), 3.19 (br, 3H, 3CH), 3.70 (s, 6H,
2CH3 [dmit]), 5.94 (s, 3H, 3CH [Pz]), 6.82 (s, 2H, 2CH [dmit]), 8.04(s, 1H, CH). 13C{1H}
NMR (CDCl3): 22.64 (CH(CH3)2),

23.13 (CH(CH3)2), 25.88 (CH(CH3)2), 27.73

(CH(CH3)2), 35.64 (CH3 [dmit]), 63.43 (HC), 99.96 (4-C (Pz)), 118.58 (2CH2 [dmit]), ,
150.76 (3-C (Pz)), 159.5 ( C=S), 160.09 (5-C (Pz)). IR (cm-1): 670 vs, 691 s,722 vs, 747
vs, 763 vs, 797 vs, 806 s, 826 s, 861 s, 879 s, 903 s, 927 s, 961 s, 999 w, 1016 s, 1057 s,
1071 s, 1109 s, 1177 s, 1243 s, 1270 s, 1291 s, 1309 s, 1364 s,1380 s, 1465 w, 1552 s,
1571 s, 1621 s, 1656 b, 1729 s, 2722 b, 3038 b, 3079 s, 3104 s, 3148 s, 3196 b. Mp:
223-227◦C. UV-vis (CH3CN): 260 nm. Mass spectrum (ESI-MS): m/z 657.2
[TpmiPrCu(dmit)]+, 529.3 [TpmiPrCu]+, 319.0 [Cu(dmit)2]+, 232.0 [Cu-dmit + MeOH]+,
191.0 [dmit-Cu]+. Molar conductivity: 24.54 S cm2 mol-1. Anal. Calc. for
C33H54CuN8SCl: C, 57.14; N, 16.16; H, 7.79. Found: C, 56.40; N, 15.69; H, 7.88.
[TpmiPrCu(dmise)][Cl] (12). Complex 12 was prepared following the above
procedure for 9 except that TpmiPr (466 mg, 1 mmol) was used in place of Tpm*. Yield:
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42% (311 mg, 0.42 mmol). 1H NMR (CDCl3): 1.22 (d, JHH = 6 Hz, 36H, 6(CH3)2), 3.10
(sept, JHH = 6 Hz, 3H, 3CH), 3.19 (sept, JHH = 6 Hz, 3H, 3CH), 3.79 (s, 6H, 2CH3
[dmise]), 5.94 (s, 3H, 3CH [Pz]), 6.98 (s, 2H, 2CH [dmise]), 8.04 (s, 1H, CH).
NMR (CDCl3): 22.66 (CH(CH3)2),

13

C{1H}

23.13 (CH(CH3)2), 25.93 (CH(CH3)2), 27.72

(CH(CH3)2), 37.56 (CH3 [dmise]), 71.1 (HC), 99.92 (4-CH [Pz]), 120.54 (2CH [dmise]),
150.81 (3-CH [Pz]), 152.03 (C=Se), 160.25 (5-CH [Pz]). IR (cm-1): 668 vs, 722 vs, 740
vs, 752 vs, 797 vs, 806 s, 825 s, 860 s, 879 s, 903 s, 927 s, 1004 s, 1015 s, 1056 s, 1072 s,
1109 s, 1151 s, 1180 vs, 1234 s, 1270 vs, 1290 s, 1308 s, 1380 s, 1464 b, 1552 s, 1565 s,
1595 b, 1656 b, 2125 b, 3093 b, 3146 s. Mp: 234-236◦C. UV-vis (CH3CN): 205, 268 nm.
Mass-spectrum (ESI-MS): m/z 705.2 [TpmiPrCu(dmise)]+, 570.3 [TpmiPrCu + MeOH]+,
529.2 [TpmiPrCu]+, 414.9 [Cu(dmise)2]+. Molar conductivities: 23.29 S cm2 mol-1. Anal.
Calc. for C33H54CuN8SeCl: C, 53.51; N, 15.14; H, 7.30. Found: C, 52.89; N, 15.21; H,
7.25.
X-ray Data Collection and Structural Determination. Single crystals grown from
vapor diffusion were mounted on a glass filament with silicon grease and immediately
cooled to 168 ± 2 K in a cold nitrogen gas stream. The crystals were grown by vapor
diffusion of diethyl ether into an acetonitrile solution for [Tpm*Cu(dmise)][BF4] (1) and
[Tpm*Cu(dmit)][BF4]

(2);

[TpmCu(dmise)][BF4]

(3)

diethyl
and

ether

into

a

[TpmCu(dmit)][BF4]

methanol
(4);

diethyl

solution

for

ether

into

dichloromethane solution for [TpmiPrCu(dmise)][BF4] (6); and diethyl ether into a
dichloromethane / methanol solution for Tp*Cu(dmit) (7) and Tp*Cu(dmise) (8).
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S
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diffractometer. The space groups P21/c for 1, 2, and 3; P212121 for 4; C2/c for 6 and
P21/m for 7 and 8 were determined from the observed systematic absences. Data
reduction including the application of Lorentz and polarization (Lp) effects and
absorption corrections used the CrystalClear program.82 The structures were solved by
direct methods and subsequent Fourier difference techniques, and refined anisotropically,
by full-matrix least squares, on F2 using SHELXTL 6.10.83 The quantity minimized by
the least square program was

w = (Fo2 - Fc2)2 where w = {[ 2(Fo2)] + (0.0585P)2 +

1.89P]} for 1, w = {[ 2(Fo2)] + (0.0843P)2 + 1.58P]} for 2, w = {[ 2(Fo2)] + (0.0298P)2
+ 46.69P]} for 3, w = {[ 2(Fo2)] + (0.0469P)2 + 0.34P]} for 4, w = {[ 2(Fo2)] +
(0.0993P)2 + 4.78P]} for 6, w = {[ 2(Fo2)] + (0.0619P)2 + 0.93P]} for 7, w = {[ 2(Fo2)]
+ (0.0537P)2 + 1.39P]} for 8, and P = (Fo2) + 2Fc2)/3]. In the final cycle of least and
squares, independent anisotropic displacement factors were refined for the non-hydrogen
atoms and the methyl hydrogen atoms were fixed in idealized positions with C-H = 0.96
Å. Their isotropic displacement parameters were set equal to 1.5 times Ueq of the attached
carbon atom.
For complex 1, the largest peak in the final Fourier difference map (0.81 e·A-3)
was located 0.92 Å from F(2), and the lowest peak (-0.68 e·A-3) was located at a distance
of 0.81 Å from Se. The largest peak for complex 2 in the final Fourier difference map
(1.014 e·A-3) was located 0.02 Å from Cu, and the lowest peak (-0.676 e·A-3) was located
at a distance of 0.76 Å from Cu. The largest peak for complex 3 in the final Fourier
difference map (1.635 e·A-3) was located 0.29 Å from H(3AA), and the lowest peak (0.740 e·A-3) was located at a distance of 0.80 Å from Se(1A). The largest peak for 4 in

52

the final Fourier difference map (0.77 e·A-3) was located 1.59Å from H(11A), and the
lowest peak (-0.41 e·A-3) was located at a distance of 0.80 Å from Cu. The largest peak for
6 in the final Fourier difference map (0.94 e·A-3) was located 0.04 Å from Se(1), and the
lowest peak (-0.60 e·A-3) was located at a distance of 0.89 Å from Se(1). The largest peak
for 7 in the final Fourier difference map (0.583 e·A-3) was located 0.92 Å from H(20B),
and the lowest peak (-0.628 e·A-3) was located at a distance of 0.11 Å from H(20A). The
largest peak for 8 in the final Fourier difference map (0.71 e·A-3) was located 2.44 Å
from H(13B), and the lowest peak (-0.51 e·A-3) was located at a distance of 0.81 Å from
Se(1). Final refinement parameters for the structures of 1, 2, 3, 4, 6, 7, and 8 are given in
Tables 2.10, 2.11, and 2.12. Crystal structure diagrams of the copper complexes are
shown in Figures 2.3-2.5 and 2.7-2.10, and their crystal packing diagrams are shown in
Figures 2.6 and 2.14-2.19.
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Table 2.10. Summary of crystallographic data for complexes 1 and 2.
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

1
C21H30BCuF4N8Se
623.84
P21/c
Monoclinic
12.199(2)
16.322(3)
13.043(3)
90
93.54(3)
90
2592.2(9)
4
1.598
[-15, -20, -16]
[12, 20, 15]
333
1264
2.302
2.50 - 26.71
21217
5472
0.0435
0.1101
0.0508
0.1163
1.110
0.808
-0.682

2
C21H30BCuF4N8S
576.94
P21/c
Monoclinic
12.248(2)
16.233(3)
12.914(3)
90
93.41(3)
90
2563.2(9)
4
1.495
[-15, -20, -16]
[13, 19, 16]
333
1192
0.990
3.01- 26.73
22159
5406
0.0508
0.1349
0.0557
0.1426
1.098
1.014
-0.676

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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Table 2.11. Summary of crystallographic data for complexes 3 and 4.
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

3
C15H18BCuF4N8Se
539.69
P21/c
Monoclinic
10.176(2)
17.734(3)
22.586(4)
90
96.47(3)
90
4049.9(13)
8
1.770
[-12, -21, -24]
[11, 21, 26]
546
2144
2.932
2.96 – 25.05
30276
7119
0.0692
0.1713
0.0741
0.1732
1.180
1.490
-0.619

4
C15H18BCuF4N8S
492.78
P2(1)2(1)2(1)
Orthorhombic
9.7241(19)
11.335(2)
18.262(4)
90
90
90
2012.9(7)
4
1.626
[-8, -14, -23]
[12, 14, 23]
274
1000
1.245
2.76 – 26.72
16710
4255
0.0354
0.0845
0.0388
0.0871
1.139
0.766
-0.412

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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Table 2.12. Summary of crystallographic data for complexes 6, 7, and 8.
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data)R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

6
C33H54BCuF4N8Se
792.15
C2/c
Monoclinic
23.822(5)

16.733(3)
19.931(4)
90
100.04(3)
90
7823(3)
8
1.345
[-29, -20, -21]
[28, 20, 24]
447
3296
1.541
2.43 – 26.32
38614
7938
0.0628
0.1619
0.1023
0.1969
1.050
0.941
-0.598

7
C20H30BCuN8S
488.93
P21/m
Monoclinic
8.2925(17)
11.808(2)
11.934(4)
90
91.32(3)
90
1168.3(4)
2
1.390
[-10, -14, -14]
[9, 14, 14]
160
512
1.048
3.02 – 26.74
11607
2586
0.0394
0.1041
0.0413
0.1073
1.102
0.583
-0.628

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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8
C20H30BCuN8Se
535.83
P21/m
Monoclinic
8.3319(17)
11.771(2)
12.082(2)
90
92.09(3)
90
1184.2(4)
2
1.503
[-9, -14, -15]
[10, 14, 11]
160
548
2.483
3.02 – 26.29
9538
2494
0.0383
0.0953
0.0465
0.1021
1.059
0.712
-0.513

Figure 2.13. Cyclic voltammetry (CV) scans for A) Tp*Cu(dmise), B)
Tp*Cu(dmit), C) [TpmCu(dmise)][BF4], D) [TpmCu(dmit)][BF4], E)
[Tpm*Cu(dmise)][BF4], F) [Tpm*Cu(dmit)][BF4]. All data collected with 1
mM complex in acetonitrile. Potentials are reported versus NHE.
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Figure 2.13 (cont.). Cyclic voltammetry (CV) scans for G)
[Tpm*Cu(dmise)][Cl], H) [Tpm*Cu(dmit)][Cl], I) [TpmiPrCu(dmise)][BF4], J)
[TpmiPrCu(dmit)][BF4], K) [TpmiPrCu(dmise)][Cl], L) [TpmiPrCu(dmit)][Cl].
All data collected with 10 mM complex in acetonitrile. Potentials are reported
versus NHE.
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Figure 2.13 (cont.). Cyclic voltammetry (CV) scans for M)
[Tpm*Cu(NCCH3][BF4], N) [TpmiPrCu(NCCH3][BF4], O) Tpm*CuCl, P)
TpmiPrCuCl. All data collected with 10mM complex in acetonitrile. Potentials
are reported versus NHE.
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Figure 2.14. Crystal packing diagram of [Tpm*Cu(dmise)][BF4] (1) at 50%
probability density ellipsoids displaying H and F short contact interactions
along the a-axis.
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Figure 2.15. Crystal packing diagram of [TpmCu(dmise)][BF4] (3) at 50%
probability density ellipsoids displaying H and F short contact interactions
along the b-axis.
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Figure 2.16. Crystal packing diagram of [Tpm*Cu(dmit)][BF4] (2) at 50%
probability density ellipsoids displaying H and F short contact interactions along
the b-axis.
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Figure 2.17. Crystal packing diagram of [TpmCu(dmit)][BF4] (4) at 50%
probability density ellipsoids displaying H and F short contact interactions
along the c-axis.
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Figure 2.18. Crystal packing diagram of Tp*Cu(dmit) (7) at 50% probability
density ellipsoids along the b-axis.
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Figure 2.19. Crystal packing diagram of Tp*Cu(dmise) (8) at 50% probability
density ellipsoids along the a-axis.
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CHAPTER THREE
REACTIVITY OF BIOLOGICALLY RELEVANT CHALCOGENONES AND THEIR
Cu(I) COMPLEXES WITH H2O2: INSIGHTS INTO SELENIUM AND SULFUR
ANTIOXIDANT ACTIVITY

Introduction
Hydrogen peroxide (H2O2) is a byproduct of respiration and is reduced by copper
(I) in the Fenton-like reaction, resulting in the formation of the damaging hydroxyl
radical (reaction 1).1 Cellular reductants can reduce Cu2+ to Cu+, making ˙OH formation
catalytic.2 The generated ˙OH causes cellular DNA damage and can be enhanced by
genetic diseases such as Wilson’s and Menkes disease that result in mis-regulation of
copper levels.3 Copper-generated hydroxyl radical has been implicated as an underlying
cause

of

diabetes,

amyotrophic

lateral

sclerosis,

cancer,

inflammatory

and

neurodegenerative diseases, and Alzheimer’s disease.4-7
Cu+ + H2O2 → Cu2+ + HO∙ + OH- (1)
Selenium and sulfur antioxidants can prevent or reduce oxidative DNA
damage8-11 and may be important in preventing stomach, colorectal and prostate cancers,
although their mechanism of action is not fully understood.12-15 Two major clinical trials
(NPC and SELECT) showed conflicting results on the ability of selenium
supplementation to prevent prostate cancer, emphasizing the need for additional research
into selenium antioxidant mechanisms.16,17 Our previous research has determined that
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metal coordination is required for inhibition of copper- mediated DNA damage by sulfur,
oxo-sulfur, and selenium compounds,8,9,18-21 and this copper binding mechanism is
different from traditional mechanisms such as radical scavenging or glutathione
peroxidase-like activity. 22
To determine how coordination to sulfur and selenium inhibits copper mediated
oxidative damage, biologically relevant Cu+-N,N’-dimethylimidazole selone (dmise) and
thione (dmit) complexes with tris(pyrazolyl)methane ligands have been synthesized,23
and their reactivities examined with H2O2. The heterocyclic chalcogenone ligands used in
this study resemble selenoneine,24 and ergothioneine,25 naturally occurring selenium and
sulfur antioxidants found in animals and plants. Previous studies have shown that
coordination of selone and thione ligands to copper in [Tpm*CuX]+ (Tpm* = tris(3,5dimethylpyrazolyl)methane; X = dmise or dmit) results in more negative Cu2+/+ reduction
potentials.23 If similar complexes form in vivo, this lowered copper potential may prevent
reduction of Cu2+ by cellular reductants such as NADH, preventing Cu+ regeneration and
inhibiting catalytic generation of •OH.
In addition to altering Cu2+/+ reduction potentials, sulfur and selenium may also
prevent DNA damage by acting as sacrificial antioxidants by reacting with H2O2 directly,
preventing copper generation of •OH. If this sacrificial reactivity occurs, it is expected
that the more oxophilic selone will be a more effective antioxidant than the thione. 26 The
sacrificial antioxidant ability of selone and thione ligands was investigated by treating
dmise and dmit with H2O2. Similarly, [Tpm*Cu(dmise)]+ and [Tpm*Cu(dmit)]+
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complexes were treated with H2O2 to determine whether the chalcogenone ligand or Cu+
reacts preferentially with H2O2. If the chalcogenone ligands are more reactive with H2O2
than Cu+, the bound selenium or sulfur ligand will hinder oxidation of the Cu+ center to
Cu2+. Sacrificial oxidation of copper-bound sulfur and selenium ligands would represent
an alternative antioxidant mechanism compared to prevention of copper redox cycling.

Results and Discussion
Oxidation of dmise and dmit. The oxidation of the dmise and dmit ligands was
conducted by treating the chalcogenones compounds with one or two equiv of H2O2,
respectively, in methanol under an argon atmosphere. 1H NMR spectra of the untreated
dmise and dmit ligands have two resonances corresponding to the methyl protons (δ 3.60
and δ 3.56, respectively ) and olefinic protons (δ 7.04 and δ 6.90, respectively; Figures
3.1 and 3.2).

A

B

E
a

N

2

4 5
b

A

N

E
N

C

N

B

Figure 3.1. Structures of the heterocyclic chalcogenone ligands
(E = S, dmit; E = Se, dmise) showing A) 1H NMR resonance
labels and B) 13C{1H} NMR resonance labels. Ring numbering
is shown in A.
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Upon treatment of dmise and dmit ligands with H2O2, the 1H NMR spectra show
shifted resonances that correspond to the methyl protons (δ 3.98 for both) and olefinic
protons (δ 7.60 and δ 7.61 for dmise and dmit, respectively) along with the emergence of
a new resonance at δ 8.91 (Figure 3.2). The methyl and olefinic protons of the H2O2treated chalcogenone ligands are shifted downfield relative to untreated dmise and dmit.
The new resonance at δ 8.91 suggests cleavage of the selenium or sulfur atom from the
heterocyclic ring followed by hydrogen insertion. This new resonance at δ 8.90 is very
similar to the H2 resonance of the 1,3-dimethylimidazolium cation.27

Figure 3.2. 1H NMR spectra of A) dmise before and after treatment with 1 equiv
H2O2, B) dmit before and after treatment with 2 equiv of H2O2.
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The

13

C{1H} NMR spectra of dmise and dmit show three resonances

corresponding to the methyl carbons (δ 37.0 and δ 36.3, respectively), olefinic carbons (δ
120.5 and δ 119.2, respectively) and the quaternary carbon (δ 156.8 and 162.4,
respectively; Figure 3.3). Upon treatment of dmise and dmit with H2O2, the

13

C{1H}

NMR resonances corresponding to the methyl carbons shift very little (δ 35.70
and δ 35.20, respectively). In contrast, the olefinic C-4 and C-5 carbons are slightly
shifted downfield (δ 123.59 and δ 123.50, respectively), whereas the C-2 carbon is
shifted upfield by about δ 20. This upfield shift of the C-2 carbon coupled with the 1H
NMR resonance at δ 8.90 indicates cleavage of the C=Se or C=S bonds from the
heterocyclic rings and formation of the dimethylimidazolium cation.26

Figure 3.3. 13C{1H} NMR of A) dmise before and after treatment with 1 equiv H2O2
and B) dmit before and after treatment with 2 equiv H2O2. Solvent molecule labeled
with the pound sign.
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Electrospray ionization (ESI) mass spectra of the oxidized products obtained from
the

reaction

of

dmise

or

dmit

with

H2O2

confirm

formation

of

the

N,N’-dimethylimidazolium cation (m/z 97.071) as the major product in the positive
ionization mode. Two oxidized sulfur products at m/z 96.99 [SO4H]-, 79.98 [SO3H]- and
one oxidized selenium product at m/z 112.96 [SeO2H]- were identified in the negative
ionization mode. The different oxidized species seen upon dmit and dmise oxidation may
result from the higher concentration of H2O2 required for complete oxidation of dmit
relative to dmise.
The identity of the oxidized selenium product was confirmed using
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Se{1H}

NMR spectroscopy. The untreated dmise ligand has a selenium resonance at δ -29.5 in
CD3OD that shifts to δ 1345 upon treatment with 1 equiv H2O2 (Figure 3.4). A 77Se{1H}
NMR resonance near δ 1345 is expected for the [SeO2H]- ion.20

Figure 3.4. 77Se{1H} NMR spectra of A) dmise ligand and B) oxidized dmise ligand
after reaction with H2O2.
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Based on our experimental results, treatment of the chalcogenone ligands with
H2O2 results in the oxidation and cleavage of selenium and sulfur atoms from the
five-membered heterocyclic ring with the formation of the 1,3-dimethylimidazolium
cation (Figure 3.5). Reactivity of dmise and dmit with the reactive oxygen species
peroxynitrite has been investigated by Bhabak et al.26 and the authors have determined
that peroxynitrite oxidizes dmise and dmit to yield the 1,3-dimethylimidazolium cation
and selenium and sulfur oxides, respectively. Elimination of the selenium and sulfur
atoms from the five-membered rings occurs through formation of unstable
selenic/sulfenic acids and seleninic/sulfinic acids. Theoretical DFT calculations
conducted by our collaborator Dr. Craig Bayse (Old Dominion University) also suggest
formation of unstable selenic/sulfenic and seleninic/sulfinic acid intermediates upon
reaction of dmise or dmit with H2O2 leading to cleavage of C=Se or C=S bond.

H

E
N

N

H2O2

N

N

+ EOnH

Figure 3.5. Reaction of dmise and dmit with H2O2 (E = Se, n =
2; E = S, n = 3, 4).
The higher oxophilicity of dmise relative to dmit is illustrated by the reactivity of
this compound with H2O2. Upon reaction of dmise with 1 equiv of H2O2, the selenium
atom is completely cleaved from the C-2 carbon, whereas the dmit ligand requires 2
equiv H2O2 to completely react. Thus, dmise is a more sensitive H2O2 scavenger
compared to dmit and could prevent copper mediated oxidative damage by H2O2 more
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effectively. These results are in agreement with results reported by Bhabak et al.,
indicating that selone containing compounds generally prevented more peroxynitrite
mediated nitration of free tyrosine relative to analogous thione compounds.26
Reactivity of tris(3,5-dimethylpyrazolyl)methane Cu selone and thione complexes
with H2O2. The tris(3,5-dimethylpyrazolyl)methane copper selone and thione complexes
were treated with H2O2 to determine whether the Cu+ or the chalcogenone atoms would
preferentially react with H2O2. Acetonitrile solutions of the [Tpm*Cu(X)]+ (X = dmise or
dmit) complexes were treated with 0.5, 1, and 2 molar equiv H2O2 for the selone complex
or 1, 2, and 3 molar equiv H2O2 for the thione complex. 1H NMR spectra of the oxidized
[Tpm*Cu(X)]+ (X = dmise or dmit) copper complexes (Figure 3.6) show sharply-defined
peaks, indicating that the diamagnetic Cu+ center is not oxidized upon treatment with
H2O2. The resonances corresponding to the tripodal Tpm* ligand do not shift upon H2O2
treatment, indicating that this reactive oxygen species only reacts with the dmise or dmit
ligand.
The 1H NMR spectra of the [Tpm*CuX]+ (X = dmise or dmit) copper complexes before
treatment with H2O2 have dmise ligand resonances at δ 3.88 for the methyl protons and δ
7.17 for the olefinic protons, whereas the corresponding dmit resonances are observed at
δ 3.87 and δ 7.00 respectively.23 Upon treatment with H2O2, oxidized [Tpm*CuX]+ (X =
dmise or dmit) copper complexes have dmise resonances at δ 3.86 for the methyl protons,
δ 7.36 for the olefinic protons and a new resonance at δ 8.49 corresponding to an
integration of one proton (Figure 3.6).
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Figure 3.6. 1H NMR spectra of A) [Tpm*Cu(dmise)][BF4] upon treatment with
0.5, 1.0, and 2.0 equiv of H2O2 and B) [Tpm*Cu(dmit)][BF4] upon treatment with
1.0, 2.0, and 3.0 equiv of H2O2. Solvent and H2O resonances are labeled with an
asterisk and pound sign respectively.
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Upon similar oxidation, dmit resonances are observed at δ 3.85 for the methyl
protons, δ 7.36 for the olefinic protons and a new resonance at 8.47 (Figure 3.6). The
olefinic protons of the oxidized dmise and dmit ligands shift downfield relative to their
resonances in the untreated copper selone or thione complexes.23 This downfield shift
upon oxidation coupled with the appearance of a new resonance ~ δ 8.48 indicates
oxidation of the selenium and sulfur and formation of the 1,3-dimethylimidazolium
cation, similar to the oxidation products of dmise and dmit. Complete oxidation of the
selone ligand in [Tpm*Cu(dmise)]+ requires 2 equiv of H2O2, whereas the analogous
copper-thione complex requires 3 equiv of H2O2 to completely react, indicating that the
bound selone is more oxophilic relative to the bound thione. Both copper-bound selone
and thione ligands sacrificially react with H2O2, and this reactivity prevents Cu+
oxidation.
The ESI mass spectrometry data for the oxidized products obtained from the
treatment of [Tpm*CuX]+ (X = dmise/dmit) complexes with H2O2 indicate formation of
[Tpm*Cu(NCCH3)]+ (m/z 402.12) and N,N’-dimethylimidazolium (m/z 97.071) in the
positive ionization mode, corroborating 1H NMR results. Negative ion ESI-MS results
indicate several oxidized sulfur (m/z 79.98 [SO3H]- and 96.99 [SO4H]-) and selenium
products (112.96 [SeO2H]-). The different oxidized species arising from sulfur and
selenium ligands may result from the higher concentration of H2O2 required for the
complete oxidation of [Tpm*Cu(dmit)]+ complex (3 equiv H2O2)
[Tpm*Cu(dmise)]+ (2 equiv H2O2).
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Figure 3.7. Reaction of [Tpm*CuX]+ (X = dmise or dmit) with H2O2 (E = Se,
n = 2; E = S, n = 3, 4).

Figure 3.8. Space filling diagram of [Tpm*Cu(dmise)]+ and X-ray crystal
structure of [Tpm*Cu(NCCH3)]+ showing 50% probability density ellipsoids.
Hydrogen atoms and counterions are omitted for clarity.

The overall reaction of [Tpm*CuX]+ (X = dmise or dmit) with H2O2 is given in
Figure 3.7. Figure 3.8 reveals that both the Cu+ center and selenium atoms are accessible
for oxidation by H2O2, but H2O2 treatment preferentially oxidizes the chalcogenone
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ligand without oxidation of the Cu+ center. Similar to the results obtained in the oxidation
of the unbound chalcogenones, dmise in [Tpm*Cu(dmise)]+ is a more sensitive H2O2
scavenger compared to dmit in [Tpm*Cu(dmit)]+. These results indicate that the copper
selone complexes may prevent copper-mediated oxidative damage by H2O2 more
effectively than their thione analogs.
Cu+ complexes treated with O2 and H2O2 form peroxo, side-on, end-on and oxo
bridged dinuclear Cu2+ complexes.28 Of particular interest is the reaction of
[Tpm*Cu(NCCH3)]+ with H2O2 that results in the formation of an oxo-bridged dicopper
Tpm* complex, [{Tpm*Cu(OH)}2]2+ with the oxidation of Cu+ to Cu2+.29 The peroxo
dicopper complexes previously obtained with tris(pyrazolyl)copper(I)-acetonitrile
complexes and are usually characterized by formation of a deep purple solution at low
temperatures,30 a phenomenon that was absent in our system.
Treating [Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile rresults in
the formation of [Tpm*Cu(NCCH3)][BF4]. The [Tpm*Cu(NCCH3)][BF4] complex can
be independently synthesized from [Cu(NCCH3)4][BF4] and Tpm*,31 but its structure has
not been reported.

The Cu+ center in [Tpm*Cu(NCCH3)][BF4] (Figure 3.8) adopts

distorted tetrahedral geometry, bound in a κ3 fashion to three nitrogen atoms from the
tridentate Tpm* ligand and terminally bound to an acetonitrile solvato ligand. The small
bite angle of the Tpm* ligand results in pinning back of the nitrogen atoms upon
coordination to copper, producing small N-Cu-N angles ranging from 85.9 to 89.9°
(Table 3.1),31 with Cu-N bond lengths of 2.08-2.09 Å. These C-N bond lengths and
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N-Cu-N angles are comparable to other tris(pyrazolyl)methane copper(I) complexes such
as [TpmCu(NCCH3)][BF4] (2.05-2.14 Å, 87.8º),32 [Tpm*Cu(1,4-CNC6H4NC)][BF4]
(2.06-2.09 Å, 87.2º),32 [Tpm3-tBuCu(NCCH3)][PF6] (2.06-2.14 Å, 89.2º),31 and
[TpmiPrCu(CO)][PF6] (avg. 2.05 Å, 88.1º).33 The Cu-N bond distance of 1.87 Å for the
terminal acetonitrile bond is comparable with previously reported Cu+ acetonitrile
complexes.32,34,35

Figure 3.9. X-ray crystal structure diagram of [Tpm*Cu(NCCH3)][BF4]
showing 50% probability density ellipsoids. Hydrogen atoms and counterions
are omitted for clarity.
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Table 3.1. Selected bond lengths (Å) and angles (deg) for [Tpm*Cu(NCCH3)][BF4].
Cu-N(1)
Cu-N(4)
Cu-N(4)
Cu-N(7)
N(7)-C(17)

2.088(4)
2.080(4)
2.089(3)
1.865(4)
1.137(7)

N(4)-Cu-N(1)
N(4)-Cu-N(5)
N(1)-Cu-N(5)
N(7)-Cu-N(1)
N(7)-Cu-N(4)
N(7)-Cu-N(5)

85.92(14)
89.93(14)
87.74(14)
130.26(16)
124.68(16)
125.35(16)

Treating [Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile results in
preferential oxidation of the dmise or dmit ligand and formation of oxidized selenium and
sulfur species, the dimethylimidazolium cation and [Tpm*Cu(NCCH3)][BF4]. Since these
copper-selone and -thione complexes undergo sacrificial oxidation of chalcogenone
atoms without oxidation of the Cu+ center, if similar copper-selenium and -sulfur
complexes are formed in vivo, such complexes may scavenge H2O2 and inhibit coppermediated oxidative damage. These studies indicate that coordination of selenium and
sulfur compounds to Cu+ may prevent copper-mediated DNA damage in one of two
ways: coordination of selone or thione to Cu+ alters the Cu2+/+ reduction potential hence
preventing reduction of Cu2+ by NADH and inhibiting copper redox cycling or by
efficiently scavenging H2O2 by bound selenium or sulfur compounds.

Conclusions
The reactivity of biologically relevant selone and thione ligands and their copper
complexes with H2O2 has been determined and compared. Treatment of dmise and dmit
with H2O2 results in cleavage of the C=Se or C=S bond and oxidation of the selenium
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and sulfur atoms along with formation of the dimethylimidazolium cation. Treating
[Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile results in preferential
oxidation of the dmise or dmit ligand and formation of oxidized selenium and sulfur
species, the dimethylimidazolium cation and [Tpm*Cu(NCCH3)][BF4]. In contrast, upon
treating Cu+ complexes without bound selenium or sulfur ligands with the same number
of equivalents of H2O2, the Cu+ is oxidized.29 Since these copper-selone and -thione
complexes undergo sacrificial oxidation of chalcogenone atoms without oxidation of the
Cu+ center, if similar copper-selenium and -sulfur complexes are formed in vivo, such
complexes may scavenge H2O2 and inhibit copper-mediated oxidative damage.

Experimental Section
Materials. Methanol and acetonitrile were dried using standard procedures and
freshly distilled prior to use. N,N’-dimethylimidazole selone (dmise),36 N,N’dimethylimidazole thione (dmit),36 [Cu(NCCH3)4][BF4],37 [Tpm*Cu(dmise)][BF4], and
[Tpm*Cu(dmit)][BF4],23 were synthesized according to published procedures. The
following reagents were used as received: selenium powder (VWR), sulfur powder
(VWR), cuprous oxide (stabilized, Aldrich), 1-methylimidazole (VWR), methyliodide
(VWR), 3,5-dimethylpyrazole (VWR), and 30% H2O2 (VWR).
Instrumentation. 1H,

13

C{1H}, and

77

Se{1H} NMR spectra were obtained on

Bruker AVANCE-500 or -300 NMR spectrometers. 1H and
shifts are reported in

13

C{1H} NMR chemical

vs. trimethylsilane (TMS; δ 0). 77Se{1H} NMR chemical shifts are
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reported relative to dimethyl selenide (δ 0) and externally referenced to diphenyl
diselenide (δ 461).38 19F{1H} NMR spectra were externally referenced to CCl3F ( 0).39
Infrared spectra were obtained using nujol mulls on KBr salt plates with a Magna
550 IR spectrometer. Abbreviations used in the description of vibrational data are as
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a
Turbo Ionspray ionization source. Samples were run under both positive and negative
mode, with an ionspray voltage of 5500 V, and TOF scan mode. All the peak envelopes
obtained match calculated isotopic abundances.
Reactivity of dmise with H2O2. Dmise (175 mg, 1 mmol) was dissolved in
methanol (15 mL), and H2O2 (115 μL of 30%, 8.667 M; 1 mmol) was added. The
reaction mixture was stirred for 5 h and dried in vacuo to afford a light brown oil. Yield
of oxidized dmise: 100 % by 1H NMR spectroscopy. 1H NMR (CD3OD): 3.978 (s,
2CH3), 7.579 (2H, 2CH), 8.91 (s, 1H, CH).
123.59 (CH), 136.98 (CH (C-2)).

13

C{1H} NMR (CD3OD): 35.70 (CH3),

77

Se{1H} NMR (CD3OD): 1346.22. ESI-MS: m/z,

positive ionization 97.07 [C5H9N2]+; negative ionization: 112.96 [SeO2H]-.
Reactivity of dmit with H2O2. Dmit (128 mg, 1 mmol) was dissolved in methanol
(15 mL) and treated with 1equiv H2O2 (115 μL of 30%, 8.667 M; 1 mmol) or 2 equiv of
H2O2 (230 μL of 30%, 8.667 M; 2 mmol). Yield of oxidized dmit: 100 % by 1H NMR
spectroscopy with 2 equiv H2O2. 1H NMR (CD3OD): 3.98 (s, 2CH3), 7.61 (2H, 2CH),
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8.91 (s, 1H, CH).

13

C{1H} NMR (CD3OD): 35.20 (CH3), 123.50 (CH), 137.31(CH (C-

2)). ESI-MS: m/z, positive ionization 97.07 [C5H9N2]+; negative ionization: 96.99
[SO4H]-, 79.98 [SO3H]-.
Reaction of [Tpm*Cu(dmise)][BF4] with H2O2. [Tpm*Cu(dmise)][BF4] (320 mg,
0.5 mmol) was dissolved in acetonitrile (10 mL) and to this was added 0.5, 1.0, or 2.0
equiv of H2O2 (0.25, 0.5, or 1 mmol; 29, 58, or 115 μL). The reaction mixtures were
stirred for 8 h and dried in vacuo. A control experiment using degassed water instead of
H2O2 showed no reaction. Single crystals of [Tpm*Cu(NCCH3)][BF4] were grown via
slow diffusion of ether into acetonitrile solution. Yield of oxidized dmise: 85% by 1H
NMR spectroscopy with 2 equiv H2O2. 1H NMR (CD3CN): 2.31 (s, 9H, 3CH3), 2.51 (s,
9H, 3CH3), 3.86 (s, 6H, 2CH3), 6.05 (s, 3H, 3CH), 7.36 (s, 2H, 2CH (dmise)), 7.75 (s,
1H, CH), 8.49 (s, 1H, CH (dmise)). 13C{1H} NMR (CD3CN): 11.05 (CH3), 13.48 (CH3),
36.64 (CH3 (dmise)), 68.65 (CH), 107.22 (pz), 124.35 (CH (dmise)), 141.96 (CH (pz)),
151.52 (CH (pz)). IR (cm-1): 520 w, 630 s, 662 s, 704 vs, 739 vs, 794 vs, 815 vs, 855 vs,
970 vs, 978 w, 1066 b, 1150 s, 1176 s, 1252 vs, 1307 vs, 1392 vs, 1417 vs, 1464 vs, 1568
vs, 1675 w, 2854 vs, 2924 b, 3142 s, 3171 s, 3501 w. ESI-MS: m/z positive ionization:
402.12 [Tpm*Cu(NCCH3)]+, 380.10 [Tpm*Cu(OH) + 2H]+, 361.09 [Tpm*Cu]+, 97.07
[C5H9N2]+; negative ionization: 112.96 [SeO2H]-, 87.03 [BF4]-.
[Tpm*Cu(dmit)][BF4] with H2O2. [Tpm*Cu(dmit)][BF4] (273 mg, 0.5 mmol)
were dissolved in acetonitrile (10 mL) and to this was added 1, 2, or 3 equiv of H2O2 (0.5,
1.0, or 1.5 mmol; 58, 115, or 173 μL). The reaction mixture was stirred overnight and
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dried in vacuo. Yield of oxidized dmit: 68% by 1H NMR spectroscopy with 3 equiv
H2O2. 1H NMR (CD3CN): 2.28 (s, 9H, 3CH3), 2.51 (s, 9H, 3CH3), 3.85 (s, 6H, 2CH3),
6.05 (s, 3H, 3CH), 7.36 (s, 2H, 2CH (dmit)), 7.75 (s, 1H, CH), 8.47 (s, 1H, CH (dmit)).
13

C{1H} NMR (CD3CN): 11.04 (CH3), 13.43 (CH3), 36.61 (CH3 (dmit)), 68.65 (CH),

107.24 (pz), 124.35 (CH (dmit)),141.98 (CH (pz)), 151.53 (CH (pz)). IR (cm-1): 491 w,
521 s, 631 s, 672 vs, 704 vs, 740 s, 814 s, 857 vs, 907 vs, 1065 b, 1175 s, 1258 vs, 1286
w, 1308 vs, 1394 s, 1418 s, 1464 s, 1567 vs, 1676 w, 2917 b, 3144 s. ESI-MS: m/z
positive ionization: 489.09 [Tpm*Cu(NCCH3)][BF4]+, 402.12 [Tpm*Cu(NCCH3)]+,
380.10 [Tpm*Cu(OH) + 2H]+, 361.09 [Tpm*Cu]+, 97.07 [C5H9N2]+; negative ionization:
96.99 [SO4H]-, 79.98 [SO3H]-, 87.03 [BF4]-.
X-ray data collection and structural determination. Single crystals of
[Tpm*Cu(NCCH3)][BF4] grown from vapor diffusion were mounted on a glass filament
with silicon grease and immediately cooled to 168±2 K in a cold nitrogen gas stream.
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S
diffractometer. The space groups C2/c for [Tpm*Cu(NCCH3)][BF4] was determined from
the observed systematic absences. Data reduction including the application of Lorentz
and polarization (Lp) effects and absorption corrections used the CrystalClear program. 40
The structures were solved by direct methods and subsequent Fourier difference
techniques, and refined anisotropically, by full-matrix least squares, on F2 using
SHELXTL 6.10.41
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Table 3.2. Summary of crystallographic data for
[Tpm*Cu(NCCH3)][BF4].
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

C18H25BCuF4N7

489.80
C2/c
Monoclinic
25.997(5)
7.598(15)
25.019(5)
90
116.18(3)
90
4435.2(15)
8
1.467
[-30, -7, -28]
[30, 9, 29]
287
2016
1.038
1.81-25.05
16722
3917
0.0636
0.1724
0.0823
0.1948
1.060
1.173
-0.761

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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In the final cycle of least squares, independent anisotropic displacement factors
were refined for the non-hydrogen atoms and the methyl hydrogen atoms were fixed in
idealized positions with C-H = 0.96 Å. Their isotropic displacement parameters were set
equal to 1.5 times Ueq of the attached carbon atom. The high wR2 value results from
disorder in the tetrafluoroborate counterion. Final refinement parameters for structure of
[Tpm*Cu(NCCH3)][BF4] are given in Table 3.1, and selected bond angles and distances
are summarized in Table 3.2.
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CHAPTER FOUR
REDUCTION OF Cu(II) BY N,N’-DIMETHYLIMIDAZOLE CHALCOGENONES
AND THE COORDINATION CHEMISTRY OF BIS(1-METHYLIMIDAZOLYL)
DISELENIDE TO Cu(II)

Introduction
The applications and coordination chemistry of heterocyclic selenoamides and
thioamides with transition metals has been extensively studied for the past 20 years
because of their applications in catalysis, their use as precursors for the synthesis of
semiconductors via chemical vapor deposition (CVD), and their use as mimics for
metalloproteins in bioinorganic chemistry.1-6 Recently, we have investigated the ability of
N,N’-dimethylimidazole selone (dmise) and thione (dmit) to reduce Cu2+ to Cu+ as well
as the coordination chemistry of bis(1-methylimidazolyl) diselenide with Cu2+. These
selone and thione ligands are of interest because they resemble thiol-histidines such as
ergothioneine7,8 and ovothiols,9 as well as the seleno-histidine selenoneine,10 naturally
occurring antioxidant sulfur and selenium compounds found in plants and animals
(Figure 4.1).
Previous work has shown that Cu+ complexes of thio and selonoureas can be
prepared via reduction of Cu2+ salts using an excess seleno- and thioamide containing
ligands with concomitant oxidation of the seleno- and thioamide compounds.11-14 Against
this background, we carried out the reaction of CuCl2 and Cu(OTf)2 with molar
equivalents of dmise or dmit to determine the products formed and the ability of these
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heterocyclic chalcogenone ligands to reduce Cu2+ to Cu+. In biological systems, most
thiols are oxidized upon interacting with metal ions such as Cu2+ or by other redox
processes. Thiol oxidation results in formation of disulfide bonds that play important role
in cellular redox regulation.15 Selenocysteine residues in SeI L selenoproteins or Grx3
mutants also can form diselenide bonds. The diselenide-containing protein SeI L is absent
in mammals but present in aquatic organisms such as jawless fish, tunicates, and
crustaceans. SeI L selenoproteins have very low reduction potential (-332 mV) which
may have unique physiological and catalytic roles.16
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E = Se, selenoneine
E = S, ergothioneine

Figure 4.1. A) Ligands used in this study. B) Structures of naturally occurring
selone and thione antioxidants and the drug methimazole.
Ergothioneine and selenoneine coordinate divalent metal ions such as Cu2+and are
easily oxidized to form ergothioneine disulfide and selenoneine diselenide.9,17,18 The
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metal binding properties of ergothioneine disulfide, and its selenium analog selenoneine
diselenide, to transition metals (Fe2+, Ni2+, Co2+, Zn2+, and Cu+) chlorides have been
investigated by using bis(1-R-imidazolyl) disulfides and diselenides as coordination
mimics (R = H, Me, Ph, tBu; Figure 4.1).18 These disulfide and diselenide mimics are
excellent bidentate ligands, coordinating metals through the imidazolyl nitrogens and
resulting in metal (Fe2+, Ni2+, Co2+, and Zn2+) complexes with distorted tetrahedral
geometries.18
In this chapter, the coordination chemistry of Cu2+ with bis(1-methylimidazolyl)
diselenide (MISeox) is explored to determine the potential binding modes of selenoneine
diselenide. Cu2+ capping with the tripodal ligand tris(1,3-diisopropylpyrazolyl)methane
(TpmiPr) ligand is used to ensure Cu2+ coordination to only one diselenide ligand.
Electrochemical studies of the [TpmiPrCu(MISeox)]2+ cation will determine the effect of
diselenide coordination on the Cu2+/+ reduction potential.

Results and Discussion
Oxidation of dmise and dmit ligands. Oxidation of the chalcogenones dmise and
dmit was performed by treating the anhydrous copper(II) salts Cu(OTf)2 and CuCl2 with
1 equiv of dmise or dmit in acetonitrile (Scheme 4.1) to yield the diselenide (1 and 3) and
disulfide (2) dication salts. Both the diselenide and disulfide dications are indefinitely
stable in air.
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Scheme 4.1
2
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N
3; 20% yield

1

H NMR spectra of dmise and dmit show two sets of resonances corresponding to

the methyl protons (δ 3.60 for dmise and δ 3.56 for dmit) and olefinic protons (δ 7.04 for
dmise and δ 6.90 for dmit).19 Upon oxidation of these chalcogenone compounds, these
methyl and olefinic resonances shift downfield (δ 3.67 and 7.63 for 1, and δ 3.73 and
7.64 for 2). The presence of only two resonances for the oxidized dmise and dmit
compounds, coupled with the significant downfield shift of the olefinic protons compared
with the unoxidized compounds, suggest the formation of aromatic dichalcogenone
dications.
The diselenide dication 1 has three

13

C{1H} NMR resonances at δ 37.6 (CH3

groups), δ 125.9 (olefinic carbon atoms) and δ 140.6 (C-Se). The methyl and olefinic
carbons of 1 are slightly shifted downfield compared to dmise by δ 0.6 and 6.2,
respectively.19 In contrast, the C-2 carbon resonance of 1 is shifted upfield by δ 17
compared to dmise. This upfield shift is consistent with a shift of electron density from
the selenocarbonyl group to the neighboring N-C bond and formation of an aromatic
98

imidazolium cation.20-23 The 77Se{1H} NMR spectrum of the diselenide dication 1 shows
a resonance at δ 329, significantly shifted downfield relative to that of dmise (δ -1).19 The
13

C{1H} NMR spectrum of the analogous disulfide 2 shows similar resonance shifts (δ

+1, +9.3 and -20) for the methyl, olefinic, and S-C carbon atoms, respectively. The
identities of the three diselenide and disulfide dications (1, 2, and 3) were confirmed by
ESI mass spectrometry.
Structural analysis of the disulfide and diselenide dications. The X-ray crystal
structure of [(C5N2H8S)2]2+ (Figure 4.2) shows a [(C5N2H8S)2]2+ dication with a S-S bond
length of 2.10 Å (Table 4.1). Formation of the disulfide dication 2 results in significantly
longer S-C (1.746(3) Å) bond distance relative to dmit (1.681(5) Å).24 The bis(1,3dimethylimidazolium) disulfide dication has a C(1)-S(1)-S(2)-C(6) torsion angle of
79.70°.

Figure 4.2. Crystal structure diagram of [(C5N2H8S)2]2+ (2) showing 50%
probability density ellipsoids. Hydrogen atoms and counterions omitted for
clarity.
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Table 4.1. Selected bond distances (Å) and angles (°) for 2.
(deg)
S(1)-S(2)
2.1015(10)
S(2)-S(1)-C(1)
100.17(9)
S(1)-C(1)
1.746(3)
S(1)-S(2)-C(6)
101.76(9)
S(2)-C(6)
1.744(3)

Figure 4.3. Crystal packing diagram of [(C5N2H8S)2][(OTf)2] (2) along the aaxis showing 50% probability density ellipsoids. Short contact interactions and
hydrogen bonds between S-O, H-O, and F-H are shown.
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The two triflate anions have short contact interactions between S(2)-O(1) (2.81
Å), S(1)-O(2) (3.24 Å), S(1)-O(4) (2.94 Å), O(3)-H(3A) (2.46 Å), O(3)-H(2B) (2.56 Å),
and F(6)-H(2A) (2.53 Å) (Figure 4.3). The S-S bond distance of 2.1015(10) Å in the
crystal structure of 2 is slightly longer than the previously reported disulfide dications
[(C4H6N2S)2]I8 (2.085(2) Å),25 [(C4H6N2S)2]I3I5 (2.085(3) and 2.094(3) Å).25
X-ray structural analysis of the analogous diselenide compound 1 (Figure 4.4)
shows a Se-Se bond length of 2.3598(7) Å (Table 4.2), a distance slightly shorter than the
sum of their covalent radii (2.40 Å).26 The dication is charge-balanced by two triflate
anions with short contact interactions between O(1)-Se(1) (2.80 Å), O(6)-Se(2) (2.96 Å),
O(1)-C(1) (2.97 Å), O(6)-H(9A) (2.35 Å), O(3)-H(7C) (2.55 Å), O(6)-H(5C) (2.52 Å),
and F(5)-H(2C) (2.55 Å) (Figure 4.5). The bis(1,3-dimethylimidazolium) diselenide
dication has a C(1)-Se(1)-Se(2)-C(6) torsion angle of -77.40°. The diselenide dication 1
and the unoxidized dmise have almost identical Se-C bond lengths (1.885(3) and
1.884(10) Å, respectively).27 The Se-Se bond distance of 2.3598(7) Å in 1 is comparable
to that found in [(SeC(NH2)2]2Cl2] (2.381596) Å),28 but shorter than the Se-Se bond
lengths in (C5H8N2Se)2Br2 (2.409(2) Å), (C5H8N2Se)2I2 (2.434(2) Å), [(C5H8N2Se-)2Cl]I3
(2.440(2) Å).29
Upon treatment with anhydrous CuCl2, dmise is oxidized, resulting in the
formation of a red solid with the formula [(C5N2H8Se)2][Cu3Cl5], 3 (Scheme 4.1). The Xray structure of 3 revealed a centrosymmetric [Cu3Cl5]2- anion charge-balanced by a
[(C5N2H8Se)2]2+ dication (Figure 4.6). The diselenide dication of 3 has a slightly longer
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Se-Se bond distance of 2.3946(13) Å (Table 4.3) and a positive C(1)-Se(1)-Se(1A)C(1A) torsion angle of 70.91° compared to diselenide dication 1 (Se-Se distance of
2.3598(7) Å and a C(1)-Se(1)-Se(2)-C(6) torsion angle of -77.40°).

Figure 4.4. Crystal drawing of [(C5N2H8Se-)2]2+ (1) showing 50% probability
density ellipsoids. Hydrogen atoms and counterions are omitted for clarity.

Table 4.2. Selected bond distances (Å) and angles (°) for 1.
Se(1)-Se(2)
Se(1)-C(1)
Se(2)-C(6)

2.3598(7)
1.885(3)
1.893(3)

Se(2)-Se(1)-C(1)
Se(1)-Se(2)-C(6)
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95.89(9)
95.75(9)

Figure 4.5. Crystal packing diagram of [(C5N2H8Se)2][(OTf)2] (1) along the aaxis showing 50% probability density ellipsoids. Short contact interactions and
hydrogen bonds between Se-O, H-O, and F-H are shown.

The crystallographically centrosymmetric [Cu3Cl5]2- anion contains two
geometrically different Cu+ centers bridged by chloride atoms. Cu(1) adopts distorted
trigonal geometry with an average Cu-Cl bond distance of 2.32 Å (Table 4.3), and
Cl-Cu-Cl angles of 107 to 146.1°. The second Cu+ center, Cu(2), adopts a distorted
tetrahedral geometry with an average Cu-Cl bond distances of 2.38 Å and Cl-Cu-Cl
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Figure 4.6. Crystal structure diagram of [C10H16N4Se2][Cu3Cl5] (3) showing
50% density probability ellipsoids.
Table 4.3. Selected bond distances (Å) and angles (°) for 3.
(°)
Se(1)-Se(1A) 2.3946(13) Se(1A)-Se(1)-C(1)
94.01(15)
Se(1)-C(1)
1.884(5)
Se(1)-Se(1A)-C(1A) 94.01(15)
Cu(1)-Cu(2) 2.9201(12) Cl(1)-Cu(1)-Cu(2)
161.11(7)
Cu(1)-Cl(1)
2.2346(15) Cl(1)-Cu(1)-Cl(1A) 146.13(10)
Cu(1)-Cl(2)
2.481(3)
Cl(1)-Cu(1)-Cl(2)
106.94(5)
Cu(2)-Cl(2)
2.4910(12) Cl(3)-Cu(2)-Cl(1A) 117.47(6)
Cu(2)-Cl(3)
2.3648(17) Cl(1)-Cu(2)-Cl(2)
102.47(6)
Cl(3)-Cu(2)-Cl(3B) 101.00(5)

angles ranging from 101.0° to 117.5°. The distance between the two geometrically
distinct copper centers is 2.92 Å, longer than two times the sum of van der Waals radius
for Cu+ (2.80 Å),30 suggesting minimal Cu-Cu interaction. The diselenide dications in the
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crystal of 3 are arranged parallel to each other along the b-axis with the [Cu3Cl5]2dianions positioned between the dications (Figure 4.7). This arrangement leads to short
contact interactions between the Cl atoms of the anion and selenium and hydrogen atoms
of the cation, thereby forming a two dimensional network (Figure 4.7). The Se-Cl short
contact distance (3.38 Å) is significantly shorter than the sum of their van der Waals radii
(3.80 Å),30 indicating fairly strong interactions.

Figure 4.7. Crystal packing diagram of [C10H16N4Se2][Cu3Cl5] (3) along the b-axis
displaying 50% density probability ellipsoids. Short contact interactions between
Se-Cl and H-Cl atoms are shown.

Synthesis and characterization of [TpmiPrCu(MISeox)][(OTf)2]. The Cu2+
[TpmiPrCu(MISeox)][OTf]2 complex (5) was synthesized in a two-step, two-pot
procedure (Scheme 4.2). Treating Cu(OTf)2 with an equimolar amount of
tri(3,5-diisopropylpyrazolyl)methane (TpmiPr) in acetonitrile forms TpmiPrCu(OTf)2 (4)
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(MALDI-MS Figure 4.12). The second step is treatment of TpmiPrCu(OTf)2 (4) with 1
equiv of bis(1-methylimidazolyl) diselenide (MISeox) in a mixed solvent system of
dichloromethane and acetonitrile to afford 5 in relatively high yields.
Scheme 4.2

Cu(OTf)2 + TpmiPr

CNCH3

TpmiPrCu(OTf)2

4h

4; Yield 89%
TpmiPrCu(OTf)2 + MISeox

CNCH3/CH2Cl2
4h

[TpmiPrCu(MISeox)][(OTf)2]
5; Yield 81%

Single

crystal

X-ray

diffraction

data

were

collected

for

[TpmiPrCu(MISeox)][(OTf)2] (5), which crystallized as blue prisms. Structural parameters
and selected bond lengths and angles for 5 are summarized in Tables 4.4 and 4.6, and its
structure is shown in Figure 4.8. The Cu2+ center of 5 adopts distorted square pyramidal
coordination geometry, with the Cu2+ bound to three nitrogen atoms from the tridentate
ligand in a κ3 fashion and to the two nitrogen atoms of bis(1-methylimidazolyl)
diselenide in a κ2 fashion. The N-Cu-N angles and Cu-N bond distances in 5 from the
tris(1,3-diisopropylpyrazolyl)methane ligand range from 80.4 to 91.2º and 2.03 to 2.19 Å,
respectively. Coordination of MISeox to Cu2+ results in N(7)-Cu-N(9) angle of 98.1° and
average Cu-N bond lengths of 2.00 Å. The C-N bond distances in the bound diselenide
ligand are slightly different with a Cu-N(9) distance of 1.972(6) Å and a Cu-N(7)
distance of 2.027(6) Å. The geometry of the diselenide ligand changes noticeably upon
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Figure4.8. Crystal structure diagram of [TpmiPrCu(MISeox)][(OTf)2] (5)
showing 50% probability density ellipsoids. Hydrogen atoms and counterions
are omitted for clarity.
Table 4.4. Selected bond distances (Å) and angles (°) for 5.
Se(1)-Se(2)
Cu-N(7)
Cu-N(9)
Cu-N(2)
Cu-N(5)
Cu-N(3)

2.3128(12)
2.027(6)
1.972(6)
2.055(6)
2.034(6)
2.190(6)

N(9)-Cu-N(7)
N(9)-Cu-N(5)
N(7)-Cu-N(5)
N(9)-Cu-N(2)
N(7)-Cu-N(2)
N(5)-Cu-N(2)
N(9)-Cu-N(3)
N(7)-Cu-N(3)
N(5)-Cu-N(3)
N(2)-Cu-N(3)
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98.1(2)
167.6(3)
92.6(2)
88.2(3)
170.5(2)
80.4(3)
98.6(2)
94.8(2)
86.7(2)
91.2(2)

binding to copper. The Se-Se distance is reduced to 2.3128(12) Å upon complexation to
Cu2+ relative to the unbound ligand (2.3568(15) Å),31 whereas the C-N distances in close
proximity to the Cu-N bond are slightly increased. The N(9)-C(30)-Se(1) angle of
122.9(5)° does not change upon binding to Cu2+, but the N(7)-C(29)-Se(2) angle of
130.5(6)° increases compared to the unbound diselenide ligand (122.8(3)°).31
The electrochemical behavior of bis(1-methylimidazolyl) diselenide and the Cu2+
complex 4 were examined by cyclic voltammetry to determine the change in the Cu 2+/+
redox potential upon copper coordination. Bis(1-methylimidazolyl) diselenide has a
reduction potential of -1.067 mV versus normal hydrogen electrode (NHE), and exhibits
quasi-reversible electrochemical behavior (Figure 4.9 and Table 4.5).

Figure 4.9. Cyclic voltammetry (CV) scan for MISeox in acetonitrile.
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The cyclic voltammogram of the TpmiPrCu(OTf)2 (4) complex exhibits two oneelectron, chemically reversible potential waves belonging to the Cu2+/+ and Cu+/0
reduction and oxidation processes (Figure 4.10, Table 4.5). At negative potentials, a peak
corresponding to Cu+/0 is observed at -911 mV. After switching the scan direction, the
Cu0 is then stripped off the electrode at -647 mV. The Cu2+/+ reduction potential for
TpmiPrCu(OTf)2 (4) is -339 mV and the complex exhibits small separation between the
cathodic and anodic waves (∆E 204 mV) relative to previously synthesized
tris(pyrazolyl)Cu(I)-acetonitrile complexes (∆E 844 to 1778 mV),32 suggesting fast
electron transfer kinetics during the voltammetry scan,33 or small reorganization energies
between a five-coordinate Cu2+ complex and a distorted tetrahedral Cu+ complex.34

Figure 4.10. Cyclic voltammetry (CV) scan for the TpmiPrCu(OTf)2 (4) complex in
acetonitrile vs. NHE.
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The cyclic voltammogram of [TpmiPrCu(MISeox)][(OTf)2] (5) is very different
from the analogous acetonitrile complex, TpmiPrCu(OTf)2 (4) due to the fact that it does
not exhibit a typical Cu+/0 reduction and oxidation wave, but instead shows two different
reduction and oxidation waves (Figure 4.11). These two redox waves correspond to
Cu2+/+ reduction couples for [TpmiPrCu(MISeox)][(OTf)2] (5) at -508 mV and most likely
a ligand (MISeox) based reduction potential at -1334 mV (Table 4.5). Complexation of
MISeox to TpmiPrCu(OTf)2 (4) lowers the Cu2+/+ redox potential by 170 mV. The Cu2+/+
reduction potential of -508 in 5 is comparable to the macrocyclic copper(II) complex
[Cu(dtne)](ClO4)2·CH3CH2OH (-544 mV),35 but more negative compared to other
reported Cu2+ complexes with nitrogen containing ligands such as [Cu(tnpa)(OH)]ClO4
(-28 mV).36

Figure 4.11. Cyclic voltammetry (CV) scan for [TpmiPrCu(MISeox)][(OTf)2]
(4) in acetonitrile vs. NHE.

110

Table 5. Reduction potentials of MISeox, TpmiPrCu(OTf)2 (4), and
[TpmiPrCu(MISeox)][(OTf)2] (5) vs. NHE.
Cu2+/+
Compound
MISeox
TpmiPrCu(OTf)2 (4)
[TpmiPrCu(MISeox)][(OTf)2] (5)

Epa (mV)
-916
-236
129, -1037

Epc (mV)
-1218
-440
-1146, -1630

∆E (mV)
302
204
1275, 593

E1/2 (mV)
-1067
-338
-508, -1334

remove space

Table 6. Cu+/0 reduction potential of TpmiPrCu(OTf)2 (4) vs. NHE.
Cu+/0
Compound
TpmiPrCu(OTf)2 (4)

Epa (mV)
-647

Epc (mV)
-1175

∆E (mV)
528

E1/2 (mV)
-911

The bis(1-methylimidazolyl) diselenide is used to mimic coordination of naturally
occurring selenoneine diselenide to biologically relevant divalent metals such as Cu2+.
The coordination of MISeox to Cu2+ occurs at the imidazolyl nitrogen atoms and alters
Cu2+/+ reduction potentials to stabilize Cu2+. The Cu2+/+ reduction potential of -508 mV
for 5 is much lower than that of cellular reductant NADH (-324 mV),37 and if similar
copper complexes are formed in vivo their potentials may be lower enough to prevent
reduction of Cu2+ and biological copper redox cycling.

Conclusions
Dmise and dmit ligands reduce Cu2+ to Cu+ with concomitant formation of the
oxidized diselenide and disulfide dications. The reduction of Cu(OTf)2 by dmise or dmit
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results in formation of diselenide or disulfide dications which are stabilized by two
triflate anions (1 and 2, respectively), whereas reduction of CuCl2 by dmise forms the
diselenide dication stabilized by a centrosymmetric [Cu3Cl5]2- anion (3). This complex
anion has two geometrically distinct Cu+ centers bridged by chloride atoms. The
diselenide compound MISeox coordinates Cu2+ through both the imidazolyl nitrogen
atoms as a bidentate ligand. X-ray structural analysis revealed that the Cu2+ center in
[TpmiPrCu(MISeox)][(OTf)2] (5) adopts a distorted square pyramidal geometry. MISeox
coordination to TpmiPrCu(OTf)2 (4) lowers the Cu2+/+ reduction potential by 170 mV
compared to TpmiPrCu(OTf)2, thus stabilizing Cu2+.
The results presented in this chapter illustrate the ability of dmise and dmit to
reduce Cu2+. In addition studies with Cu2+-MISeox coordination shed new light on the
possible coordination chemistry of selenoneine diselenide and the analogous
ergothioneine disulfide with biologically relevant metal ions such as Cu2+. Diselenide
coordination may result in lowered Cu2+/+ reduction potentials, and could potentially slow
the rate of copper redox cycling to inhibit copper-mediated oxidative damage.

Experimental Methods
Materials. Methanol and acetonitrile were dried using standard procedures and
freshly distilled prior to use. The following compounds were synthesized according to
published

procedures:

3,5-diisopropyl

pyrazole,38

hydrotris(3,5-diisopropyl-1-

pyrazoyl)methane (TpmiPr),39 N,N’-dimethylimidazole selone (dmise),19
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N,N’-

dimethylimidazole thione (dmit),19 and bis(1-methylimidazolyl) diselenide.31 The
following reagents were used as received: 3,5-dimethyl-1-pyrazole (Aldrich), tetra-nbutylammonium bromide (Aldrich), sodium carbonate (VWR), selenium powder, sulfur
powder,

diisobutyrylmethane

(VWR),

hydrazine

monohydrate

(VWR),

1-

methylimidazole (VWR), methyliodide (VWR) , CuCl2 (VWR) and Cu(OTf)2 (Alfa
Aesar).
Instrumentation. 1H, 13C{1H}, 19F{1H}, and 77Se{1H} NMR spectra were obtained
on a Bruker AVANCE 500 or 300 NMR spectrometers. 1H and
shifts are reported in

relative to trimethylsilane (TMS; δ 0).
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13

C{1H}NMR chemical

Se{1H} NMR chemical

shifts are reported relative to dimethyl selenide (δ 0) and externally referenced to
diphenyl diselenide (δ 461).40 19F{1H} NMR spectra were externally referenced to CCl3F
( 0).41
Infrared spectra were obtained using nujol mulls on KBr salt plates using a Magna
550 IR spectrometer. Abbreviations used in the description of vibrational data are as
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a
Turbo Ionspray ionization source. Samples were run under both positive and negative
mode, with ionspray voltage of 5500, and TOF scan mode. MALDI-TOF-MS was
conducted

on

a

Bruker

Microflex.

Trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-

propenylidene]-malononitrile was used as a matrix for co-crystallization of the copper
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complex characterized. All the peak envelopes matched their calculated isotopic
distributions.
Formation of [(C5N2H8Se)2][(OTf)2] (1) by oxidation with Cu(OTf)2. Cu(OTf)2
(362 mg, 1 mmol) was dissolved in acetonitrile (15 mL) to give a light blue solution, and
to this was cannula added a solution of dmise (175 mg, 1 mmol) in acetonitrile (10 mL).
Upon addition, the solution color changed from light blue to orange. The reaction mixture
was stirred for 6 h, and then the solvent volume was reduced to about 5 mL in vacuo. The
desired product was precipitated by addition of ether, and the solid precipitate was
filtered and dried in vacuo. Crystals of 1 were grown via slow vapor diffusion of ether
into acetonitrile solution. Yield 37% (240 mg, 0.369 mmol). Mp. 227 °C. 1H NMR
(CD3CN): 3.67 (s, 6 H, 2CH3), 7.63 (s, 2H, 2CH). 13C{1H} NMR (CD3CN): 37.59 (CH3),
125.94 (CH), 135.57 (C-Se). 19F{1H} NMR (CD3CN): -79.24. 77Se{1H} NMR (CD3CN):
329.37. UV-vis (CNCH3): 206, 226 (shoulder), 275 nm. IR (cm-1): 517 s, 573 s, 620 s,
637 vs, 666 s, 739 s, 749 vs, 778 s, 1029 vs, 1139 vs, 1223 vs, 1254 b, 1377 vs, 1407 w,
1463 vs, 1502 vs, 1566 s, 1598 w, 2728 w, 2853 b, 3128 w, 3154 w, 3177 w. ESI-MS:
m/z positive ionization: 175.9 [(C5N2H8Se)2]2+; negative ionization 148.97 [(CF3SO3)2]2-.
Anal. Calc. for C12H16N4Se2O6S2F6 : C, 22.23; N, 8.64; H, 2.49. Found C, 22.05; N, 8.43;
H, 2.28.
Formation of [(C5N2H8S)2][(OTf)2] (2) by oxidation with Cu(OTf)2. Cu(OTf)2
(362 mg, 1 mmol) was dissolved in acetonitrile (15 mL), and to this solution was cannula
added dmit (192 mg, 1.5 mmol) in acetonitrile (10 mL). Upon addition, the color changed
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from light blue to light yellow. The reaction mixture was stirred for 6 h, and then the
solvent volume was reduced to about 5 mL in vacuo. The product was precipitated out
using ether and the precipitate was filtered and dried in vacuo. Crystals of 2 suitable for
X-ray diffraction analysis were grown through slow vapor diffusion of ether into
acetonitrile. Yield 34% (189 mg, 0.339 mmol). Mp. 181°C. 1H NMR (CD3CN): 3.73 (s, 6
H, 2CH3), 7.64 (s, 2H, 2CH).
140.64 (C-S).

19

13

C{1H} NMR (CD3CN): 37.27 (CH3), 126.94 (CH),

F{1H} NMR (CD3CN): -79.24. UV-vis (CNCH3): 215, 265, 305

(shoulder) nm. IR (cm-1): 517 s, 573 s, 637 vs, 679 s, 723 s, 741 s, 754 vs, 790 s, 1031 vs,
1139 vs, 1232 vs, 1259 b, 1377 vs, 1407 s, 1463 vs, 1506 vs, 1564 s, 1603 w, 2361 w,
2727 w, 2913 b, 3123 w, 3152 w. ESI-MS: m/z positive ionization: 128.2 [(C5N2H8S)2]2+;
negative ionization; 148.98 [(CF3SO3)2]2-. Anal. Calc. for C12H16N4S4O6F6 : C, 25.99; N,
10.10; H, 2.91. Found C, 25.85; N, 9.95; H, 2.73.
Formation of [(C5N2H8Se)2][Cu3Cl5] (3) by oxidation with CuCl2. CuCl2 (135 mg,
1 mmol) was dissolved in ethanol (15 mL), and to this solution was cannula added dmise
(175 mg, 1 mmol) in dichloromethane (10 mL). Upon addition, the solution changed
color from light brown to dark brown. The reaction mixture was stirred for 6 h and a red
solid precipitated from the solution. The precipitate was filtered and dried in vacuo.
Crystals of 3 were grown through slow vapor diffusion of ether into acetonitrile solution.
Yield 20% (153 mg, 0.200 mmol). 1H NMR (d6-DMSO): 3.89 (s,12 H, 4CH3), 7.61 (s,
4H, 4CH).
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C{1H} NMR (d6-DMSO): 37.03 (CH3), 122.25 (CH), C-Se resonance not

observed. IR (cm-1): 467 w, 504 w, 660 vs, 739 vs, 761 s, 1079 w, 1155 s, 1223 vs, 1243
s, 1377 vs, 1463 vs, 1494 s, 1562 s, 2855 s, 2928 b. ESI-MS: m/z 175.9 [(C5N2H8Se)2]2+.
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Anal. Calc. for C10H16N4Se2Cu3Cl5 : C, 16.73; N, 7.80; H, 2.25. Found C, 18.73; N, 7.84;
H, 2.3.
TpmiPrCu(OTf)2 (4). Cu(OTf)2 (362 mg, 1 mmol) was dissolved in acetonitrile (10
mL), and to this was added TpmiPr (428 mg, 1 mmol) in acetonitrile (10 mL). The
reaction mixture was stirred for 4 h, dried in vacuo, and the obtained green solid product
was washed with diethyl ether and dried in vacuo to afford TpmiPrCu(OTf)2. Yield: 89%
(724 mg, 0.89 mmol). UV-vis (CH3CN): 272 nm. Mp: 132°C. IR (cm-1): 517 s, 573 s,
638 s, 673 s, 724 s, 755 s, 832 s, 904 w, 924 w, 1031 s, 1059 s, 1153 s, 1268 s, 1377 s,
1463 s, 1560 s, 2300 w, 2327 s, 2926 b, 3127 w. Mass spectrum (Maldi): m/z 529.33
[TpmiPrCu]+, 678.22 [TpmiPrCu(OTf)]+. Anal. Calc. for C39H60CuF6N10O7S2Se2: C, 39.68;
N, 11.86; H, 5.12. Found: C, 42.87; N, 11.13; H, 5.63.
[TpmiPrCu(MISeox)][(OTf)2] (5). [TpmiPrCu(OTf)2 (4) (414 mg, 0.5 mmol) was
dissolved in acetonitrile (10 mL), and into this solution was cannula transferred MISeox
(162 mg, 0.5 mmol) in dichloromethane (10 mL). Upon addition, the color of the reaction
mixture changed from blue to brown. The reaction mixture was stirred for 4 h, the solvent
volume was reduced to about 3 mL, and a light green solid was precipitated with ether.
The solid was then filtered and dried in vacuo. Crystals of 4 suitable for X-ray analysis
were grown by slow vapor diffusion of ether into acetonitrile solution. Yield: 81% (450
mg, 0.405 mmol). UV-vis (CH3CN): 268 nm. IR (cm-1): 517 s, 573 w, 638 s, 683 s, 725 s,
771 s, 831 s, 922 w, 944 w, 1014 w, 1030 s, 1057 s, 1156 s, 1189 w, 1224 w, 1261 s,
1378 s, 1463 s, 1560 s, 1638 w, 2286 w, 2855 s, 2926 b, 3116 s, 3470 b. Mass spectrum
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(ESI-MS): m/z 425.6 [TpmiPrCu(MISeox)]2+, 321.9 [MISeox]+. Anal. Calc. for
C39H60CuF6N10O7S2Se2: C, 39.68; N, 11.86; H, 5.12. Found: C, 40.12; N, 11.96; H, 5.24.
X-ray data collection and structural determination. Crystals were grown by vapor
diffusion of diethyl ether into an acetonitrile solution for [(C5N2H8Se)2][(OTf)2] (1),
[(C5N2H8S)2][(OTf)2] (2), [(C5N2H8Se)2][Cu2Cl5] (3), and [TpmiPrCu(MISeox)][(OTf)2]
(4). Single crystals were mounted on a glass filament with silicon grease and immediately
cooled to 168±2 K in a cold nitrogen gas stream. Intensity data were collected using a
Rigaku Mercury CCD detector and an AFC8S diffractometer. The space groups P2 1/c for
1 and 2, C2/c for 3, and P21/n for 4 were determined from the observed systematic
absences. Data reduction including the application of Lorentz and polarization (Lp)
effects and absorption corrections used the CrystalClear program.42 The structures were
solved by direct methods and subsequent Fourier difference techniques, and refined
anisotropically, by full-matrix least squares, on F2 using SHELXTL 6.10.43
Crystallographic data for 1, 2, 3, and 5 are summarized in Tables 4.7 and 4.8. In the final
cycle of least squares, independent anisotropic displacement factors were refined for the
non-hydrogen atoms and the methyl hydrogen atoms were fixed in idealized positions
with C-H = 0.96 Å. Their isotropic displacement parameters were set equal to 1.5 times
Ueq of the attached carbon atom. The high wR2 value for complex 5 is due to disorder of
the triflate anions and diisobutyl groups on the pyrazole ring.
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Table 4.7. Summary of crystallographic data for complexes 1 and 2.
Chemical Formula
F.W. (g/mol)
Space group
Temp./K
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Extinction coefficient
Largest diff. Peak
Largest diff. Hole
a

1
C12H16F6N4O6S2Se2
648.33
P21/c
168±2
Monoclinic
8.5501(17)
20.249(4)
13.002(3)
90
100.53(3)
90
2236.3(8)
4
1.946
[-9, -21, -16]
[10, 25, 16]
293
1272
3.580
2.57- 26.25
18636
4449
0.0346
0.0839
0.0383
0.0870
1.125
0.0022(9)
0.621
-0.712

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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2
C12H16F6N4O6S4
554.53
P21/c
168±2
Monoclinic
8.5235(17)
19.874(4)
12.926(3)
90
98.29(3)
90
2166.8(8)
4
1.700
[-10, -22, -16]
[10, 24, 16]
293
1128
0.528
2.41 – 26.32
18721
4393
0.0471
0.1192
0.0568
0.1304
1.105
0.689
-0.476

Table 4.8. Summary of crystallographic data for the complexes 3, and 4.
Chemical Formula
F.W. (g/mol)
Space group
Temp./K
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Extinction coefficient
Largest diff. Peak
Largest diff. Hole
a

3
C12H16N4Se2Cu3Cl5
716.06
C2/c
168±2
Monoclinic
12.238(2)
12.217(2)
14.123(3)
90
108.61(3)
90
2001.2(7)
4
2.383
[-10, -15, -17]
[15, 15, 17]
112
1376
7.466
3.04-26.29
8327
2022
0.0435
0.1043
0.0546
0.1137
1.111

4
C39H60CuF6N10O7S2Se2
1180.55
P21/n
168±2
Monoclinic
15.196(3)
24.359(5)
15.260(3)
90
116.96
90
5034.7(170
4
1.557
[-15, -28, -18]
[18, 28, 16]
614
2412
2.040
2.69-25.05
33101
8864
0.0771
0.1972
0.1001
0.2159
1.087

1.216
-1.122

1.673
-0.731

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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Figure 4.12. MALDI-TOF-MS for TpmiPrCu(OTf)2 (4)
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CHAPTER FIVE
SYNTHESIS, CHARACTERIZATION, AND DFT STUDIES OF THIONE AND
SELONE, Cu(I) COMPLEXES WITH VARIABLE COORDINATION GEOMETRIES

Introduction
There is increased interest in the chemistry of copper with soft Lewis base
donors such as thiolates, thioamides, selenolates and selenoamides for use in
catalysis1 and in bioinorganic chemistry for the study of copper metallothioneins and
metallochaperones.2-5 Of particular interest is the coordination chemistry of selenium
with biologically-important transition metals (Cu, Fe, Ni, Zn, Mn, Mo, etc.), since
selenium has been shown to possess stronger and unique antioxidant properties
relative to sulfur.6-8 Our group has determined that copper coordination to sulfur and
selenium containing ligands is a novel mechanism for selenium and sulfur antioxidant
activity.9-13 We are interested in the chemistry of N,N’-dimethylimidazole selone
(dmise) and thione (dmit) because these and similar ligands are effective antioxidants
(FFigure 5.1).14,15 The dmise and dmit ligands are similar to methimazole, a drug
currently used in the treatment of hyperthyroidism, 16 and also resemble
ergothioneine17,18 and selenoneine,15 sulfur- and selenium-containing antioxidants
naturally found in plants and animals.
The coordination of heterocyclic thioamides and selenoamides to copper
results in diverse architectures ranging from mononuclear complexes to polynuclear
networks with a variety of binding modes. The coordination modes of the heterocyclic
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chalcogenones range from monodentate to bridging via coordination of sulfur or
selenium atoms.19-21 Mono-alkylated heterocyclic thiones and selones can also bind
metals via the non-alkylated nitrogen atom. 22-24 The applications and coordination
chemistry of thiones and selones with transition metals has been extensively reviewed
by Raper,25,26 Akrivos,27 Spicer, et al.,28 Pettinari,29 and Parkin.30 Although the
coordination chemistry of N-alkylimidazole thiones and N,N‟-dialkylimidazole
thiones with transition metals is well developed, 1,20,21,25,26,31-34 few reported
complexes

bearing

the

analogous

selenium

ligands

have

been

reported:

Zn(dmise)2Cl2,32,35 Co(dmise)2Cl2,36,37 [Cd(dmise)4][PF6],38 RuCl2(PPh3)(mtse)2, (mtse
=

selenometh-imazolyl),39

HgCl2(N-i-PrImSe)2,

(N-i-PrImSe

=

N-isopropyl-

imidazolidine-2-selone),40 HgCl2(MeImSe)3, (MeImSe = N-methyl-imidazolidine-2selone),41
[2ClO4],

[TpmRCu(dmise)] +,
(phen

=

Tp*Cu(dmise), 19

phenanthroline), 42

Cu2LY3

[Cu(1,10-phen)2(C5H10N2Se)](Y

=

Cl,

Br;

L =

N,N’-

dimethylimidazolidine selone), 43 and Cu2(btseme)3X2 (X = Cl, Br, NO 3, ½SO4;
btseme = N-methylbenzothiazole-2-selone).44
Se
N

S
N 2 N

N

4 5

dmise

dmit

Figure 5.1. Chalcogenone ligands used in this study.
This work reports the synthesis of copper halide complexes with dmise and
dmit ligands, with the aim of studying their different coordination modes and
electrochemistry. Complexes of the formulas Cu 4(μ-L4)(μ-X2)X2, CuL2X, CuL´2X,
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CuL2Y and CuL´2Y (L = dmise, L´ = dmit; X = I-, Br-; Y = Cl-) have been synthesized
and characterized using

1

H,

13

C{1H} and

77

Se{1H} NMR spectroscopy, cyclic

voltammetry, X-ray structural analysis, X-ray powder diffraction (XRD), and
electrospray ionization mass spectrometry (ESI-MS). Observed differences in the
coordination geometries and packing orientations of these complexes are also
examined using density functional theory (DFT) calculations. This chapter has been
submitted to Dalton Transactions for publication (Kimani, M. M.; Brumaghim, J. L.;
Bayse, C. A. Dalton Trans. submitted).45

Results and Discussion
Synthesis of Cu(I)-chalcogenone halide complexes. The target metal
complexes were synthesized by treating copper halides with either one or two molar
equivalents of selone or thione. The reaction of CuI and CuBr with one molar
equivalent of dmise resulted in formation of tetranuclear copper complexes with
bridging selone ligands (1 and 6; Figure 5.2A). The tetranuclear copper-iodide-selone
complex (1) can also be synthesized via a two-step, one-pot reaction with molar
equivalents of [Cu(NCCH 3)4][BF4] and dmise in acetonitrile followed by cannula
addition of KI in methanol. The reaction of CuI with dmise results in an insoluble
precipitate that is redissolved by addition of KI in methanol, similar to a method
previously described by Niu, et al.46 Both synthetic methods result in similar yields of
1.
Treating CuI with two molar equivalents of dmise or dmit in acetonitrile and
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dichloromethane results in the formation of monomeric three-coordinate copper-iodo
complexes (2 and 3a) characterized by intramolecular π-π interactions between the
two heterocyclic five-membered rings (Figure 5.2B). In contrast, treating two molar
equivalents of dmit with CuI in a mixed solvent system of ethanol and
dichloromethane results in the formation of a trigonal copper complex (3b) with no
intramolecular π-π interactions (Figure 5.2C).

Figure 5.2. Synthetic procedures for the preparation of tetrameric and trigonal
planar copper complexes.
The three-coordinate copper chloride or bromide complexes (4, 5, 7, and 8) are

127

synthesized by treating two molar equivalents of dmit or dmise with CuCl or CuBr in
a mixed solvent system (Figure 5.2C). The X-ray crystal structure of Cu(dmit) 2Cl has
been reported by Kim, et al. but its synthesis and characterization was not reported. 1
The trigonal copper complexes (2, 3a, 3b, 4, 5, 7 and 8) can be synthesized with good
yields (85-92%), whereas the tetrameric complexes 1 and 6 have an average yield of
23%. Crystals of the target metal complexes are stable in air but the Cu + ions are
easily oxidized to Cu2+ in solution.
Crystallographic studies of tetrameric Cu(I) halides complexes with
heterocyclic selone ligands. The X-ray crystal structures of Cu 4(μ-dmise)4(μI)2 I2·1.5CNCH3 (1) and Cu4(μ-dmise)4(μ-Br)2Br2·0.5CNCH3 (6) show two different
coordination geometries around the copper ions (Figure 5.3). Two selenium atoms
and one iodide or bromide ion coordinate to a single Cu(I) ion, forming a threecoordinate complex with the selone ligands adopting a cis conformation relative to
I(2)/Br(2) and I(2A)/Br(2A) along the copper chalcogenone bond. The Cu(2) and
Cu(2A) ions have distorted trigonal planar geometry. Trigonal copper bond angles
range from 116.11(3)° to 121.81(6)° in 1 and from 119.56(3)° to 119.71(5)° for the
less distorted trigonal copper centers in 6. Cu-I and Cu-Br bond distances are 2.58 Å
and 2.43 Å, respectively, for 1 and 6, and the Cu-Se bond distances are 2.42 Å and
2.41Å, respectively.
The two additional copper centers (Cu(1) and Cu(1A)) in 1 and 6 adopt
distorted tetrahedral geometries with a Cu 2(μ-I)2 or Cu2(μ-Br)2 core (average Cu-Cu
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Figure 5.3. X-ray crystal structure diagrams of Cu4(μ4-dmise)(μ-I2)I2 (1; left)
and Cu4(μ4-dmise)(μ-Br2)Br2 (6; right) showing 50% probability density
ellipsoids. Hydrogen atoms are omitted for clarity.

Table 5.1. Experimental crystal data (EXP) vs. theoretical DFT calculations
for selected bond lengths (Å) and angles (deg) of Cu4(μ-dmise)4(μ-I)2I2 (1)
and Cu4(μ-dmise)4(μ-Br)2Br2 (6).
1:1 complex
Cu(1)-Y
Cu(1)-X(1)
Cu(1)-Cu(1A)
Cu(2)-Y(2)
Cu(2)-X(2)
Cu(2)-X(1)
Y-Cu(2)-Y
Y-Cu(2)-X(2)
Y-C(1)

X=I; Y=Se
(EXP) (1)
2.4148(8)
2.7613(9)
2.607(2)
2.4203(9)
2.5820(13)
3.251
121.81(6)
116.11(3)
1.882(5)

X=I; Y=Se
(DFT)
2.470
2.731
2.591
2.459
2.566
3.492
119.9
118.7
1.904

X=Br; Y=Se
(EXP) (6)
2.4087(7)
2.6470(10)
2.631(2)
2.4130(8)
2.4298(13)
3.428
119.71(5)
119.56(3)
1.890(5)

X=Br; Y=Se
(DFT)
2.446
2.582
2.630
2.434
2.382
3.763
118.3
120.7
1.900

distance 2.62 Å) and two bridging selenium atoms from the dmise ligand. Each Cu +
ion in the core has distorted tetrahedral geometry with angles about each copper
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varying from 89.6 to 140.7° in 1 and 90.3° to 142.7° in 6. The central Cu 2(μ-I)2 core
in 1 is rhomboidal with bridging Cu-I bond distances of 2.76 Å, longer than the
terminal Cu-I bond distances of 2.58 Å. The angles in the Cu 2(μ-I)2 core are 56.3° for
I(1)-Cu(I)-(1A) and 123.7° for Cu(1)-I(1)-Cu(1A), whereas the Cu 2(μ-Br)2 core in 6
has Br(1)-Cu(1)-Br(1A) and Cu(1)-Br(1)-Cu(1A) angles of 50.6° and 120.4°,
respectively (Table 5.1). The tetrameric complex 6 has bridging Cu-Br bond distances
of 2.65 Å, longer than the terminal Cu-Br bond distances of 2.43 Å.
In the X-ray structures of 1 and 6, the average Cu-Se bond lengths of 2.41 Å
are shorter or comparable to most reported bridging copper-selenium complexes in
the literature47-49 but longer than previously synthesized mononuclear copper-selone
complexes such as [Tpm*Cu(dmise)] + (2.30 Å) and Tp*Cu(dmise) (2.33 Å). 19 The
bond distances for Cu(1)-I(1) (2.76 Å), Cu(2)-I(2) (2.58 Å), Cu(1)-Br(1) (2.65 Å) and
Cu(2)-Br(2) (2.43 Å) are shorter than the sum of the ionic radii of Cu + and I- (2.97 Å)
and Cu+ and Br- (2.73 Å), respectively. 50 Short-contact interactions between iodine
and hydrogen atoms are observed in the packing diagram of complex 1 (Figure 5.8),
whereas the packing diagram of complex 6 shows no short-contact interactions. The
short contact interactions of 3.16 Å between I(2)-H2B in 1 are within the sum of their
van der Waals radii (3.18 Å) and possibly promote stability of this complex. The long
Cu(1)-Cu(1A) distances in 1 and 6 indicate little interaction between these ions.
Density functional theory studies for tetrameric copper(I) halide complexes.
Theoretical DFT calculations were conducted on the tetrameric complexes 1 and 6 to
determine the effects of the halide and chalcogenone ligands on the observed crystal
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structures. The DFT(B3PW91)-optimized structures of 1 and 6 were optimized in C 2h
symmetry and are in good agreement with X-ray crystallographic data (Table 5.1)
with bond distances and angles generally within 0.04 Å and 2° of experimental
values. The Cu(2)-X(1) short contact is underestimated (DFT(B3PW91) = 0.25-0.35
Å; DFT(BP86) = 0.4-0.55 Å), especially for the BP86 xc functional which is known
to perform poorly for non-bonding interactions. Slight overestimation of the
calculated X-H2B short contacts may be attributed to the absence of intermolecular
X-H interactions in the gas phase. The DFT(B3PW91)-optimized geometries of the
hypothetical thione analogs (1(S) and 6(S)) were similar to 1 and 6 with shorter Cu-Y
bond distances. The energies of formation (ΔE+ZPE) of these species relative to the
CuX(dmit/dmise) monomers were ~10 kcal/mol less favorable than for 1 and 6.
Crystallographic studies of trigonal Cu(I) halides complexes with heterocyclic
selone and thione ligands Treating copper halides with two equivalents of dmise or
dmit results in the formation of monomeric three-coordinate complexes with differing
geometries. The molecular structures and atom numbering schemes for Cu(dmise) 2I
(2), Cu(dmit)2I (3a), and Cu(dmise)2Br (8) are given in Figure 5.4, and Table 5.2 lists
their selected bond distances and angles. X-ray structural studies established that
these complexes are monomeric with two non-bridging selone and thione ligands
coordinated to copper. The heterocyclic rings in complexes 2, 3a, and 8 adopt a trans
conformation relative to the halogen atom along the copper-chalcogenone bond. The
Cu+ ion has distorted trigonal geometry with angles ranging from 111.56° to 136.87°
for Cu(dmise)2I (2); 111.82° to 136.87° for Cu(dmit) 2I (3a); and 108.0° to 144.0° for
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Cu(dmise)2Br (8). The Cu-Se and Cu-S bond distances are 2.34 Å for 2 and 8 and
2.23 Å for 3a, whereas the avg. Cu-I bond distance of in 2 and 3a is 2.56 Å. Short
contact interactions between iodine and hydrogen atoms are found within the unit cell
of Cu(dmit)2I (3a; Figure 5.9) but are absent in the unit cell of the selenium analog
Cu(dmise)2I (2). The short contact interaction of 3.18 Å between I and H5C is equal
to the sum of their van der Waals radii (3.18 Å).

Figure 5.4. X-ray crystal structure diagrams of the trans structures: A) Cu(dmise)2I
(2), B) Cu(dmit)2I (3a), and C) Cu(dmise)2Br (8) showing 50% probability ellipsoids.
Hydrogen atoms are omitted for clarity.

Table 5.2. Experimental X-ray data (EXP) vs. theoretical DFT calculations for
selected bond lengths (Å) and angles (deg) for Cu(dmit)2I (3a), Cu(dmise)2I (2), and
Cu(dmise)2Br (8).
1:2
complex
Cu-X
Cu-Y
X-Cu-Y
Y-Cu-Y
C-Y-Cu
Y-C(1)

X=I; Y=S
(EXP) (3a)

X=I;
Y=S
(DFT)
2.5742(6)
2.497
2.2345(10) 2.301
111.823(19) 114.3
136.35(4)
131.4
107.59(7)
113.2
1.715(2)
1.710

X=I;
Y=Se
(EXP) (2)
2.5585(10)
2.3351(8)
111.56(2)
136.87(4)
105.55(13)
1.864(4)
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X=I;
Y=Se
(DFT)
2.507
2.394
111.4
137.1
110.0
1.871

X=Br;
Y=Se
(EXP) (8)
2.4117(10)
2.3430(7)
107.983(17)
144.03(4)
103.74(12)
1.867(4)

X=Br;
Y=Se
(DFT)
2.334
2.408
113.7
132.6
110.6
1.867

Relatively short distances between the selone heterocyclic ligands ranging
from 3.63 Å (A) to 3.95 Å (B) are observed for 2 (Figure 5.5), whereas distances of
3.67 Å (A) to 3.90 Å (B) are observed between the two heterocyclic thione ligands in
complex 3a, indicating intramolecular π-π interactions are present in both. In contrast,
complex 8 exhibits no intramolecular π-π interactions between the two heterocyclic
rings (minimum distance 4.13 Å) due to a shift in the C(1)-Se(1)-Cu(1)-Se(1A)
torsion angle (-11.08°) that results in a staggered orientation of the two fivemembered rings. The copper complexes 2, 3, and 8 have no intermolecular π-π
interactions as determined from inspection of their packing diagrams.

Figure 5.5. Diagram showing π-π
distances between heterocyclic ligands.

Treating copper halides with two equivalents of dmit or CuCl with two
equivalents of dmise also results in the formation of monomeric copper thione/selone
complexes. X-ray structural analysis shows that Cu(dmit) 2I (3b), Cu(dmit)2Cl (4),
Cu(dmise)2Cl (5), and Cu(dmit)2Br (7) have planar, three-coordinate geometry around
the Cu+ ion with one halide anion and two terminal thione or selone ligands. In each
case, the heterocyclic rings of the thione or selone ligands adopt a cis conformation
relative to the halide atoms (Figure 5.6).
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Figure 5.6. Crystal structure diagrams of A) Cu(dmit)2I (3b), B) Cu(dmit)2Cl (4), C)
Cu(dmit)2Br (7), and D) Cu(dmise)2Cl (5) displaying 50% probability density
ellipsoids. Hydrogen atoms are omitted for clarity.
Table 5.3. Experimental crystal data vs. theoretical DFT calculations for
selected bond lengths (Å) and angles (deg) of Cu(dmit)2Cl (4), Cu(dmit)2Br (7).

Cu-X
Cu-Y
X-Cu-Y
Y-Cu-Y
C-Y-Cu
Y-C(1)

X=Cl; Y=S
(EXP) (4)
2.2497(9)
2.2376(6)
120.692(17)
118.62(3)
106.07(7)
1.714(2)

X=Cl; Y=S
(DFT)
2.252
2.282
121.69
116.62
98.26
1.72
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X=Br; Y=S
(EXP) (7)
2.3857(8)
2.2298(9)
118.84(2)
122.32(5)
104.00(10)
1.717(3)

X=Br; Y=S
(DFT)
2.387
2.285
121.67
116.66
98.84
1.72

Table 5.4. Experimental crystal data vs. theoretical DFT calculations for selected
bond lengths (Å) and angles (deg) of Cu(dmit)2I (3b), Cu(dmise)2Cl (5).

Cu-X
Cu-Y
X-Cu-Y
Y-Cu-Y
C-Y-Cu
Y-C(1)

X=I; Y=S
(EXP) (3b)
2.5373(9)
2.2401(11) (avg)
120.085(3) (avg)
119.84(5)
99.425(12) (avg)
1.712(3) (avg.)

X=I;Y=S
(DFT)
2.550
2.291
122.8
114.5
99.3
1.720

X=Cl; Y=Se (EXP)
(5)
2.238(2)
2.3459(14) (avg.)
123.00(7) (avg.)
113.89(5)
104.5(2)
1.862(8)

X=Cl; Y=Se
(DFT)
2.253
2.392
122.0
116.0
94.9
1.878

The Cu+ ion has distorted trigonal geometry with angles ranging from 116.8°
to 123.4° for Cu(dmit) 2I (3b); 118.6° to 120.7° for Cu(dmit) 2Cl (4); and 118.8° to
122.3° for Cu(dmit)2Br (7). The Cu-S bond distances in complexes 3a (transCu(dmit)2I), 3b (cis-Cu(dmit)2I), 4, and 7 range 2.23 to 2.41 Å (Table 5.3 and 5.4).
The Cu+ ion in complex 5 has a distorted trigonal geometry with angles ranging from
113.9° to 125.8°, and its Cu-Se bond distance of 2.34 Å is identical to that of
Cu(dmise)2I (2) and Cu(dmise)2Br (8) (2.34 Å) but shorter than those found in the
tetrameric copper complexes 1 (2.42 Å) and 6 (2.41 Å).
Changes in the halide ligand have no significant effects on Cu-S bond
distances, since the Cu-S bond lengths of 2.2345(10) Å for trans-Cu(dmit)2I (3a),
avg. 2.2401(11) Å for cis-Cu(dmit)2I (3b), 2.2376(6) Å for Cu(dmit) 2Cl (4) and
2.2298(9) Å for Cu(dmit) 2Br (7) are very similar. The Cu-S bond distances in 3a, 3b,
4, and 7 are comparable to previously reported trigonal planar or tetrahedral
coordinated copper complexes, 19,51-55 but shorter than other reported copper thione
complexes such as Cu2X2(mimzSH)4 (X = Cl, Br, I, and mimzSH = 1-methyl-1,3-
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imidazoline-2-thione, 2.31-2.52 Å),56 Cu2I2(Ph3PS)2(NCCH3)2 (2.34 Å),57 and
[CuBr(ε2-S-μ-C5H5NS)(p-Tol3P)]2 (2.39 and 2.42 Å).31 Coordination of the thione
ligand to copper in complexes 3a, 3b, 4, and 7 results in almost identical S-C(1) bond
distances, 1.71-1.72 Å, which are longer than the S-C(1) bond distance in the free
thione ligand (1.68 Å). 58 Increasing van der Waals radii of the halogens coordinated
to copper (1.7-1.9 Å for Cl < 1.8-2.0 Å for Br < 1.95-2.12 Å for I), 50 results in
decreased C(1)-S(1)-Cu(1) bond angles; Cu(dmit) 2Cl (4; 106.1°), Cu(dmit)2Br (7;
104°), and cis-Cu(dmit)2I (3b; average 99.5°).
The three-coordinate copper-selone complexes Cu(dmise) 2I (2), Cu(dmise)2Cl
(5), and Cu(dmise)2Br (8) have identical Cu-Se bond distances of 2.34 Å, distances
shorter than previously-reported copper selenium complexes such as [Cu(oC6H4(SeMe)2)2][PF6] (2.42 Å),59 and [Cu(C11H14Se2)2][BF4] (average 2.41 Å). 60 The
Cu-Se bond length of 2.34 Å in complexes 2, 5, and 8 is longer than that in the
tetrahedrally coordinated tris(pyrazolyl)copper-selone complexes [TpmRCu(dmise)]+
(2.29-2.31 Å), and Tp*Cu(dmise) (2.33 Å). 19 Coordination of the selone ligand to
copper results in relatively unchanged Se-C(1) bond lengths of 1.88 Å for 1 and 1.89
Å for 6, but slightly shorter Se-C(1) bond lengths of 1.86 Å for 2 and 5 and 1.87 Å for
8, relative to that of the uncoordinated dmise ligand (1.89 Å). 61 The polarizability and
size differences between chloride, bromide and iodide have the most pronounced
effect on the X-ray structures of complexes 1, 2, 3a, 3b, 4, 5, 6, 7, and 8, but have no
observable effects on Cu-Se or Cu-S bond lengths.
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Density functional theory studies for trigonal copper halide complexes.
DFT(B3PW91) geometry optimizations predict the cis isomer to be the lowest energy
conformation for each of the 1:2 Cu:thione/selone complexes. The geometries of 3b,
4, 5, and 7 agree with the X-ray structures of (Table 5.3 and 5.4) and accurately
reproduce the X-H5C short contacts (3.160, 2.711, 2.742, 2.888 Å, respectively). Full
optimization of complexes 2, 3a, and 8 in C2 symmetry using the BP86 xc functional
led to a C2v configuration in which there is no -π interaction and the imidazole rings
of the thione/selone ligands form an electrostatic interaction with the halide (anion-π
interaction). Surprisingly, the C 2v conformation is roughly degenerate (ΔE+ZPE < 1.0
kcal/mol) with the experimentally observed structures indicating that the anion -π and
X-H5C interactions between the halide and the dimethylimidazole fragment are
similar in magnitude.
To obtain conformations with

-π interactions, the 1:2 complexes were

optimized with the N2(2)-C(2)-Se-Cu dihedral angles constrained to the experimental
value followed by a full optimization with a small step size in the search algorithm.
The local minima with π-π interactions were found only for 2, 3a, and 8 and their
structures generally agree with the experimental X-ray crystal data (Table 5.2).
However, these structures were ~10 kcal/mol less stable than structures without
intramolecular π-π interactions. In addition, the experimental structures show an
apparent attractive interaction between the π-clouds of the dimethylimidazole rings
(d(C1-C1A) < d(C3/4-C3/4(A)), not found in the DFT calculations. This attraction
may be due to X-H3/4 interactions between molecules in the crystal, which would
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explain why the „attractive‟ interaction is more pronounced when X is the smaller
bromide (8). This suggests that for the structures of 2, 3a, and 8, π-π interactions may
actually be preferred conformations due to the weak hydrogen-bonding interactions
between units of the crystal. Such a conformation would be disfavored for X = Cl due
to repulsive forces at the shorter C3/4-C3/4(A) distances required for Cl-H3/4
interactions to the smaller halogen. The lack of π-π interactions in 8 may be explained
similarly if Br-H3/4 interactions are comparable to Se-H5 interactions such that
complex 8 maintains the face-to-face orientation of the heterocyclic rings, but with a
twist to increase the Se-H5 interaction.
For comparison to 1 and 6, the energies of formation of the cis 1:2 complexes
from CuX(dmit/dmise) and an additional dmit/dmise ligand were calculated. The
energy per chalcogenone is lower for the selones than the thiones (ΔE+ZPE = -6.0–6.3 versus -5.2–-5.7 kcal mol -1 chalcogenone-1). These values are comparable to the
formation energy per chalcogenone for the hypothetical 1:1 sulfur analogues 1(S) 6(S)
(-5.8 and -5.5 kcal mol -1 chalcogenone-1, respectively). Therefore, the 1:1 clusters are
energetically preferred for selones, but, the similar energies per thione suggest that
experimental conditions favor the 1:2 complexes.
Powder X-ray diffraction studies of copper(I) halide complexes. Powder X-ray
diffraction (XRD) studies of both the tertrameric and monomeric copper complexes
were carried out to determine whether more than one conformer was present in the
reaction products. Experimental powder XRD patterns of the copper chloride
complexes 4 and 5 fully matched their simulated patterns, suggesting that only the cis
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conformer is formed and corroborating DFT calculation results (Figures 5.18-5.19). In
contrast, powder XRD patterns reveal the presence of both cis and trans conformers
of CuI(dmit)2 (3a and 3b; Figure 5.7) in powder samples. Diffraction patterns for Cu
complexes 1, 2, 6, 7, and 8 also do not fully match the simulated patterns determined
from their respective single crystallographic data (Figures 5.10-5.17), indicating that
more than one conformer may be present. Attempts to grow crystals of additional
conformers using different solvent systems, seeding the crystallization solution with
an analogous crystal of the desired conformer, or crystallizing at low temperatures
were not successful.

Figure 5.7. Experimental powder X-ray diffraction pattern of A) CuI(dmit)2
and simulated powder patterns for B) trans-CuI(dmit)2 (3a) and C) cisCuI(dmit)2 (3b).

139

Generally, structural and stoichiometric predictions of metal complexes
depend on the geometrical flexibility of the metal ion coupled with the steric and
electronic requirements of ligands. We found that changing the halide ligand had the
most profound effect on the coordination number and geometry of the resulting
copper-chalcogenone complexes. Similarly to previous reports, 62-64 formation of
halide bridges are generally favored for the soft iodide but not for the harder chloride
ligands, whereas both bridging and terminal bonding modes were observed for the
bromide ligands, since bromide lies on the borderline between soft and hard Lewis
bases. Formation of the tetrameric bridging selone complexes 1 and 6 are likely
favored by the presence of two highly polarizable atoms, selenium and iodine or
bromine, with high propensities to bridge metal centers.
The conformations obtained for the three coordinate copper complexes 2, 3a,
3b, 4, 5, 7, and 8, depend on several factors, including packing forces, halide ligand,
and the number and strength of stabilizing short-contact interactions between X-H or
Y-H (X = I, Br, or Cl; Y = Se or S). For the trigonal complexes 2 and 3a that have
intramolecular π-π interactions between the heterocyclic rings, only very weak short
contact intermolecular interactions between I-H atoms of 3.18 Å exist in 3a, whereas
2 has no short-contact intermolecular interactions. In contrast, complexes without
intramolecular π-π interactions (3b, 4, 5, 7, and 8) have more significant shortcontact intermolecular interactions between the halides or chalcogenones and
neighboring hydrogen atoms. These short- contact interactions likely stabilize the cis
conformations (or the twisted trans conformation of 8) of these complexes relative to
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the trans conformations of 2 and 3a, corroborating DFT results indicating that
complexes with intramolecular π-π interactions were generally less stable than
structures without intramolecular π-π interactions. The lack of short contact
interactions in 2 and 3a suggest that these complexes may be stabilized by the
intramolecular π-π interactions between the heterocyclic rings, whereas complexes
3b, 4, 5, 7, and 8 are primarily stabilized by crystal packing forces resulting from
short-contact intermolecular interactions between X-H (X = Cl, Br, I, Se, and S).
IR spectroscopy. In the IR spectra of the copper thione complexes, the
diagnostic ν(C=S) peak appears at lower wavenumbers (1171-1173 cm -1) for the
trigonal complexes 3, 3b, 4, and 7 compared to 1181cm -1 for uncoordinated dmit. 65 In
contrast, the ν(C=Se) peaks are shifted to slightly higher energies (1149-1163 cm-1)
for complexes 1, 2, 5, 6, and 8 than uncoordinated dmise (1148 cm -1).66,67 Although it
is not clear why this difference between S and Se coordination occurs between these
complexes, the shift to lower energy for ν(C=S) upon coordination of dmit to copper
may indicate weakening of C=S bond due to copper back-bonding, whereas the shift
to higher energy for ν(C=Se) upon dmise coordination to copper indicates a slight
strengthening of the C=Se bond due to Cu-Se donor bond formation. The same trend
was observed for tetrahedral coordinated tris(pyrazolyl)methane/borate-copper-thione
(ν(C=S) 1172-1178 cm-1) and –selone (ν(C=Se) 1150-1151 cm-1) complexes19 as well
as Zn2+ and Cd2+ complexes of these ligands. 32,38,68 DFT calculations assign the
C=Se/S stretching band as symmetric and asymmetric modes. For 3b, 4, 5, and 7, the
lower-frequency asymmetric mode is more intense, whereas the symmetric stretch is
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more intense for the face-to-face complexes 2, 3a, and 8.
NMR spectroscopy of copper(I) halide thione and selone complexes. For all the
copper complexes 1-8, the 1H NMR resonances for the methyl and olefinic protons of
the copper-bound dmise or dmit ligands are shifted downfield relative to unbound
ligand, consistent with reports by Lobana, et al.,20,21,56 Rabinovich, et al.,69 and
Kimani, et al.19 In the

13

C{1H} NMR spectra, upfield shift of the C-2 resonance of the

dmise and dmit (both δ ~6) is also observed upon copper complexation. Similar
upfield shifts for the C=Se or C=S carbon atoms were observed for Cu+ complexes
[TpmRCu(L)] + and Tp*Cu(L) (L = dmit or dmise). 19 The downfield shift of the
olefinic protons resonances in the 1H NMR spectra, as well as similar downfield shifts
of the C-4 and C-5 resonances in the

13

C{1H} NMR spectra, may result from minor

increases in deshielding effects on C-4 and C-5 carbons due to increased electron
density on the C-N bond of the heterocyclic five-membered ring upon metal
complexation and concomitant weakening of the C=S/Se bond.70,71 This explanation
is consistent with the observed shift of the ν(C=S) band to lower energies upon dmit
coordination, but not consistent with the observed shift of the ν(C=Se) band to higher
energies, indicating differences between S and Se coordination in these complexes.
The trans conformer (3a) has thione 1H resonances at
13

C{1H} resonances at

thione 1H resonances at

3.63 and 7.32 and

36.0, 120.4, and 155.1, whereas the cis conformer (3b) has
3.59 and 7.27 and

13

C{1H} resonances at

35.9, 120.2, and

155.9. When the cis and trans conformers were combined in a single NMR sample, a
single set of resonances were observed in both the 1H and
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13

C{1H} NMR, indicating

that the two conformers interconvert in solution, a result that is consistent with
electrochemical results.
77

Se{1H} NMR resonances for the copper-selone complexes 1, 2, 5, 6, and 8

are shifted upfield (δ -13.4 to -75.0) upon copper coordination relative to the free
dmise ligand (δ 21.8). This upfield shift is a result of the selenium atom binding to the
electron-rich copper ion, but no correlation exists between Cu-Se bond lengths and
77

Se{1H} NMR shifts.
Electrochemical studies of the copper halide complexes. Electrochemical

properties of the copper(I)-halide complexes 1, 2, 3a, 3b, 4, 5, 6, 7, and 8 were
examined by cyclic voltammetry (CV) to determine the difference in Cu 2+/+ redox
potential upon Cu-selone or Cu-thione coordination. Cyclic votammograms of these
copper complexes exhibit two, one-electron, chemically-reversible potential waves
for the Cu2+/+ and Cu+/0 redox potentials. A wave corresponding to the Cu +/0 redox
couple is observed at potentials more negative than -1000 mV vs. NHE. The Cu0 is
then stripped off the electrode after switching the scan direction at a potential around
-800 mV (Table 5.6).
Electrochemical studies of the three-coordinate copper complexes 2, 3a, 3b, 4,
5, 7, and 8 were carried out in acetonitrile solution with tetra-n-butylammonium
phosphate electrolyte and a carbon working electrode. All the complexes exhibit
chemically reversible Cu 2+/+ reduction waves. Complexes 2, 4, 5, 7 and 8 exhibit
quasi-reversible oxidation and reduction waves, whereas complexes 1, 3a, 3b, and 6
exhibit irreversible electrochemical behavior for the Cu 2+/+ couple (Table 5.5). The

143

selone complexes 2, 5, and 8 have lower Cu2+/+ reduction potentials ranging from
-340 to -362 mV compared to Cu 2+/+ reduction potentials of the analogous thione
complexes 3a, 3b, 4, and 7, which range from -177 to -284 mV (CV voltammograms
are provided in Figures 5.20). Additionally, the thione- copper complexes show larger
peak separations between the cathodic and anodic waves compared to the copper
selone complexes. The large peak separations of the copper thione complexes may
indicatre instability of the oxidized products during the voltammetry sweep due to
slow electron transfer kinetics. 72
The copper selone complexes CuX(dmise)2 (X = I, Br and Cl) have reduction
potentials more negative by an average of 108 mV relative to the copper thione
complexes CuX(dmit)2 (X = I, Br and Cl), consistent with previous reports. 19 The
CuI(dmit)2 complex 3b (cis-conformation, -177 mV), has a more positive Cu 2+/+
reduction potential than complex 3a (trans-conformation, -239 mV). A mixed sample
of the two conformers revealed a single Cu 2+/+ at -256 mV (Figure 20G); these results
coupled with 1H and

13

C{1H} NMR data, indicate that these conformers interconvert

in solution.
Cyclic voltammogram for CuCl(dmit) 2 (4), CuCl(dmise)2 (5), CuBr(dmit)2 (7),
CuBr(dmise)2 (8), exhibit two, one-electron, waves belonging to Cu 2+/+ and Cu+/0
redox potentials. In contrast, cyclic voltammograms of Cu 4(μ4-dmise)(μ-I)2 I2 (1),
CuI(dmise)2 (2), CuI(dmit)2 (3a), CuI(dmit)2 (3b), and Cu4(μ4-dmise)(μ-Br)2Br2 (6)
show three distinct reduction potentials waves (Figure 5.20). Two of the waves
correspond to Cu2+/+ and Cu+/0 redox potentials. The third reduction wave likely
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corresponds to I-/I2 or Br-/Br2 reduction couples. As previously observed for copper
halide complexes,73,74 the weakly coordinated iodide ligand in complexes 1, 2, 3a, and
3b or bromide ligand in complex 6 may undergo ligand subtitution with solvent
acetonitrile resulting in the observed halogen reduction peaks.
Differential pulse voltammetry (DPV) studies of complexes 1 and 6 exhibit
two distinct reduction and oxidation peaks in their voltammograms, corresponding to
Cu2+/+ and their respective halogen redox potentials (Figure 5.21). Thus, the
tetrameric copper complexes 1 and 6 exhibit a single Cu2+/+ reduction potential at
-452 and -365 mV, respectively, despite having two different copper centers with
different geometries.

Table 5.5. Reduction potentials of Cu2+/+ for the copper selone and thione
complexes vs. NHE.
Complex
Cu4(μ4-dmise)(μ-I2)I2
(1)
Cu4(μ4-dmise)(μ-I2)I2
(1)a
Cu4(μ4-dmise)(μ-Br2)Br2 (6)
Cu4(μ4-dmise)(μ-Br2)Br2 (6)a
CuCl(dmise)2
(5)
CuCl(dmit)2
(4)
CuBr(dmise)2
(8)
CuBr(dmit)2
(7)
trans-CuI(dmit)2
(3a)
cis-CuI(dmit)2
(3b)
Mixed (cis + trans)-CuI(dmit)2
CuI(dmise)2
(2)

Epa
83, -235
(mV)
34,
-285
-39,-178
-106, -139
245
52
-151
41
176
298
192
-117
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Cu2+/+
Epc
ΔE (mV)
0, -986
1069
(mV)126,
92, 379
-644
605
664
-42, 64, 381
-570
431
626
-620
672
-584
432
-524
565
-653
829
-651
949
-705
897
-562
445

E1/2 (mV)
-452
80, -475
-342
-74, -436
-355
-284
-362
-241
-239
-177
-256
-340

Table 5.6. Reduction potentials of Cu+/0 for the copper selone and thione
complexes vs. NHE.
Complex
Cu4(μ4-dmise)(μ-I2)I2
(1)
Cu4(μ4-dmise)(μ-Br2)Br2 (6)
CuCl(dmise)2
(5)
CuCl(dmit)2
(4)
CuBr(dmise)2
(8)
CuBr(dmit)2
(7)
trans-CuI(dmit)2
(3a)
cis-CuI(dmit)2
(3b)
Mixed (cis + trans)-CuI(dmit)2
CuI(dmise)2
(2)

Epa
-866
(mV)
-881
-821
-861
-812
-850
-828
-868
-656
-878

Cu+/0
Epc (mV) ΔE (mV)
-1355
489
-1274
393
-1211
390
-1232
371
-1203
391
-1219
369
-1335
507
-1335
467
-1.321
665
-1223
345

E1/2
-1111
(mV)
-1078
-1016
-1046
-1008
-1034
-1082
-1101
-989
-1051

The changes in Cu2+/+ reduction potentials of the three-coordinate complexes 2,
3a, 3b, 4, 5, 7, and 8 are correlated to the halide and chalcogenone ligands. For the
copper thione complexes, reduction potentials are shifted to lower voltages in the
following order: CuI(dmit)2 (3b; -177 mV), CuBr(dmit)2 (7; -241 mV), and CuCl(dmit)2
(4; -284 mV), a trend previously observed for copper halide complexes.74 Less
polarizable halide ligands stabilize Cu2+ relative to Cu+, resulting in a more negative
Cu2+/+ reduction potential for the copper thione complexes. The analogous copper selone
complexes have more negative potentials relative to the thione complexes, but the trend
observed for the thione complexes is not fully followed: CuI(dmise)2 (2; -340 mV),
CuCl(dmise)2 (5; -355 mV), and CuBr(dmise)2 (8; -362 mV).
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Conclusions
Copper halides (CuI, CuBr, and CuCl) with selone and thione ligands have
been synthesized and characterized, and their electrochemistry has been investigated
and compared. The X-ray crystal structures for tetranuclear complexes 1 and 6, and
trigonal complexes 2, 3, 3b, 4, 5, 7, and 8 have been determined. The tetrameric
omplexes 1 and 6 have two different copper coordination environments and a Cu 2(μI)2 or Cu2(μ-Br)2 core coordinated to two bridging selenium atoms. In contrast, the
three-coordinate thione and selone complexes 2, 3a, 3b, 4, 5, 7 and 8 adopt distorted
trigonal planar geometry, where Cu + is bound to a halide (Cl, Br, or I) and two thione
or selone ligands. The geometry and stochiometry of the copper complexes obtained
depends on several factors, including halide and chalcogenone ligand, intramolecular
π-π interactions, and intermolecular short contact interactions in the crystal. DFT
calculations show good correlation to the observed X-ray structures for compounds 18. Cyclic voltammetry studies for the three-coordinate complexes show lower
reduction potentials for copper selone complexes relative to the copper thione
complexes regardless of the coordinated halide ligand. These results highlight the rich
coordination chemistry and variable binding modes of heterocyclic selone and thione
ligands.

Experimental Section
Materials. The synthesis and manipulation of all copper complexes was
performed under an inert atmosphere of argon or nitrogen using standard Schlenk
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techniques. Acetonitrile, methanol, dichloromethane, and ether were purified using
standard procedures and freshly distilled under argon atmosphere prior to use. N,N’dimethylimidazole selone (dmise), N,N’-dimethylimidazole thione (dmit) 75 and
[Cu(NCCH3)4][BF4]76 were synthesized according to published procedures. Selenium
powder, sulfur powder, cuprous chloride (Aldrich), cuprous iodide (Aldrich), cuprous
bromide (Alfa Aesar), cuprous oxide (stabilized, Aldrich), potassium iodide
(Aldrich), 1-methylimidazole (VWR), and methyliodide (VWR) were used as
received.
Instrumentation. 1H, 13C{1H}, and 77Se{1H} spectra were obtained on a BrukerAVANCE 500 MHz NMR spectrometer. 1H and
reported in

13

C{1H} NMR chemical shifts are

relative to tetramethylsilane (TMS) and referenced to solvent.

77

Se{1H}

NMR chemical shifts were externally referenced to diphenyl diselenide (δ 461), 77 and
reported relative to dimethyl selenide (δ 0). Electrochemical experiments were
performed with a BAS 100B potentiostat. A three compartment cell was used with a
Ag/AgCl reference electrode, a Pt counter electrode, and a carbon working electrode.
Freshly distilled acetonitrile was used as the solvent with tetra-n-butylammonium
phosphate as the supporting electrolyte (0.1 M). Solutions containing 1 mM analyte
were deaerated for 2 min by vigorous nitrogen purge. All E1/2 values were calculated
from (Epa + Epc)/2 at a scan rate of 100 mV/s. Differential pulse voltammetry (DPV)
experiments were conducted using a pulse amplitude of 0.080 V and a pulse width of
0.050 s, in conjunction with a sample width of 0.045 s and a pulse period of 0.200 s.
The powder X-ray diffraction (XRD) patterns were measured using an angle
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dispersive diffractometer (Rigaku Ultima IV) with monochromated Cu-Kα (λ = 1.540)
radiation at 40 kV. Infrared spectra were obtained using nujol mulls on KBr salt
plates with a Magna 550 IR spectrometer. Abbreviations used in the description of
vibrational data are as follows: vs, very strong; s, strong; m, medium; w, weak; b,
broad. Electrospray ionization mass spectrometry (ESI-MS) was performed using a
QSTAR XL Hybrid MS/MS System from Applied Biosystems via direct injection of
sample (0.05 mL/min flow rate) into a Turbo Ion spray ionization source. Samples
were run under positive mode, with ion-spray voltage of 5500 V, and TOF scan mode.
Melting points were determined using a Barnstead Electrothermal 9100 apparatus in
silicon-grease-sealed glass capillary tubes. UV-vis spectra were collected using a
Shimadzu UV-3101 PC spectrophotometer in quartz cuvettes with a path length of 1
cm. Elemental analysis was performed by Atlantic Microlabs, Inc.
Theoretical methods. Geometry optimizations were performed with the
B3PW91 and BP86 exchange-correlation (xc) functionals using PQS version 3.3. 78
Copper and selenium were represented by the Ermler-Christiansen relativistic
effective core potential.79 The copper basis set was modified to include the CoutyHall 4p contraction.80 The Wadt-Hay RECP basis set for sulfur and the halogens were
augmented with a set of diffuse s- and p-functions.81 Nitrogen, oxygen and hydrogen
centers attached to non-carbon heavy atoms were represented by the Dunning splitvalence triple-δ plus polarization function basis set (TZVP). 82 Hydrocarbon fragments
were double-δ quality with polarization functions added to carbon. 83 Frequency
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calculations were used to confirm that the reported structures are minima on the
respective potential energy surfaces.

Cu4(μ4-dmise)(μ-I2)I2 (1). Method 1. The dmise ligand (176 mg, 1 mmol) was
dissolved in acetonitrile (20 mL) and this solution was cannula transferred into a
solution of [Cu(CNCH3)4][BF4] (312 mg, 1 mmol) in acetonitrile (20 mL). The
reaction mixture was stirred at room temperature for 1 h until the reaction mixture
was clear and colorless. Into this reaction mixture was cannula transferred KI (332
mg, 2 mmol) in methanol (15 mL) and the reaction was stirred for 5 h. The solvent
was removed in vacuo, and the product was extracted using acetonitrile. Acetonitrile
was removed in vacuo, yielding a white solid. Yield: 234 mg, 16%. Single crystals for
X-ray analysis were grown from slow vapor diffusion of ether into an
acetonitrile/DMF solution of the complex.
Method 2. The dmise ligand (176 mg, 1 mmol) was dissolved in acetonitrile
(20 mL) and this solution was cannula transferred into a solution of CuI (190 mg, 1
mmol) in acetonitrile (20 mL). The reaction mixture was stirred at room temperature
for 1 h, resulting in the formation of a white precipitate. Into this reaction mixture
was cannula transferred KI (332 mg, 2 mmol) in methanol (15 mL), resulting in a
clear solution followed by gradual formation of a white precipitate. The mixture was
stirred for 6 h, dried in vacuo, and the desired product was extracted using acetonitrile
(10 mL). The filtrate was dried in vacuo to yield a white powder. Single crystals for
X-ray

analysis

were

grown

from

slow
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vapor

diffusion

of

ether

into

anacetonitrile/DMF solution of the complex. Yield: 312 mg, 21%. Mp. 193 °C.
Found: C, 16.83; N, 7.15; H, 2.22; requires C20H32Cu4N8Se4I4 C, 16.43; N, 7.66; H,
2.21%. UV-vis [λmax, nm (εM, M-1 cm-1)] in CH3CN: 245 (206,028), 276 sh (53,555).
IR (cm-1): 623 s, 658 s, 751 s, 773 s, 831 s, 1027 s, 1082 s, 1144 s, 1163 s, 1229 s,
1378 s, 1465 b, 1561 s, 1600 s, 1660 b, 2923 b. δH (500 MHz; CD2Cl2; Me4Si): 3.88
(6H, s, 2CH3), 6.97 (2H, s, 2CH). δ C (500 MHz; CD2Cl2; Me4Si): 37.58 (CH3), 121.60
(CH), 150.51 (C=Se). δ Se (500 MHz; (CD3)2SO; PhSeSePh): -42.8; m/z (ESI-MS):
796.5

[Cu3(dmise)3I2]+,790.5

[Cu2(dmise)3I]+,

604.7

[Cu2(dmise)2I]+,

414.9

[Cu(dmise)2]+.
Cu(dmise)2I (2). A dichloromethane solution (20 mL) of dmise (350 mg, 2
mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile
(20 mL). The reaction mixture was stirred at room temperature for 6 h, resulting in
the formation of a white precipitate. The white precipitate was filtered and dried in
vacuo to yield a white powder. Single crystals for X-ray analysis were grown by slow
vapor diffusion of ether into an acetonitrile/DMF solution in the complex. Yield: 459
mg, 85%. Mp. 156 °C. Found: C, 22.31; N, 10.19; H, 2.85; requires C 10H16CuN4Se2I
C, 22.22; N, 10.36; H, 2.98%. UV-vis [λmax, nm (εM, M-1 cm-1)] in CH3CN: 228
(65,990). IR (cm -1): 474 w, 623 s, 662 s, 724 w, 750 s, 772 s, 831 s, 1092 s, 1117 s,
1148 s, 1163 s, 1232 vs, 1378 vs, 1466 vs, 1566 vs, 1600 w, 2855 vs, 2924 b, 3110 s,
3143 s. δH (500 MHz; (CD3)2SO; Me4Si): 3.70 (6H, s, 2CH3), 7.46 (2H, s, 2CH). δ C
(500 MHz; (CD3)2SO; Me4Si): 37.66 (CH3), 122.20 (CH), 147.81 (C=Se). δ Se (500
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MHz; (CD3)2SO; PhSeSePh): -48.9; m/z (ESI-MS): 414.85 [Cu(dmise) 2]+, 255.04
[Cu(dmise) + OH] +, 238.89 [Cu(dmise)] +, 158.98 [Cu(C5N2H8)]+.
trans-Cu(dmit)2I (3a). Method 1. A dichloromethane solution (20 mL) of dmit
(260 mg, 2 mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in
acetonitrile (10 mL). The reaction mixture was stirred at room temperature for 6 h,
resulting in the formation of a white precipitate. The white precipitate was filtered
and dried in vacuo to yield a white powder. Single crystals for X-ray analysis were
grown by slow vapor diffusion of ether into an acetonitrile/DMF solution in the
complex. Yield: 410 mg, 92%.
Method 2. An acetonitrile solution (20 mL) of dmit (260 mg, 2 mmol) was
cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile (20 mL).
The reaction mixture was stirred at room temperature for 1 h, resulting in the
formation of a white precipitate. To this reaction mixture was added KI (332 mg, 2
mmol) in methanol (15 mL), resulting in a clear solution that was stirred for 6 h, and
then dried in vacuo. The desired product was extracted using acetonitrile (10 mL),
and the filtrate was dried in vacuo to yield a white powder. Single crystals for X-ray
analysis were grown from slow vapor diffusion of ether into acetonitrile solution.
Yield: 401 mg, 89%. Mp. 152 °C. Found: C, 26.51; N, 12.39; H, 3.55. requires
C10H16CuN4S2I C, 26.88; N, 12.54; H, 3.61%. UV-vis [λmax, nm (εM, M-1 cm-1)] in
CH3CN: 246 (38,384). IR (cm -1): 629 s, 673 s, 721 s, 744 s, 826 s, 1030 s, 1082 s,
1171 s, 1227 s, 1379 s, 1466 s, 1564 s, 2926 b. δH (500 MHz; (CD3)2SO; Me4Si): 3.63
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(6H, s, 2CH3), 7.32 (2H, s, 2CH). δ C (500 MHz; (CD3)2SO; Me4Si): 36.02 (CH3),
120.46 (CH), 155.12 (C=S); m/z (ESI-MS): 318.98 [Cu(dmit)2]+, 231.98 [Cu(dmit) +
MeOH] +, 190.96 [Cu(dmit)] +.
cis-Cu(dmit)2I (3b). A dichloromethane solution (20 mL) of dmit (260 mg, 2
mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile
(20 mL). The reaction mixture was stirred at room temperature for 6 h. The reaction
mixture was reduced to about 5 mL in vacuo and the desired product precipitated by
addition of ether. The precipitate was filtered, dried in vacuo to yield a white powder.
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into
an acetonitrile/dichloromethane solution of the complex. Yield 404 mg, 90%. Mp. 152
°C. Found: C, 26.51; N, 12.39; H, 3.55; requires C 10H16CuN4S2I C, 26.88; N, 12.54;
H, 3.61%. UV-vis [λmax, nm (εM, M-1 cm-1)] in CH3CN: 247 (29,773). IR (cm-1): 629 s,
673 s, 721 s, 744 s, 826 s, 1030 s, 1082 s, 1171 s, 1227 s, 1379 s, 1466 s, 1564 s, 2926
b. δH (500 MHz; (CD3)2SO; Me4Si): 3.59 (6H, s, 2CH3), 7.27 (2H, s, 2CH). δ C (500
MHz; (CD3)2SO; Me4Si): 35.88 (CH3), 120.22 (CH), 155.87 (C=S); m/z (ESI-MS):
318.98 [Cu(dmit)2]+, 222.98 [Cu(dmit) + MeOH] +, 190.96 [Cu(dmit)] +.
Cu(dmit)2Cl (4). A dichloromethane (20 mL) solution of dmit (260 mg, 2
mmol) was cannula transferred into a solution of CuCl (99 mg, 1 mmol) in ethanol
(20 mL). The reaction mixture was stirred at room temperature for 1 h, resulting in
the formation of a white precipitate. The filtrate was removed via cannula filtration
and the precipitate was dried in vacuo yielding a white powder. Single crystals for X-
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ray analysis

were

grown

from

slow

vapor

diffusion

of

ether

into

an

acetonitrile/methanol solution of the complex. Yield: 313 mg, 87%. Mp. 158 °C.
Found: C, 33.76; N, 15,67; H, 4.48; requires C10H16CuN4S2Cl C, 33.80; N, 15.76; H,
4.54%. UV-vis [λmax, nm (εM, M-1 cm-1)] in CH3CN: 261 (22,595). IR (cm -1): 663 s,
670 s, 730 s, 748 s, 763 vs, 803 w, 867 w, 1087 s, 1173 vs, 1242 vs, 1378 vs, 1464 vs,
1571 s, 1621 s, 1728 w, 2924 b, 3147 w. δH (500 MHz; (CD3)2SO; Me4Si): 3.56 (6H,
s, 2 CH3), 7.28 (2H, s, 2 CH2). δC (500 MHz; (CD 3)2SO; Me4Si): 35.75 (CH3), 120.45
(CH), 154.63 (C=S); m/z (ESI-MS): 318.98 [Cu(dmit)2]+, 222.98 [Cu(dmit) +
MeOH] +, 190.96 [Cu(dmit)] +, 128.03 [dmit] +.
Cu(dmise)2Cl (5). Complex 5 was prepared using the same procedure for 4
except that dmise (350 mg, 2 mmol) was used instead of dmit. Single crystals for X ray analysis were grown from slow vapor diffusion of ether into an acetonitrile/DMF
solution of the complex. Yield: 414 mg, 92%. Mp. 170 °C. Found: C, 26.98; N, 12.52;
H, 3.51; requires C 10H16CuN4Se2Cl C, 26.71; N, 12.47; H, 3.59%. UV-vis [λmax, nm
(εM, M-1 cm-1)] in CH3CN: 273 (9,844). IR (cm -1): 653 s, 658 s, 719 vs, 743 vs, 764
vs, 868 w, 1027 vs, 1069 b, 1149 vs, 1243 vs, 1378 vs, 1465 vs, 1570 s, 1625 w, 2916
b. δH (500 MHz; (CD3)2SO; Me4Si): 3.66 (6H, s, 2 CH 3), 7.44 (2H, s, 2 CH2). δC (500
MHz; (CD3)2SO; Me4Si): 37.55 (CH3), 122.36 (CH), 146.23 (C=Se). δSe (500 MHz;
(CD3)2SO; PhSeSePh): -39.3; m/z (ESI-MS): 414.85 [Cu(dmise) 2]+, 270.91
[Cu(dmise) + MeOH] +, 255.04 [Cu(dmise) + OH] +, 238.89 [Cu(dmise)] +, 158.98
[Cu(C5N2H8)]+.

154

Cu4(μ4-dmise)(μ-Br2)Br2 (6). CuBr (144 mg, 1 mmol) was dissolved in ethanol
(15 mL) and to this was cannula added a solution of dmise (175 mg, 1 mmol) in
dichloromethane (15 mL). The reaction was stirred for 6 h, and the solvent reduced in
vacuo to about 5 mL. The desired product was precipitated using ether (10 mL). This
white precipitate was filtered and dried in vacuo. Single crystals suitable for X-ray
analysis were grown by slow diffusion of ether into an acetonitrile solution of the
complex. Yield: 306 mg, 24%. Mp. 212°C. Found: C, 18.89; N, 8.81; H, 2.60;
requires C20H32Cu4N8Se4Br4 C, 18.83; N, 8.79; H, 2.53%. UV-vis [λmax, nm (εM, M-1
cm-1)] in CH3CN: 261 (26545). IR (cm-1): 659 s, 744 s, 770 w, 1103 w, 1150 s, 1227
s, 1261 s, 1378 vs, 1464 vs, 1563 s, 2925 b. δ H (500 MHz; (CD3)2SO; Me4Si): 3.65 (6
H, s, 2 CH3), 7.41 (2 H, s, 2 CH 2). δC (500 MHz; (CD3)2SO; Me4Si): 37.43 (CH3),
122.67 (CH), 144.69 (C=Se). δ Se (500 MHz; (CD 3)2SO; Me4Si): -75.0; m/z (ESI-MS):
414.85 [Cu(dmise)2]+, 270.91 [Cu(dmise) + MeOH] +, 255.04 [Cu(dmise) + OH] +,
238.89 [Cu(dmise)] +.
Cu(dmit)2Br (7). CuBr (144 mg, 1 mmol) was dissolved in ethanol (15 mL),
and to this was cannula added a solution of dmit (260 mg, 2 mmol) in
dichloromethane (15 mL). The reaction was stirred for 6 h, the solvent was reduced in
vacuo to about 5 ml, and the desired product was precipitated with ether (10 mL). The
white precipitate was filtered and dried in vacuo. Single crystals suitable for X-ray
analysis were grown by slow diffusion of ether into an acetonitrilesolution of the
complex. Yield 347 mg, 86%. Mp. 152 °C. Found C, 29.83; N, 13.84; H, 3.90;
requires C10H16CuN4Se2Br C, 30.04; N, 14.01; H, 4.03%. UV-vis [λmax, nm (εM, M-1
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cm-1)] in CH3CN: 261 (32,442). IR (cm -1): 671 s, 722 w, 757 vs, 1073 b, 1173 s, 1244
s, 1377 vs, 1464 vs, 1570 s, 1611 w, 2854 s, 2929 b, 3080 w, 3102 w, 3146 w. δH
(500 MHz; (CD3)2SO; Me4Si): 3.58 (6H, s, 2 CH 3), 7.25 (2H, s, 2 CH2). δC (500
MHz; (CD3)2SO; Me4Si): 35.65 (CH3), 119.99 (CH), 156.30 (C=S); m/z (ESI-MS):
318.98 [Cu(dmit)2]+, 222.97 [Cu(dmit) + MeOH] +, 190.95 [Cu(dmit)] +, 128.03
[dmit]+.
Cu(dmise)2Br (8). CuBr (144 mg, 1 mmol) was dissolved in ethanol (15 mL),
and to this was cannula added a solution of dmise (350 mg, 2 mmol) in
dichloromethane (15 mL). The reaction was stirred for 48 h and resulted in the
formation of a white precipitate, which was filtered and dried in vacuo. Single
crystals suitable for X-ray analysis were grown by slow diffusion of ether into an
acetonitrile/DMF solution of the complex. Yield 450 mg, 91%. Mp. 160 °C. Found C,
24.43; N, 11.43; H, 3.17; requires C 10H16CuN4Se2Br C, 24.33; N, 11.35; H, 3.27%.
UV-vis [λmax, nm (εM, M-1 cm-1)] in CH3CN: 258 (15,611). IR (cm -1): 617 w, 662 s,
740 vs, 749 vs, 804 w, 854 w, 1025 w, 1087 vs, 1150 vs, 1233 vs, 1379 vs, 1394 s,
1464 vs, 1565 vs, 1599 w. 2920 b, 3094 w, 3145 w. δH (500 MHz; (CD3)2SO; Me4Si):
3.67 (s, 6 H, 2 CH3), 7.42 (s, 2 H, 2 CH 2). δC (500 MHz; (CD3)2SO; Me4Si): 37.48
(CH3), 122.01 (CH), 147,74 (C=Se). δ Se (500 MHz; (CD3)2SO; Me4Si): -13.4; m/z
(ESI-MS): 414.85 [Cu(dmise) 2]+, 270.91 [Cu(dmise) + MeOH] +, 255.04 [Cu(dmise) +
OH]+, 238.89 [Cu(dmise)] +, 158.98 [Cu(C5N2H8)]+.
X-ray structural data collection and processing. Single crystals of Cu 4(μ4-
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dmise)(μ-I)2 I2 (1), Cu(dmise)2I (2), Cu(dmit)2I (3a, 3b), Cu(dmit)2Cl (4),
Cu(dmise)2Cl (5), Cu4(μ4-dmise)(μ-Br)2Br2 (6), Cu(dmit)2Br (7), and Cu(dmise)2Br
(8) were mounted on a glass filament with silicon grease and immediately cooled to
168 ± 2 K in a cold nitrogen gas stream. Intensity data were collected using a Rigaku
Mercury CCD detector and an AFC8S diffractometer. The space groups C2/m for 1
and 6, C2/c for 2, 3a, 4, 7, and 8, and P21/c for 3b and 5 were determined from the
observed systematic absences. Data reduction, including the application of Lorentz
and polarization effects (Lp) and absorption corrections were performed using the
CrystalClear program. 84 The structures were solved by direct methods and subsequent
Fourier difference techniques, and refined anisotropically on F2 using full-matrix least
squares, with SHELXTL 6.10. 85 The presence of several residue electron density
peaks in 1 and 6, indicating disordered solvent peaks, could not be fully described and
were accounted for with the Squeeze routine in PLATON. 86 Squeeze calculated a
solvent-accessible void volume of 166.00 Å 3, corresponding to 29 electrons per unit
cell for 1, and a solvent-accessible void volume of 159.00 Å 3, corresponding to 26
electrons per unit cell, for 6. The contribution of these diffusely-scattering species
was removed from subsequent structure factor calculations. The reported F(000),
Dcalc, and formula weight (FW) for 1 and 6 reflect known unit cell contents only. In
the final cycle of least squares, independent anisotropic displacement factors were
refined for the non-hydrogen atoms and the methyl hydrogen atoms were fixed in
“idealized” positions with C-H = 0.96 Å. Their isotropic displacement parameters
were set equal to 1.5 times Ueq of the attached carbon atom.
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For complex 1, the largest peak in the final Fourier difference map (1.03 e·Å -3)
was located 1.62 Å from H(5A), and the lowest peak (-0.94 e·Å-3) was located at a
distance of 0.89 Å from I(1). The largest peak for complex 2 in the final Fourier
difference map (1.20 e·Å -3) was located 1.64 Å from C(3), and the lowest peak (-0.79
e·Å-3) was located at a distance of 0.81 Å from I(1). The largest peak for complex 3a
in the final Fourier difference map (0.53 Å) was located (1.70 Å) from H(4A), and the
lowest peak (-0.80 e·Å-3) was located at a distance of 0.71 Å from I. The largest peak
for 3b in the final Fourier difference map (1.12 e·Å -3) was located 0.03Å from I(1),
and the lowest peak (-0.99 e·Å-3) was located at a distance of 0.98 Å from I(1). The
largest peak for 4 in the final Fourier difference map (0.70 e·Å -3) was located 1.73 Å
from C(1), and the lowest peak (-0.40 e·Å-3) was located at a distance of 0.80 Å from
Cu1. The largest peak for 5 in the final Fourier difference map (2.05 e·Å -3) was
located 0.04 Å from Se(2), and the lowest peak (-0.95 e·Å-3) was located at a distance
of 0.93 Å from Se(2). The largest peak for 6 in the final Fourier difference map (1.69
e·Å-3) was located 0.07Å from Br(1), and the lowest peak (-0.1.15 e·Å-3) was located
at a distance of 0.72 Å from Cu(2). The largest peak for 7 in the final Fourier
difference map (1.15 e·Å -3) was located 1.73 Å from H(2A), and the lowest peak
(-0.49 e·Å-3) was located at a distance of 0.78 Å from Cu(1). The largest peak for 8 in
the final Fourier difference map (0.93 e·Å -3) was located 1.72 Å from N(2), and the
lowest peak (-0.93 e·Å-3) was located at a distance of 0.87 Å from Se(1). Final
refinement parameters for the structures of 1, 2, 3a, 3b, 4, 5, 6, 7, and 8 are given in
Tables 5.7, 5.8, and 5.9; selected bond distances and angles are provided in Tables
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5.7, 5.8, 5.9, and 5.10.
Table 5.7. Summary of crystallographic data for complexes 1, 2, and 3a.
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2ζ range,
Collected reflections
Unique reflections
Final R (obs. Data)a,
wR2
R1 R (all data), R1
Final
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

1
C20H32Cu4I4N8Se4
1462.1
C2/m
Monoclinic
18.802(4)
12.833(3)
8.4800(3)
90
95.07(3)
90
2046.0(7)
2
2.374
[-14, -16, -10]
[23, 16, 10]
98
1344
8.650
3.01 - 26.71
15543
2263
0.0341
0.0778
0.0425
0.0818
1.107
1.031
-0.937

2
C10H16CuIN4Se
540.63
C2/c
2
Monoclinic
15.278(3)
10.874(2)
11.190(2)
90
118.56(3)
90
1632.8(6)
4
2.199
[-16, -13, -13]
[19, 13, 12]
86
1016
7.676
2.66-26.40
6421
1674
0.0323
0.0721
0.0395
0.0775
1.132
1.197
-0.793

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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3a
C10H16CuIN4S
446.83
C2/c
2
Monoclinic
15.062(6)
10.726(2)
11.085(2)
90
117.73(2)
90
1585.2(8)
4
1.864
[-18, -13, -14]
[19, 13, 10]
85
864
3.577
4.16- 26.76
6879
1522
0.0237
0.0576
0.0244
0.0583
1.203
0.531
-0.802

Table 5.8. Summary of crystallographic data for complexes 3b, 4, and 5.
3b
4
Chemical Formula
C10H16CuIN4S2 C10H16ClCuN4S2
F.W. (g/mol)
446.83
355.38
Space group
P21/c
C2/c
Crystal system
monoclinic
Monoclinic
a, Å
9.925(2)
10.348(2)
b, Å
10.861(2)
9.328(19)
c, Å
14.868(3)
16.123(3)
α, °
90
90
β, °
92.02(3)
105.64(3)
γ, °
90
90
V, Å3
1601.8(6)
1498.6(5)
Z
4
4
Dcal, Mg/m3
1.853
1.575
Indices (min)
[-12,-11,-18]
[-12, -11, -20]
(max)
[12,13,18]
[12, 10, 20]
Parameters
167
85
F(000)
872
728
μ, mm-1
3.540
1.902
2.05-26.34
2.62 – 26.34
2ζ range,
Collected reflections
13385
6856
Unique reflections
3225
1522
a
Final R (obs. Data) ,
0.0386
0.0303
wR2
0.0916
0.0753
R1 R (all data), R1
Final
0.0422
0.0318
wR2
0.0943
0.0764
Goodness of fit (S)
1.039
1.123
Largest diff. Peak
1.119
0.700
Largest diff. Hole
-0.988
-0.397
a

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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5
C10H16ClCuN4S
449.18
e2
P21/c
Monoclinic
15.794(3)
7.0226(14)
14.263(3)
90
104.64(3)
90
1533.7(5)
4
1.949
[-18,-8,-16]
[18,7,16]
167
872
6.345
2.67 – 25.05
10854
2713
0.0684
0.1680
0.0797
0.1868
1.138
2.050
-0.949

Table 5.9. Summary of crystallographic data for complexes 6, 7, and 8.
6
Chemical Formula
C20H32Br4Cu4N
F.W. (g/mol)
1274.18
Space group
C2/m
8Se4
Crystal system
Monoclinic
a, Å
18.374(4)
b, Å
12.867(3)
c, Å
8.4581(17)
α, °
90
β, °
96.71(3)
γ, °
90
3
V, Å
1985.9(7)
Z
2
Dcal, Mg/m3
2.131
Indices (min)
[-22, 0, 0]
(max)
[22, 15, 10]
Parameters
98
F(000)
1200
μ, mm-1
9.826
2.42 - 26.26
2ζ range,
Collected reflections
8469
Unique reflections
2049
a
Final R (obs. Data) ,
0.0379
wR2
0.1042
R
Final
R (all data), R1
0.0423
1
wR2
0.1079
Goodness of fit (S)
1.110
Largest diff. Peak
1.693
Largest diff. Hole
-1.152
a

7
C10H16BrCuN4S2
399.84
C2/c
Monoclinic
10.385(2)
9.583(2)
16.002(3)
90
104.15 (3)
90
1544.2(5)
4
1.72
[-12, -11, -18]
[12, 11, 19]
86
800
4.261
2.93-26.27
6419
1552
0.0346
0.0842
0.0404
0.0884
1.150
1.15
-0.489

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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8
C10H16BrCuN4Se2
493.64
C2/c
Monoclinic
10.297(2)
10.390(2)
14.824(3)
90
101.47(3)
90
1554.2(5)
4
2.110
[-12,-12,-18]
[9,12,18]
85
944
8.648
2.80-26.28
6449
1560
0.0389
0.0906
0.0437
0.0955
1.114
0.933
-0.927

Figure 5.8. Crystal packing diagram of Cu4(μ-dmise)4(μ-I)2I2·1.5CNCH3 (1)
along the c-axis depicting short contact interactions between Se and H atoms.
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Figure 5.9. Crystal packing diagram of CuI(dmit)2 (3a) along the a-axis
depicting short contact interactions between Se and H atoms.
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Figure 5.10. Powder X-ray diffraction pattern of A) Cu4(μ-dmise)4(μ-I)2I2 (1),
vs. simulated powder pattern B) for Cu4(μ-dmise)4(μ-I)2I2 (1).

Figure 5.11. Powder X-ray diffraction pattern for A) CuI(dmise)2 (2), vs.
simulated powder pattern for B) CuI(dmise)2 (2).
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Figure 5.12. Experimental powder X-ray diffraction pattern of
A) Cu4(μ-dmise)4(μ-I)2I2 (1), vs. simulated powder pattern for B)
Cu4(μ-dmise)4(μ-I)2I2 (1), and C) CuI(dmise)2 (2).

Figure 5.13. Powder X-ray diffraction pattern for A) CuI(dmit)2 (3b)
vs. simulated powder pattern for B) CuI(dmit)2 (3b).
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Figure 5.14. Powder X-ray diffraction pattern for A) CuI(dmit)2 (3a) vs.
simulated powder pattern for B) CuI(dmit)2 (3a).

Figure 5.15. Experimental powder x-ray diffraction pattern of
A) Cu4(μ-dmise)4(μ-Br)2Br2 (6) vs. simulated powder pattern
B) for Cu4(μ-dmise)4(μ-Br)2Br2 (6).
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Figure 5.16. Experimental powder x-ray diffraction pattern of
B) CuBr(dmise)2 (8), vs. simulated powder pattern A) for
CuBr(dmise)2 (8).

Figure 5.17. Experimental powder x-ray diffraction pattern of
A) Cu4(μ-dmise)4(μ-Br)2Br2 (6), vs. simulated powder pattern
B) for Cu4(μ-dmise)4(μ-Br)2Br2 (6), and C) CuBr(dmise)2 (8).
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Figure 5.18. Experimental powder X-ray diffraction pattern of A)
CuCl(dmit)2 (4), vs. simulated powder pattern for B) CuCl(dmit)2 (4).

Figure 5.19. Experimental powder X-ray diffraction pattern of A)
CuCl(dmise)2 (5), vs. simulated powder pattern for B) CuCl(dmise)2 (5).
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B

A

C

D

F

E

Figure 5.20. Cyclic voltammetry scans for A) CuCl(dmit)2, B) CuCl(dmise)2,
C) CuBr(dmit)2, D) CuBr(dmise)2, E) CuI(dmit)2 3a, F) CuI(dmit)2 3b. All data
collected with 1 mM complex in acetonitrile.
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G

H

I

J

Figure 5.20 (cont.). Cyclic voltammetry scans for G) mixed trans- and cisCuI(dmit)2 (3a and 3b), H) CuI(dmise)2, I) Cu4(μ-dmise)4(μ-Br)2Br2, J) Cu4(μdmise)4(μ-I)2I2. All data collected with 1 mM complex in acetonitrile.
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Figure 5.21. Differential pulse voltammograms: A) positive scan of Cu4(μ4-dmise)(μBr)2Br2 (6); B) negative scan of Cu4(μ4-dmise)(μ-Br)2Br2 (6). DPV data were collected
at a concentration of 1 mM in acetonitrile.

A

B

Figure 5.22. Differential pulse voltammograms: A) positive scan of Cu 4(μ4dmise)(μ-I)2I2 (1); B) negative scan of Cu4(μ4-dmise)(μ-I)2I2 (1). DPV data
were collected at a concentration of 1 mM in acetonitrile.
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CHAPTER SIX
SYNTHESIS , CHARACTERIZATION AND ELECTROCHEMICAL STUDIES OF
DINUCLEAR Cu(I)-COMPLEXES WITH
BIS(SELENO/THIOIMIDAZOLYL)METHANE OR ETHANE AND N,N’DIMETHYLIMIDAZOLE SELONE AND THIONE LIGANDS

Introduction
The chemistry of monodentate and bidentate “soft” sulfur and selenium Lewis
donor ligands with soft and borderline metals has recently received much attention due to
their potential applications in catalysis, 1,2 radiopharmaceuticals,3 supramolecular,
bioinorganic, organometallic and coordination chemistry. 4 Great strides have been made
in understanding the coordination chemistry of bis(thioimidazolyl)borate and methane
ligands first pioneered by Parkin5 and Reglinski,6 but the neutral selenium analog,
bis(selenoimidazolyl)methane, has received relatively little attention. We are interested in
the coordination chemistry of N,N’-dimethylimidazole selone, N,N’-dimethylimidazole
thione,

bis(thioimidazolyl)methane

and

bis(selenoimidazolyl)methane,

bis(thioimidazolyl)ethane and bis(selenoimidazolyl)ethane ligands with copper in the
hope of understanding the fundamentals of copper-selenium/sulfur coordination and it’s
effects on Cu2+/+ reduction potentials. The high propensity for selenium and sulfur to
bridge also results in diverse coordination architectural frameworks7 and these ligands are
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also potential synthons for the formation of heterocyclic carbenes via potassium metal
reduction.8 There is also increased interest in copper chalcogenolates and mixed
chalcogenolates as single source precursors in the synthesis of semiconductor materials
via metal organic chemical vapor deposition. 9
Different coordination models of mbit with metal ions such as Pb2+,10,11 Sn2+,12
Sb3+,13 Bi3+,13 Ag+,14 Rh3+,1,15 Re+,3 Ni2+,16 Co2+,16 and Ir3+,1 have been reported, but it's
rather surprising that their Cu+ complexes have not been synthesized to date. While the
coordination chemistry of mbit with transition metals is well established, that of the
analogous selenium ligand (mbis) is very uncommon. Only a handful of transition metal
complexes with mbis or ebis ligands have been reported: [Cp*Ir(ebis)Cl][Cl],
[Cp*Rh(mbis)Cl][Cp*RhCl3],1

NiBr2(mbis),

NiBr2(ebis),

[CoCl2(mbis)]n

and

[CoCl2(ebis)]n.16 It is expected that coordination of mbis and ebis to copper should have
stronger coordination bonds relative to mbit and ebit due to increased nucleophilicity and
polarizability of selenium compared to that of sulfur.17
In this chapter, we report the synthesis and crystal structures of dinuclear, threeand four-coordinate Cu+ complexes with the aim of understanding their modes of
coordination and the effect of the alkane linker and chalcogenone binding on Cu2+/+
reduction potentials. The Cu2+/+ reduction potentials can also be tuned by synthesizing
homoleptic copper complexes using a variety of different selone and thione ligands or
heteroleptic copper complexes using mixed chalcogenone ligands. Such redox tuning has
practical applications ranging from understanding biological processes such as electron
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transfer in blue copper proteins and respiration,18 to industrial and synthetic applications
in catalysis.2,19 Copper(I) complexes bearing homogeneous and heterogeneous
monodentate (dmise or dmit) and bidentate (mbis, mbit, ebis and ebit) chalcogenone
ligands have been synthesized and characterized using 1H,
77

13

C{1H},

19

F{1H} and

Se{1H} NMR spectroscopy, X-ray structural analysis, electrospray ionization mass

spectrometry and cyclic voltammetry.

Figure 6.1. Chalcogenone ligands used in this study.

Results and Discussion
Synthesis of dinuclear Cu(I) selone and thione complexes. Homoleptic dinuclear
copper complexes were synthesized via the reaction of appropriate amounts of
[Cu(NCCH3)4][BF4]

with

N,N’-dimethylimidazole
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selone

(dmise)

and

N,N’-dimethylimidazole thione (dmit) in acetonitrile (Scheme 6.1, reaction 1) or
bis(selenoimidazolyl)methane

(mbis),

bis(selenoimidazolyl)ethane

(ebis),

bis(thioimidazolyl)methane (mbit), and bis(thioimidazolyl) ethane (ebit) in a mixed
solvent system of acetonitrile and dichloromethane (Scheme 6.1, reactions 2 and 3).

Scheme 6.1
CH3CN
[Cu2(-X)(X)4][2BF4]

[Cu(NCCH3)4][BF4] + 2.5 eq. X
rt, 3 h

[Cu(NCCH3)4][BF4] + 1.5 eq. Y

CH2Cl2/CH3CN
rt, 3 h

[Cu(NCCH3)4][BF4] + 1.5 eq. Y

CH2Cl2/CH3CN
rt, 3 h

(1)

X = dmise (1);dmit (2)

[Cu2(-Y)(Y)2][2BF4]

(2)

Y = mbis (3); mbit (4)

[Cu2(Y)3][2BF4]

(3)

Y = ebis (5); ebit (6)

1) X
[Cu(NCCH3)4][BF4]

CH3CN, rt, 3 h
2) Y
CH2Cl2, 12 h

[Cu2(-Y)2(X)2][2BF4]

(4)

Y = mbis; X = dmise (7);dmit (8)
Y = mbit; X = dmise (9)

1) dmit
[Cu(NCCH3)4][BF4]

CH3CN, rt, 3 h
2) mbit
CH2Cl2, 12 h

[Cu(-dmit)(mbit)]n[BF4]n

(5)

(10)

Heteroleptic dinuclear complexes of Cu+ were synthesized via a convenient twostep, one-pot synthesis by treating equimolar amounts of [Cu(NCCH 3)4][BF4] and dmise
or dmit in acetonitrile, followed by cannula addition of mbis or mbit in dichloromethane
(Scheme 6.1, reaction 4). Treating equimolar amounts of [Cu(NCCH 3)]4[BF4] with dmit
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in acetonitrile followed by addition of equimolar amount of mbit in dichloromethane
afforded a copper complex with infinite chains of mbit and dmit (Scheme 6.1, reaction 5).
Structural analysis of dinuclear copper complexes. Single crystal diffraction data
were collected for [Cu2(μ-dmise)(dmise)4][2BF4 ]·CH3CN
[2BF4]·CH3CN

(3),

[Cu2(ebit)3][2BF4]

(6),

(1), [Cu2(μ-mbis)(mbis)2]-

[Cu2(μ-mbis)2(dmise)2][2BF4]

(7),

[Cu2(μ-mbis)2(dmit)2][2BF4] (8), and [Cu(mbit)(μ-dmit)]n[BF4]n (10), which crystallized
as colorless plates. The structural parameters for 1, 3, 6, 7, 8, and 10 are summarized in
Tables 6.1 to 6.4, and their structures are shown in Figures 6.2 to 6.5.
The X-ray crystal structure of [Cu2(μ-dmise)(dmise)4][2BF4]·CH3CN (1) is shown
in Figure 6.2, and selected bond lengths and angles are given in Table 6.1. The structural
unit of [(Cu(dmise)2)(μ-dmise)][2BF4] is made up of a dimer with two Cu+ centers, with
one of the Se atoms of the dimethylimidazole selone (dmise) bridging two Cu atoms,
forming a trigonal Cu2Se core. Each copper atom is further bonded to two selenium
atoms from dmise and thus each copper adopts a distorted trigonal geometry. The Cu-Cu
bond distance, 2.63 Å is longer than sum of ionic radii of Cu+ (1.48 Å). The average CuSe bond distance is 2.37 Å which is slightly longer than monomeric copper selone
complexes reported by Kimani, et al.20 The average bond length of bridging Cu-Se bond
(2.42 Å) is longer than the average non bridging Cu-Se bond length (2.35 Å). The
dinuclear copper selone complex 1 adopts a distorted trigonal planar geometry with
average Cu-Se bond lengths of 2.37 Å, longer than the previously synthesized three-
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coordinate copper-selone complexes Cu(dmise)2X, (X = I, Br, or Cl) with Cu-Se bond
distances of 2.34 Å,21 [Cu3I3{Ph2P(Se)-(CH2)3-P(Se)Ph2}2]n (2.35 Å).22

Figure 6.2. The crystal structure diagram of [Cu2(μ-dmise)(dmise)4][2BF4]·CH3CN
(1) showing 50% probability ellipsoids. Hydrogen atoms, counterions, and the solvent
molecule are omitted for clarity.
Table 6.1. Selected bond lengths (Å) and angles (°) for 1.
Cu(1)-Se(1)
Cu(2)-Se(1)
Cu(1)-Se(3)
Cu(1)-Se(5)
Cu(2)-Se(2)
Cu(2)-Se(4)
Cu(1)-Cu(2)

2.3986(9)
2.4382(10)
2.3460(10)
2.3377(9)
2.3458(11)
2.3592(12)
2.6326(11)

Se(5)-Cu(1)-Se(3)
Se(5)-Cu(1)-Se(1)
Se(3)-Cu(1)-Se(1)
Se(2)-Cu(1)-Se(4)
Se(2)-Cu(1)-Se(1)
Se(4)-Cu(1)-Se(1)

118.37(4)
128.11(4)
113.34(3)
133.26(4)
111.91(4)
112.68(4)

The molecular structure of [Cu2(μ-mbis)(mbis)2][2BF4]·CH3CN (3) is shown in
Figure 6.3 and the selected bond lengths and angles are given in Table 6.2. The structural

183

unit of [Cu2(μ-mbis)(mbis)2][2BF4] (3) is made up of a Cu+ dimer, and two of the Se
atoms from bis(seleno-methylimidazole) methane (mbis) bridge two copper atoms
forming a Cu2Se2 core. The Cu+ ions are bound to two additional selenium atoms from
the bidentate mbis ligand, hence each Cu+ ion adopts a distorted tetrahedral geometry
with angles ranging from 100.50 to 123.36°. The Cu-Cu distance, 2.96 Å is longer than
the sum of their ionic radii, suggesting the absence of Cu-Cu interactions. The average
bond length of the bridging Cu-Se bonds (2.54 Å) is longer than the average non-bridging
Cu-Se bond length (2.45 Å).

Figure 6.3. The crystal structure diagram of [Cu2(μ-mbis)(mbis)2][2BF4] showing
50% probability ellipsoids. Hydrogen atoms, counterions and the solvent molecules
are omitted for clarity.
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Table 6.2. Selected bond distances (Å) and angles (°) for 3.
Cu(1)-Se(1)
Cu(1)-Se(2)
Cu(1)-Se(5)
Cu(1)-Se(6)
Cu(2)-Se(1)
Cu(2)-Se(2)
Cu(2)-Se(3)
Cu(2)-Se(4)
Cu(1)-Cu(2)

2.5128(12)
2.5617(13)
2.4221(11)
2.4315(12)
2.5073(12)
2.4981(12)
2.4091(15)
2.4267(11)
2.9616(18)

Se(1)-Cu(1)-Se(2)
Se(1)-Cu(1)-Se(5)
Se(1)-Cu(1)-Se(6)
Se(5)-Cu(1)-Se(2)
Se(5)-Cu(1)-Se(6)
Se(1)-Cu(2)-Se(2)
Se(1)-Cu(2)-Se(3)
Se(1)-Cu(2)-Se(4)
Se(2)-Cu(2)-Se(3)
Se(2)-Cu(2)-Se(4)
Se(3)-Cu(2)-Se(4)

100.50(4)
115.76(4)
100.21(4)
110.93(4)
115.10(5)
102.43(4)
122.52(4)
95.13(4)
107.50(4)
102.71(4)
123.36(4)

The copper complex [Cu2(ebit)3][2BF4] (6) (Figure 6.4) has two Cu+ centers, each
arranged in a distorted trigonal planar geometry. The distorted trigonal geometry results
from coordination of sulfur atoms from the ebit ligand and a third sulfur atom from an
additional ebit ligand that bridges the two separate copper centers. The angles around the
copper centers are 117.72(5)° for S(3)-Cu(1)-S(2), 114.70(6)° for S(4)-Cu(1)-S(3) and
122.49(5)° for S(4)-Cu(1)-S(2), with an average Cu-S bond distance of 2.29 Å (Table
6.3).
The molecular structure of [Cu2(μ-mbis)2(dmise)2 ][2BF4] (7) is shown in Figure
6.5, and the selected bond length and angles are given in Table 6.4. The structural unit of
[Cu2(μ-mbis)2(dmise)2][2BF4] is dimeric, with two of the Se atoms from bis(selenomethylimidazole) methane (mbis) bridging two Cu+ ions to form a Cu2Se2 core that
resembles a parallelogram. The copper ions are bound to two additional selenium atoms,
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Figure 6.4. Crystal structure diagram of [Cu2(ebit)3][2BF4] (6) displaying
50% probability density ellipsoids. Hydrogen atoms are omitted for clarity.

Table 6.3. Selected bond lengths (Å) and angles (°) for
[Cu2(ebit)3][2BF4] (6).
Cu(1) - S(4)
Cu(1) - S(3)
Cu(1) - S(2)
S(4) - Cu(1) - S(2)
S(4) - Cu(1) - S(3)
S(3) - Cu(1) - S(2)

2.2871(16)
2.3030(16)
2.2900(14)
122.49(5)
114.70(6)
117.72(5)
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Figure 6.5. Crystal structure diagram of [Cu2(μ-mbis)2(dmise)2][2BF4]
(7) showing 50% probability ellipsoids. Hydrogen atoms and counterions
are omitted for clarity.

Table 6.4. Selected bond distances (Å) and angles (°) for7.
Cu-Se(1)
Cu-Se(A1)
Cu-Se(2)
Cu-Se(3)
Cu(A)-Se(1)
Cu-Cu(A)

2.5349(12)
2.4950(13)
2.4583(13)
2.4238(14)
2.4950(13)
2.739(2)

Se(1)-Cu-Se(2)
Se(1)-Cu-Se(3)
Se(1)-Cu-Se(A1)
Se(2)-Cu-Se(3)
Se(2)-Cu-Se(A1)
Se(3)-Cu-Se(A1)

105.02(5)
107.35(5)
114.02(5)
115.95(5)
94.97(5)
118.58(4)

one from an mbis ligand, and the other from a dmise ligand, hence each Cu+ center
adopts a distorted tetrahedral geometry with angles ranging from 105.02 to 115.95°.The
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Cu-Cu distance, 2.74 Å, is slightly shorter than the sum of their van der Waals radii,
suggesting weak Cu-Cu interactions. The average length of the bridging Cu-Se bonds
(2.52 Å) is longer than the average non-bridging Cu-Se bond length (2.44 Å).
The X-ray crystal structure diagram of [Cu2(μ-mbis)2(dmit)2][2BF4] (8) is shown
in Figure 6.6, and the selected bond length and angles are given in Table 6.5. The dimer
in the structural unit of 8 with a Cu2Se2 core is similar to that found in 7. The copper ions
in complex 8 are bound to two bridging and two terminal Se atoms from bis(selenomethylimidazole) methane (mbis) and two additional sulfur atoms from dmit ligand. Each
Cu+ ion adopts a distorted tetrahedral geometry with angles ranging from 95.38 to

Figure 6.6. Crystal structure diagram of [Cu2(μ-mbis)2(dmit)2][2BF4]
(8) showing 50% probability ellipsoids. Hydrogen atoms and
counterions are omitted for clarity.
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Table 6.5. Selected bond distances (Å) and angles (°) for 8.
Cu(1)-S(1)
Cu(1)-Se(2)
Cu(1)-Se(1A)
Cu(1)-Se(1)
Se(1)-Cu(1A)
Cu(1)-Cu(1A)

2.3455(16)
2.4222(12)
2.5013(11)
2.5328(11)
2.5013(11)
2.7297(19)

S(1)-Cu(1)-Se(2)
S(1)-Cu(1)-Se(1A)
Se(2)-Cu(1)-Se(1A)
S(1)-Cu(1)-Se(1)
Se(2)-Cu(1)-Se(1)
Se(1A)-Cu(1)-Se(1)

116.36(6)
95.38(5)
118.61(4)
105.58(5)
105.96(4)
114.33(4)

118.61°. The Cu-Cu distance, 2.73 Å is slightly shorter than the sum of their van der
Waals radii, suggesting weak Cu-Cu interaction. The average Cu-Se bond distance is
2.45 Å, whereas the Cu-S bond length is 2.35 Å. The average bond length of bridging
Cu-Se bond (2.52 Å) is longer than the average non bridging Cu-Se bond length (2.42 Å).
The X-ray crystal structure of [Cu(mbit)(μ-dmit)]n[BF4]n reveals an infinite chain
of tetrahedrally coordinated Cu+ centers bound to two sulfur atoms from a bidentate mbit
ligand and to bridging sulfur atom from dmit ligand (Figure 6.7). The geometry around
Cu(1) is best described as distorted tetrahedral geometry with S-Cu-S angles ranging
from 95.06° to 123.18°, and avg. Cu-S bond lengths of 2.36 Å (Figure 6.8, Table 6.6).
The tetrahedrally coordinated dinuclear copper selone complexes 3, 7, and 8 have
average Cu-Se bond lengths of 2.48 Å, longer than the average Cu-Se bond distance of
2.30 Å for [TpmRCu(dmise)][BF4] (R = H, Me, and iPr), 2.33 Å Tp*Cu(dmise),20
Cu(C11H14Se2)2][BF4] (avg. 2.41 Å),23 but slightly shorter than the Cu-Se bond distance
of 2.49 Å found in [Cu(1,10-phen)2(C5H10N2Se)][2ClO4].24 The Se-C bonds in 1, in the
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Figure 6.7. Crystal structure diagram of [Cu(mbit)(μ-dmit)]n[BF4]n (10)
showing the extended chain network. Hydrogen atoms and counterions are
omitted for clarity.

Figure 6.8. Crystal structure diagram of [Cu(mbit)(μ-dmit)]n[BF4]n
(10). Hydrogen atoms and counterions omitted for clarity.
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Table 6.6. Selected bond distances (Å) and angles (°) for 10.
Cu(1)-S(1)
Cu(1)-S(2)
Cu(1)-S(3)
Cu(1)-S(1A)
Cu(1A)-S(1)
S(1)-C(1)
S(2)-C(6)
S(3)-C(14)

2.3689(10)
2.3748(10)
2.3347(10)
2.3520(10)
2.3520(10)
1.718(3)
1.698(3)
1.694(3)

S(1)-Cu(1)-S(2)
S(1A)-Cu(1)-S(2)
S(1A)-Cu(1)-S(1)
S(3)-Cu(1)-S(1)
S(3)-Cu(1)-S(1A)
S(3)-Cu(1)-S(2)
C(1)-S(1)-Cu(1)
C(6)-S(2)-Cu(1)

110.51(5)
95.06(4)
123.18(2)
105.05(4)
105.05(4)
117.58(3)
104.53(11)
99.25(11)

range of 1.85-1.88 Å, are slightly lengthened relative to those in uncoordinated dmise
(1.89 Å).25
The copper thione complexes 6, 8, and 10 have average Cu-S bond distances of
2.33 Å, longer than most previously reported copper thione and thiolate complexes such
as [TpmRCu(dmit)][BF4] (2.20 Å, R = H, Me), Tp*Cu(dmit), 20 [Cu(diditme)2Cl] (2.23
Å),26 Cu3(BmMe)3 (avg. 2.28 Å), Cu(BmMe)(PPh3) (2.28 Å),27 but shorter than
[Cu(PPh3)2(bzimH2)Cl]

(2.38

Å),28

[CuCl(1κS-imzSH)(PPh3)2]

(2.36

Å),29and

[Cu(HB(3,5-iPrPz)3(SMeIm)] (2.45 Å).30 The S-C bond lengths in complexes 6, 8, and
10 (1.694-1.704 Å), are slightly lengthened relative to those in uncoordinated dmit (1.68
Å),31and 1-methyl-4-imidazoline-2-thione (1.68 Å).32
NMR spectroscopy of dinuclear copper thione and selone complexes. The
dinuclear copper complexes were characterized by 1H,

13

C{1H},

77

Se{1H}, and

19

F{1H}

NMR spectroscopy. In the 1H NMR spectra of dmise, dmit, mbis, mbit, ebis, and ebit the
olefinic CH protons on the heterocyclic ring are shifted downfield by  0.2 to 0.5 from its
position in the free ligand upon coordination to copper. This same downfield shift was
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observed by Rabinovich, et al.,11 for [Pb2(BmmMe)5](ClO4)4, Gardinier, et al., for
[Ag(mbit)2]+,14 and Kimani et al., for [TpmRCu(X)]+ (R = H; Tpm, R = Me; Tpm*, R =
iPr; TpmiPr; X = dmise, or dmit) complexes.20

13

C{1H} NMR resonances for the

complexed and uncomplexed selone and thione ligands are given in Table 6.7.
Substantial shifting of the C=Se/S resonances of the dmise, dmit, mbis, and mbit carbon
atoms are observed upon complexation to copper. Coordination of the selones and
thiones via the selenium and sulfur atoms results in upfield shifts of  5 to 8 for both the
C=Se and C=S carbons. The upfield shift in C=Se/S resonance results in decreased
double bond character of the seleno- and thio-carbonyl bond while enhancing that of the
adjacent C-N single bond.27,33
Table 6.7. 13C{1H} and 77Se{1H} NMR chemical shifts of the selone and thione
ligands before and after complexation with copper.

Dmise
Dmit
Mbis
Mbit
Ebis
Ebit
[Cu2(μ-dmise)(dmise)4][2BF4] (1)
[Cu(dmit)][BF4] (2)
[Cu2(mbis)3][BF4]2 (3)
[Cu2(mbit)3][BF4]2 (4)
[Cu2(ebis)3][BF4]2 (5)
[Cu2(ebit)3][BF4]2 (6)
[Cu2(μ-mbis)2(dmise)2][2BF4] (7)
[Cu2(μ-mbis)2(dmit)2][2BF4] (8)
[Cu2(mbit)2(dmise)2][2BF4] (9)
[Cu(μ-dmit)(mbit)]n[BF4]n (10)
t

C=Se
155.57t
(dmise)

C=S (dmit)

77

Se
-6

162.42t

b

157.03

16.02
b

163.71
b

155.63

22.65
162.29b

147.19t
157.34t
149.67b

-28.01
b

158.04
147.98b

-42.91
b

155.22
148.99t, 151.27b
151.63b
149.25t

= terminal, b = bridging
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t

157.65
158.75b
156.61t, 158.40b

-26.01
-24.20

77

Se{1H} NMR spectroscopy studies revealed upfield shifts of selenium

resonance in the copper complexes relative to those of the free mbis and ebis ligands. The
77

Se{1H} NMR signal for complex 1 could not be obtained, whereas all the complexes

with mbis and ebis ligands exhibited upfield selenium resonance shifts ~δ 40 upon
coordination to copper. This upfield shift of

77

Se{1H} NMR resonance upon copper

binding is direct evidence that mbis and ebis ligands bind to copper in a bidentate fashion
via the selenium atoms.
Electrochemical studies of the dinuclear copper complexes. Cyclic voltammetry
studies of the chalcogenones and their dinuclear copper complexes were conducted to
determine the influence of the alkyl linker on the redox potential of the chalcogenone
ligands and the change in Cu2+/+ reduction potential upon coordination of the
chalcogenone ligands to copper. All the uncoordinated chalcogenone ligands exhibit
chemically reversible and quasi-reversible electrochemical behavior, with the selone
ligands having more negative reduction potentials relative to the analogous thione
ligands. The unbound bidentate ethylene-bridged ligands (ebis and ebit) have larger peak
separation between the oxidized and reduced products relative to the methylene- bridged
ligands (mbis and mbit), suggesting faster electron transfer in the latter.34 The reduction
potentials of the unbound selone ligands are: dmise -367 mV < ebis (-342 mV) < mbis (333 mV). The analogous thione ligands follow the same trend: dmit (-169 mV) < ebit (148 mV) < mbit (-118 mV), versus normal hydrogen electrode (NHE; Table 6.10). The
reduction potentials of the uncoordinated bidentate chalcogenones indicate that
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increasing the length of the alkyl linker from methylene to ethylene results in more
negative reduction potentials.

Figure 6.9. Cyclic voltammetry (CV) scan for A) mbit (dashed lines) and
mbis (solid lines), B) ebit (dashed lines) and ebis (solid lines). All data were
collected with 1mM complex in acetonitrile.

The Cu+/2+ redox potentials of the complexes versus NHE are given in Table 6.10.
The cyclic voltagrams (CV) of the copper complexes 1, 2, 3, 4, 5, 6, 7, and 10 exhibit
two, one-electron redox potential waves belonging to the Cu +/2+ and Cu+/0 couples, with
exception of complexes 8 and 9 which exhibit three, one-electron redox potential waves.
The Cu+/0 redox couple commences at potentials more than -1000 mV vs. NHE and after
switching the scan direction at potentials close to 750 mV, Cu 0 is stripped off the
electrode (Figure 6.10). All the dinuclear copper selone and thione complexes exhibit
chemically reversible, Cu+/2+ one-electron oxidation and reduction, but the peak
separation between the anodic and cathodic waves is much higher relative to the
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ferrocene/ferrocenium couple at the same conditions, suggesting an electrochemically
quasi-reversible process (Figures 6.10-6.12).

Figure 6.10. Cyclic voltammetry (CV) scans for [Cu2(μ-mbis)2(dmise)2][2BF4]
(7), (dashed lines) and [Cu2(μ-mbis)2(dmit)2][2BF4 ] (8) (solid line) in acetonitrile.
Upon examination of the reduction potentials for the copper complexes 1, 2, 3, 4,
5, and 6, it is clear that the selone containing complexes exhibit more negative reduction
potentials relative to the analogous thione complexes, a similar trend observed by
Kimani, et al., for the electrochemistry of [TpmRCu(X)]+ complexes (X = dmise or
dmit).20 Interestingly, increasing the length of the alkyl bridge in the bidentate ligands
from methylene to ethylene results in lower reduction potentials for [Cu2(ebis)3][2BF4]
(5) (-369 mV) compared to [Cu2(μ-mbis)(mbis)2 ][2BF4] (3) (-306 mV), and the same
trend is observed for the thione complex [Cu2(ebit)3][2BF4] (6) (-203 mV) relative to
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Table 6.8. Redox potentials and Cu+/2+ potentials of dinuclear copper complexes vs.
NHE.
Dmise
Dmit
Mbis
Mbit
Ebis
Ebit
[Cu2(μ-dmise)(dmise)4][2BF4] (1)
[Cu2(dmit)5][2BF4] (2)
[Cu2(μ-mbis)(mbis)2][2BF4] (3)
[Cu2(mbit)3][2BF4] (4)
[Cu2(ebis)3][2BF4] (5)
[Cu2(ebit)3][2BF4] (6)
[Cu2(μ-mbis)2(dmise)2][2BF4] (7)
[Cu2(μ-mbis)2(dmit)2][2BF4] (8)
[Cu2(mbit)2(dmise)2][2BF4] (9)
[Cu(μ-dmit)(mbit)]n[BF4]n (10)

Epa

Epc

ΔE

E1/2

39

-773

812

-367

424

-761

1158

(mV)
-167

-53

-613

560

-333

289

-525

814

vs.
NHE
-118

83

-768

851

-342

292

-587

879

-148

-101

-603

502

-352

147

-565

712

-210

-37

-575

538

-306

120

-500

620

-180

-131

-606

475

-369

228

-634

862

-203

-68

-645

577

-356

192, -6

-44, -478

225, 439

74, -242

174, -23

31, -608

149, 585

102, -315

147

-535

682

-195

Table 6.9. Cu+/0 reuction potentials of dinuclear copper complexes vs. NHE.
[Cu2(μ-dmise)(dmise)4][2BF4] (1)
[Cu2(dmit)5][2BF4] (2)
[Cu2(μ-mbis)(mbis)2][2BF4] (3)
[Cu2(mbit)3][2BF4] (4)
[Cu2(ebis)3][2BF4] (5)
[Cu2(ebit)3][2BF4] (6)
[Cu2(μ-mbis)2(dmise)2][2BF4] (7)
[Cu2(μ-mbis)2(dmit)2][2BF4] (8)
[Cu2(mbit)2(dmise)2][2BF4] (9)
[Cu(μ-dmit)(mbit)]n[BF4]n (10)

Epa

Epc

ΔE

E1/2

-724

-1107

383

-920

-747

-1129

382

(mV)
-938

-796

-1336

540

-1066

-742

-1298

556

vs.
NHE
-1020

-936

-1152

216

-1044

-816

-1299

483

-1058

-774

-1231

457

-1003

-710

-1119

409

-915

-671

-1107

436

-889

-791

-1222

431

-1007
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[Cu2(mbit)3][2BF4] (4) (-180 mV). The dinuclear copper complex 7 with both mbis and
dmise ligands has a lower reduction potential of (-356 mV) relative to complex 10 which
has both mbit and dmit ligands (-195 mV) (Table 6.8).
The heterogeneous dinuclear complex [Cu2(μ-mbis)2(dmit)2][2BF4] (8; Figure
6.12I) exhibits two different reduction and oxidation potentials for the Cu 2+/+ couple,
whereas [Cu2(μ-mbit)2(dmise)2][2BF4] (9; Figure 6.12H) exhibits three oxidation and
reduction waves. One reduction and oxidation wave in the dinuclear copper complex 9
likely corresponds to the reduction potential of the bidentate mbit ligand (E1/2 = -51 mV),
whereas the remaining two waves correspond to Cu2+/+ reduction potentials, similar to
those observed for complex 8. These two different Cu2+/+ reduction potentials are only
observed for the dinuclear copper complexes with mixed sulfur and selenium ligands
(Table 6.8).
The unbound dmise and dmit have more negative reduction potentials than the
bidentate chalcogenones (mbis, mbit, ebis and ebit). The reduction potentials from the
bidentate chalcogenones indicate that increasing the length of the alkyl linker from
methylene to ethylene results in more negative reduction potentials. All the synthesized
copper-selone complexes have more negative Cu 2+/+ reduction potentials relative to the
analogous copper-thione complexes. The copper-selone complexes stabilize the Cu2+
oxidation state more effectively than the copper-thione complexes by an average of 144
mV, consistent with previously observed results. 20,21 The Cu2+/+ reduction potential of the
dinuclear copper chalcogenone complexes 1 to 10 can be tuned from a range of 102 mV
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to -369 mV by simply changing the chalcogenone and denticity of selone and thione
ligands. Compared to naturally occurring cupredoxins with Cu2+/+ reduction potential
range of 90 mV to 670 mV,35 the synthesized copper chalcogenone complexes have more
negative Cu2+/+ reduction potentials.
Conclusions
Dinuclear homoleptic and heteroleptic Cu+ complexes with monodentate and
bidentate chalcogenone ligands have been synthesized and characterized, and the
electrochemistry of the resulting Cu+ complexes has been investigated and compared.
Treating the Cu+ starting material [Cu(NCCH3)4][BF4] with bidentate (mbit, mbis, ebit,
and ebis) and monodentate chalcogenone ligands (dmise and dmit) results in the
formation of dinuclear copper complexes (1, 2, 3, 4, 5, and 6). The dinuclear copper
complexes adopt either trigonal or tetrahedral coordinate geometries with both terminal
and bridging selone or thione ligands. The heterogeneous dinuclear copper complexes
[Cu2(μ-mbis)2(dmise)2][2BF4] (7) and [Cu2(μ-mbis)2(dmit)2][2BF4] (8) adopt distorted
tetrahedral geometry where each copper is coordinated to three selenium atoms from
mbis ligand and one selenium atom from dmise for 7 and one sulfur atom from dmit for
8. Interestingly, the mixed ligand complex 10 consist of infinite chains of tetrahedrally
coordinated Cu+ ions bound to two sulfur atoms from a mbit ligand and a bridging sulfur
atom from a dmit ligand.
The copper selone complexes 1, 3, 5, and 7 have more negative Cu2+/+ reduction
potentials relative to their sulfur analogs (2, 4, 6, and 10), and increasing the length of the
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alkyl linker in the bidentate chalcogenone ligands results in more negative reduction
potentials for their copper complexes. This study provides detailed comparative
coordination chemistry of selones and thiones with copper and its effect on the Cu2+/+
reduction potentials. Simply changing the chalcogens and denticity of the selone and
thione ligands results in Cu2+/+ reduction potentials of the synthesized copper
chalcogenone complexes that can be tuned in a range of 471mV, a difference that would
have significant effects in redox-mediated reactions.

Experimental Section
Materials. The synthesis and manipulation of all copper complexes was
performed under an inert atmosphere of argon or nitrogen using standard Schlenk
techniques. Acetonitrile, methanol, and ether were purified using standard procedures and
freshly distilled under argon atmosphere prior to use. N,N’-Dimethylimidazole-selone
(dmise),

N,N’-dimethylimidazole

(selono-imidazolyl)methane

thione

(mbis),

(dmit),36

bis

[Cu(NCCH3)4][BF4],37

(thio-imidazolyl)methane

bis

(mbit),

bis(selono-imidazolyl)ethane (ebis), bis(thio-imidazolyl)ethane (ebit)1 were synthesized
according to published procedures. The following reagents were used as received:
selenium powder (VWR), sulfur powder (VWR), cuprous oxide (stabilized, Aldrich),
1-methylimidazole (VWR), methyliodide (VWR), and dibromomethane (Alfa Aesar).
Instrumentation. 1H,

13

C{1H},77Se{1H} and

19

F{1H} spectra were obtained on

Bruker-AVANCE 300 and 500 MHz NMR spectrometers. 1H and
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13

C{1H} NMR

chemical shifts are reported in  relative to tetramethylsilane (TMS) and referenced to
solvent. 19F{1H} NMR spectra were externally referenced to CCl3F ( 0).38 The 77Se{1H}
NMR chemical shifts were obtained in CDCl3 and externally referenced to diphenyl
diselenide (δ 461),39 and reported relative to dimethyl selenide (δ 0).
Electrochemical experiments were performed with a BAS 100B potentiostat. A
three compartment cell was used with an Ag/AgCl reference electrode, Pt counter
electrode, and a glassy carbon working electrode. Freshly-distilled acetonitrile was used
as the solvent with tetra-n-butylammonium phosphate as the supporting electrolyte (0.1
M). Solutions containing 1 mM analyte were deaerated for 2 min by vigorous nitrogen
purge. The measured potentials were corrected for junction potentials relative to
ferrocenium/ferrocene (0.586 mV vs. Ag/AgCl).40 All E1/2 values were calculated from
(Epa + Epc)/2 at a scan rate of 100 mV/s, and ΔE = Epa - Epc.
Infrared spectra were obtained using Nujol mulls on KBr salt plates with a Magna
550 IR spectrometer. Abbreviations used in the description of vibrational data are as
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a
Turbo Ionspray ionization source. Samples were run under positive mode, with ionspray
voltage of 5500 V, and TOF scan mode. MALDI-TOF-MS was conducted on a Bruker
Microflex. Trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]-malononitrile was
used as a matrix for co-crystallization of the copper complex characterized. All the peak
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envelopes matched their calculated isotopic distributions. Melting points were determined
using a Barnstead Electrothermal 9100 apparatus in silicon-grease-sealed glass capillary
tubes. Absorption spectra were collected using a Varian Cary-50 Bio spectrophotometer
in quartz cuvettes with a path length of 1 cm.
[Cu2(μ-dmise)(dmise)4][2BF4] (1). Dmise (437 mg, 2.5 mmol) was dissolved in
acetonitrile (30 mL) and cannula transferred to a solution of [Cu(NCCH 3)4][BF4] (312
mg, 1 mmol) in acetonitrile (20 mL). The reaction was stirred at room temperature for 3
h, and the solvent volume was reduced in vacuo to about 5 mL. The product was
precipitated with diethyl ether (10 mL) to afford an off-white solid that was dried in
vacuo. Single crystals for X-ray analysis were grown from slow vapor diffusion of
diethyl ether into acetonitrile solution. Yield: 85% (496 mg, 0.425 mmol). Mp. 126°C. 1H
NMR (CD3CN): 3.69 (s, 6H, 2CH3), 7.16 (s, 2H, 2CH).
(CH3), 121.58 (CH), 147.19 (C=Se).
1

19

13

C{1H} NMR (CD3CN): 37.06

F{1H} NMR (CD3CN): -151.56, -151.61. IR (cm-

): 521 s, 624 w, 660 s, 744 s, 933 s, 1021 b, 1238 s, 1285 s, 1378 s, 1457 s, 1570 s, 1818

w, 2252 w, 2276 vs, 2304 vs, 2918 b, 3139 w, 3172 w, 3230 w. MALDI-TOF-MS:
415.07 [Cu(dmise)2]+. Anal. Calc. for C25H40Cu2N10Se5B2F8: C, 25.53; N, 11.91; H, 3.43.
Found: C, 25.42; N, 11.73; H, 3.45.
[Cu2(dmit)5][2BF4] (2). Complex 2 was prepared following the same procedure
for 1 except that dmit (322 mg, 2.5 mmol) was used instead of dmise. Yield: 74% (350
mg, 0.371 mmol). Mp. 132°C. 1H NMR (CD3CN): 3.63 (s, 6H, 2CH3), 6.99 (s, 2H, 2CH).
13

C{1H} NMR (CD3CN): 35.13 (CH3), 120.35 (CH), 157 (C=S). IR (cm-1): 521 s, 672 vs,
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724 vs, 746 vs, 801 s, 1047 b, 1175 vs, 1236 vs, 1284 v, 1378 s, 1464 vs, 1569 vs, 1684
w, 2276 s, 2304 s, 2723 w, 2859 b, 3118 w, 3142 w. MALDI-TOF-MS: 319.51
[Cu(dmit)2]+. Anal. Calc. for C25H40Cu2N10S5B2F8: C, 31.89; N, 14.87; H, 4.28. Found:
C, 31.80; N, 14.56; H, 4.23.
[Cu2(mbis)3][BF4]2 (3). Mbis (215 mg, 0.75mmol) was dissolved in
dichloromethane (20 mL) before being cannula transferred to a solution of
[Cu(CNCH3)4][BF4] (160 mg, 0.5 mmol) in acetonitrile (10mL). The reaction mixture
was stirred at room temperature for 3 h. The solvent volume in the reaction mixture was
then reduced to about 5 mL and the product was precipitated with diethyl ether. Single
crystals for X-ray analysis were grown from slow vapor diffusion of ether into
acetonitrile solution. Yield: 45% (262 mg, 0.225 mmol). 1H NMR (DMSO): 3.54 (s, 6H,
2CH3), 6.82 (s, 2H, CH2), 7.59 (d, JHH 2.0, 2H, 2CH), 7.33 (d, JHH 2.0, 2H, 2CH3).
13

C{1H} NMR (DMSO): 37.46 (CH3), 59.67 (CH2), 121.33 (CH), 123.43 (CH), 149.67

(C=Se). 19F{1H} NMR (DMSO): -151.59, -151.63. 77Se NMR (DMSO): -28.008. UV-vis
(CH3CN): 291.6 nm. Mp. 139°C; 460 s, 473 w, 521 vs, 604 w, 655 s, 697 s, 731 vs, 779
w, 790 s, 1059 b, 1207 s, 1234 s, 1249 s, 1318 s, 1378 s, 1464 vs, 1575 vs, 1676 vs, 2727
b, 3145 w. Mass spectrum (ESI-MS): m/z 1216.59 [Cu2(mbis)3(BF4)]+, 882.68
[Cu2(mbis)2(BF4)]+, 796.67 [Cu2(mbis)2]2+, 398.83 [Cu(mbis)]+. Anal. Calc. for
C29H39Cu2N13Se6B2F8: C, 25.91; N, 13.55; H, 2.92. Found: C, 25.98; N, 13.12; H, 3.04.
[Cu2(mbit)3][BF4]2 (4). Complex 4 was prepared following the same procedure
for 3 except that mbit (186 mg, 0.75 mmol) was used instead of mbis. The growth of
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single crystals for X-ray analysis was attempted from slow vapor diffusion of diethyl
ether into acetonitrile solution. Yield: 56% (297 mg, 0.283 mmol). 1H NMR (CD3CN):
3.54 (s, 6H, 2CH3), 6.51 (s, 2H, CH2), 7.08 (d, JHH 2.5, 2H, 2CH), 7.29 (d, JHH 2.5, 2H,
2CH3).

13

C{1H} NMR (CD3CN): 35.97 (CH3), 57.55 (CH2), 119.04 (CH), 121.61 (CH),

158.04 (C=S).

19

F{1H} NMR: -151.57, -151.63, (s,

10

BF4,

11

BF4). UV-vis (CH3CN):

274.4 nm. Mp. 128°C; IR (cm-1): 521 s, 604 w, 663 s, 703 s, 734 s, 759 s, 784 s, 1046 b,
1168 s, 1215 s, 1238 s, 1286 s, 1319 s, 1378 s, 1398 s, 1467 s, 1576 s, 1700 w, 2272 w,
2304 w, 2727 w, 2855 b, 3141 w. Anal. Calc. for C27H36Cu2N12S6B2F8: C, 31.74; N,
16.45; H, 3.55. Found: C, 30.07; N, 16.25; H, 3.61.
[Cu2(ebis)3][BF4]2 (5). Complex 5 was prepared following the procedure for 3
except that ebis (223 mg, 0.75 mmol) was used in place of mbis. Yield: 30% (174 mg,
0.153 mmol). 1H NMR ((CD3)2SO): 3.58 (s, 6H, 2CH3), 4.73 (s, 4H, 2CH2), 7.33 (d, 2H,
2CH), 7.47 (d, 2H, 2CH). 13C{1H} NMR: 39.70 (CH3), 47.46 (CH2), 121.47 (CH), 122.76
(CH), 147.98 (C=Se).

19

F{1H} NMR: -148.10, -148.16 (s,

10

BF4,

11

BF4).

77

Se NMR: -

42.91 (s, Se). UV-vis (CH3CN): 288.4 nm; Mp. 270°C; IR (cm-1): 522 s, 666 vs, 724 vs,
738 vs, 747 vs, 800 w, 930 w, 1057 vs, 1128 vs, 1183 vs, 1223 s, 1246 vs, 1287 w, 1378
vs, 1409 vs, 1467 vs, 1569 vs, 2854 vs, 2919 b, 3114 w, 3146 w, 3173 w. Anal. Calc. for
C30H42Cu2N12Se6B2F8: C, 26.79; N, 12.49; H, 3.15. Found: C, 26.97; N, 12.48; H, 3.12.
[Cu2(ebit)3][BF4]2 (6). Complex 6 was prepared following the procedure for 3
except ebit (191 mg, 0.75 mmol) was used in place of mbis. Yield: 47% (252 mg, 0.236
mmol). 1H NMR ((CD3)2SO): 3.52 (s, 6H, 2CH3), 4.63 (s, 4H, 2CH2), 7.18 (d, 2H, 2CH),
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7.30 (d, 2H, 2CH). 13C{1H} NMR: 35.59 (CH3), 45.67 (CH2), 119.70 (imidazole), 120.89
(imidazole), 155.22 (C=S).

19

F{1H} NMR: -148.31, -148.35, (s,

10

BF4,

11

BF4). UV-vis

(CH3CN): 272.5 nm; Mp. 230°C; IR (cm-1): 501 w, 522 s, 622 w, 670 s, 680 s, 720 vs,
736 vs, 1059 vs, 1137 w, 1197 s, 1227 s, 1247 vs, 1287 w, 1378 vs, 1415 vs, 1466 vs,
1570 vs, 1694 w, 2927 b, 3137 w. Anal. Calc. for C30H42Cu2N12S6B2F8: C, 33.87; N,
15.50; H, 3.98. Found: C, 29.88; N, 13.68; H, 3.45.
[Cu2(μ-mbis)2(dmise)2][2BF4] (7). Dmise (176 mg, 1 mmol) was dissolved in
acetonitrile (20 mL) and cannula transferred to a solution of [Cu(NCCH 3)4][BF4] (312
mg, 1 mmol) in acetonitrile (10 mL). The reaction was stirred at room temperature for 3
h, resulting in the formation of a yellow solution. To this reaction mixture was cannula
added mbis (336 mg, 1 mmol) in dichloromethane (10 mL) and stirred overnight. The
solvent volume was reduced in vacuo to about 3 mL and the product was precipitated
with diethyl ether to afford an off-white solid which was dried in vacuo. Single crystals
for X-ray analysis were grown from slow vapor diffusion of diethyl ether into acetonitrile
solution. Yield: 46% (558 mg, 0.456 mmol). 1H NMR (CD3CN): 3.62 (s, 6H, 2CH3), 3.68
(s, 6H, 2CH3), 6.68 (s, 2H, CH2), 7.14 (s, 2H, 2CH), 7.24 (d, JHH 2.0, 2H, 2CH), 7.40 (d,
JHH 2.0, 2H, 2CH). 13C{1H} NMR: 36.45(CH3), 37.82 (CH3), 60.53 (CH2), 121.05 (CH),
122.04 (CH), 123.67 (CH), 148.99 (C=Se (dmise)), 151.27 (C=Se (mbis)).

19

F{1H}

NMR (CD3CN): -151.56, -151.61. 77Se NMR (CD3CN): -26.01. UV-vis (CH3CN): 277.6
nm. Mp. 193°C. IR (cm-1): 521 s, 623 s, 650 s, 658 s, 724 s, 745 s, 791 s, 837 s, 1055 b,
1176 s, 1207 s, 1230 vs, 1248 s, 1287 s, 1320 s, 1378 b, 1464 vs, 1571 vs, 1673 s, 2925
b,

3132

b.;

Mass

spectrum

(ESI-MS):
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m/z

732.76

[Cu(mbis)2]+,

572.81

[(dmise)Cu(mbis)]+, 398.83 [Cu(mbis)]+, 239.02 [Cu(dmise)]+. Anal. Calc. for
C28H40Cu2N12Se6B2F8: C, 25.49; N, 12.74; H, 3.06. Found: C, 24.85; N, 12.48; H, 3.00.
[Cu2(μ-mbis)2(dmit)2][2BF4] (8). Complex 8 was prepared following the same
procedure for 7 except that dmit (129 mg, 1 mmol) was used instead of dmise. Single
crystals for X-ray analysis were grown from slow vapor diffusion of diethyl ether into
acetonitrile solution. Yield: 38% (427 mg, 0.378 mmol). 1H NMR (CD3CN): 3.60 (s, 6H,
2CH3), 3.62 (s, 6H, 2CH3), 6.65 (s, 2H, CH2), 6.98 (s, 2H, 2CH), 7.23 (d, JHH 2.5, 2H,
2CH), 7.38 (d, JHH 2.0, 2H, 2CH). 13C{1H} NMR: 35.84(CH3), 37.77 (CH3), 60.51 (CH2),
120.02 (CH), 121.00 (CH), 123.31 (CH), 151.63 (C=Se (mbis)), 157.65 (C=S (dmit)).
19

F{1H} NMR (CD3CN): -151.52, -151.57.

77

Se{1H} NMR (CD3CN): -24.20. UV-vis

(CH3CN): 273.7 nm. Mp. 209 °C. IR (cm-1): 508 s, 521 s, 611 s, 640 s, 650 s, 657 s, 676
s, 723 vs, 746 vs, 790 vs, 839 s, 867 s, 1033 b, 1145 s, 1177 s, 1207 s, 1229 s, 1249 s,
1290 s, 1321 s, 1372 s, 1395 s, 1465 s, 1571 vs, 1602 s, 1673 s, 2920 b, 3088 s.; Mass
spectrum (ESI-MS): m/z 732.73 [Cu(mbis)2]+, 526.85 [(dmit)Cu(mbis)]+, 398.82
[Cu(mbis)]+,

318.97

[Cu(dmit)2]+,

190.95

[Cu(dmit)]+.

Anal.

Calc.

for

C28H40Cu2N12Se4S2B2F8: C, 27.44; N, 13.72; H, 3.29. Found: C, 27.28; N, 13.60; H, 3.27.
[Cu2(dmise)2(mbit)2][2BF4] (9). Complex 9 was prepared following the same
procedure for 7 except that mbit (242 mg, 1 mmol) was used in place of mbis. The
growth of single crystals for x-ray analysis was attempted from slow vapor diffusion of
diethyl ether into acetonitrile solution. Yield: 30% (347 mg, 0.302 mmol). 1H NMR
(CD3CN): 3.52 (s, 6H, 2CH3, mbit), 3.69 (s, 6H, 2CH3, dmise), 6.48 (s, 2H, CH2), 7.04
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(d, JHH 3.0, 2H, 2CH), 7.14 (s, 2H, 2CH, dmise), 7.26 (d, JHH 3.0, 2H, 2CH).

13

C{1H}

NMR: 35.88 (CH3), 37.74 (CH3), 57.45 (CH2), 118.91 (CH), 121.40 (CH), 122 (CH),
149.25 (C=Se (dmise)), 158.75 (C=S (mbit)).

19

F{1H} NMR (CD3CN): -151.48, -151.53.

UV-vis (CH3CN): 268.9 nm. Mp. 174°C; IR (cm-1): 521 s, 672 vs, 725 vs, 741 vs, 761
vs, 796 vs, 848 s, 983 s, 1033 b, 1217 vs, 1234 vs, 1250 vs, 1287 s, 1314 s, 1376 vs, 1401
vs, 1429 s, 1464 b, 1571 vs, 1699 b, 2851 b, 3141 s, 3171 s. Anal. Calc. for
C28H40Cu2N12Se2S4B2F8: C, 29.72; N, 14.85; H, 3.56. Found: C, 29.60; N, 14.61; H, 3.53.
[Cu(mbit)(μ-dmit)]n[BF4]n (10). Complex 10 was prepared following the same
procedure for 7 except that dmit (129 mg, 1 mmol) was used in place of dmise and mbit
(242 mg, 1 mmol) was used instead of mbis. Single crystals for x-ray analysis were
grown from slow vapor diffusion of diethyl ether into acetonitrile solution. Yield: 34%
(354 mg, 0.335 mmol). 1H NMR (CD3CN): 3.52 (s, 6H, 2CH3, mbit), 3.62 (s, 6H, 2CH3,
dmit), 6.49 (s, 2H, CH2), 7.00 (s, 2H, 2CH), 7.06 (d, JHH 2.5, 2H, 2CH), 7.25 (d, JHH 2.5,
2H, 2CH). 13C{1H} NMR: 35.94 (CH3), 57.52 (CH2), 119.00 (CH), 120.30 (CH), 121.50
(CH), 156.61 (C=S (dmit)), 158.40 (C=S (mbit)).

19

F{1H} NMR (CD3CN): -151.30, -

151.35. UV-vis (CH3CN): 267.8 nm. Mp. 159°C; IR (cm-1): 503 s, 521 s, 603 s, 633 s,
670 vs, 729 vs, 760 s, 782 s, 848 s, 1032 b, 1174 s, 1234 vs, 1286 s, 1395 vs, 1464 vs,
1572 vs, 1684 b, 2250 s, 2725 s, 2921 b, 3140 b. Anal. Calc. for C28H40Cu2N12S6B2F8: C,
32.41; N, 16.20; H, 3.88. Found: C, 32.55; N, 16.15; H, 3.97.
X-ray data collection and structural determination. Single crystals grown from
vapor diffusion were mounted on a glass filament with silicon grease and immediately
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cooled to 168.15K in a cold nitrogen gas stream. The crystals were grown by vapor
diffusion of diethyl ether into an acetonitrile solution for [Cu 2(μ-dmise)(dmise)4][2BF4]
(1),

[Cu2(μ-mbis)(mbis)2][2BF4]

mbis)2(dmise)2][2BF4]

(7),

(3),

[Cu2(ebit)3][BF4]2

[Cu2(μ-mbis)2(dmit)2][2BF4]

(8),

(6),
and

[Cu2(μ-

[Cu(mbit)(μ-

dmit)]n[BF4]n (10). Intensity data were collected using a Rigaku Mercury CCD detector
and an AFC8S diffractometer. The space groups P-1 for 1, 3, 6, 8, and 10 and P21/c for 7
were determined from the observed systematic absences. Data reduction including the
application of Lorentz and polarization (Lp) effects and absorption corrections used the
CrystalClear program.41 The structures were solved by direct methods and subsequent
Fourier difference techniques, and refined anisotropically, by full-matrix least squares, on
F2 using SHELXTL 6.10.42 In the final cycle of least squares, independent anisotropic
displacement factors were refined for the non-hydrogen atoms and the methyl hydrogen
atoms were fixed in “idealized” positions with C-H = 0.96 Å. Their isotropic
displacement parameters were set equal to 1.5 times Ueq of the attached carbon atom.
For complex 1, the largest peak in the final Fourier difference map (1.08 e·A -3)
was located 0.83 Å from Se(4) and the lowest peak (-0.81 e·A-3) was located at a distance
of 0.86 Å from Se(4). The largest peak for complex 3 in the final Fourier difference map
(0.82 e·A-3) was located 0.08 Å from Se(4) and the lowest peak (-0.79 e·A-3) was located
at a distance of 0.77 Å from Se(5). The largest peak for 7 in the final Fourier difference
map (1.16 e·A-3) was located 1.19 Å from H(6C) and the lowest peak (-0.74 e·A-3) was
located at a distance of 0.92 Å from Se(1). The largest peak for 8 in the final Fourier
difference map (1.10 e·A-3) was located 1.23 Å from N(5) and the lowest peak (-0.78
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e·A-3) was located at a distance of 0.88 Å from Se(1). The largest peak for 10 in the final
Fourier difference map (0.42 e·A-3) was located 1.73 Å from S(1), and the lowest peak
(-0.42 e·A-3) was located at a distance of 0.76 Å from Cu(1). Final refinement parameters
for the structures of 1, 3, 6, 7, 8, and 10 are given in Tables 6.10 and 6.11.

Table 6. 10. Summary of crystallographic data for complexes 1, 3, and 6.
Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

1
C27H43Cu2N11Se5B2F8
1217.22
P-1
Triclinic
11.712(2)
14.126(3)
14.800(3)
87.32(3)
73.78(3)
71.01(3)
2220.5(8)
2
1.821
[-14, -17, -18]
[14, 17, 18]
508
1184
5.124
3.19 - 26.38
18943
8943
0.0461
0.1125
0.0616
0.1263
1.117
1.081
-0.813

3
C29H39Cu2N13Se6B2F8
1344.19
P-1
Triclinic
11.972(2)
14.325(3)
15.568(3)
89.58(3)
77.29(3)
68.69(3)
2418.7(8)
2
1.846
[-14, -17, 0]
[14, 17, 19]
548
1296
5.462
2.94-26.34
9716
9716
0.0470
0.1116
0.0666
0.1276
1.062
0.817
-0.792

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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6
C33H46Cu2N13S6B2F8
1437.29
P-1
Triclinic
10.368(2)
10.699(2)
10.804(2)
98.29(3)
116.81(3)
91.25(3)
1053.4(4)
2
1.677
[-12, -11, -13]
[12, 11, 13]
274
542
1.384
3.09- 26.30
9129
9129
0.0553
0.1363
0.0553
0.1581
1.046
0.929
-0.880

Table 6.11. Summary of crystallographic data for complexes 7, 8, and 10.

Chemical Formula
F.W. (g/mol)
Space group
Crystal system
a, Å
b, Å
c, Å
α, °
β, °
γ, °
V, Å3
Z
Dcal, Mg/m3
Indices (min)
(max)
Parameters
F(000)
μ, mm-1
2θ range,
Collected reflections
Unique reflections
Final R (obs. Data)a, R1
wR2
Final R (all data), R1
wR2
Goodness of fit (S)
Largest diff. Peak
Largest diff. Hole
a

7
C28H40Cu2N12Se6B2F8
1319.18
P-1
Triclinic
8.21868(16)
11.247(2)
12.904(3)
66.67(3)
84.64(3)
77.72(3)
1066.1(4)
1
2.055
[-10, -14, 16]
[9, 14, 11]
266
636
6.194
3.12-26.75
9066
4435
0.0503
0.1120
0.0796
0.1319
1.093
1.158
-0.736

8
C28H40Cu2N12S2Se4B2F8
1225.38
P-1
Triclinic
8.1987(16)
11.198(2)
12.935(3)
65.68(3)
84.17(3)
77.75(3)
1057.5(4)
1
1.924
[-12, -21, -24]
[11, 21, 26]
267
600
4.622
2.95- 26.35
8161
4221
0.0455
0.1049
0.0658
0.1182
1.100
1.097
-0.778

R1 = [Σ||F0| - |Fc||]/ Σ|F0|; wR2 = {[Σw[(F0)2 – (Fc)2]2}1/2
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10
C28H40Cu2N12S6B2F8
1037.78
P21/c
Monoclinic
9.4763(19)
27.970(6)
7. 8016(16)
90
99. 89 (3)
90
2037.1(7)
2
1.692
[-11, -34, -7]
[11, 34, 9]
266
1056
1.429
2.18 - 26.31
16881
4096
0.0440
0.0984
0.0591
0.1074
1.089
0.416
-0.424

Figure 6.11. Cyclic voltammetry (CV) scans for A) [Cu2(μ-dmise)(dmise)4][2BF4]
(1), B) [Cu2(dmit)5][2BF4] (2), C) [Cu2(μ-mbis)3][2BF4] (3), D) [Cu2(mbit)3][2BF4]
(4), E) [Cu2(ebis)3][2BF4] (5), F) [Cu2(ebit)3][2BF4] (6). All data collected with 1 mM
complex in acetonitrile.
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Figure 6.11(cont.). Cyclic voltammetry (CV) scans for G)
[Cu2(μ-mbis)2(dmise)2][2BF4] (7), H) [Cu2(mbit)2(dmise)2][2BF4] (8), I)
[Cu2(μ-mbis)2(dmit)2][2BF4] (9), J) [Cu(mbit)(μ-dmit)]n[BF4]n (10), K) dmise, F) dmit.
All data collected with 1 mM complex in acetonitrile.
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Figure 6.12. Crystal packing diagram of [Cu2(μ-dmise)(dmise)4][2BF4] (1)
showing 50% probability density ellipsoids displaying H-F and H-Se short contact
interactions along the a-axis.
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Figure 6.13. Crystal packing diagram of [Cu2(μ-mbis)(mbis)2][2BF4] (3) showing
50% probability density ellipsoids and displaying H-F short contact interactions
along the c-axis. The short-contact interaction between the acetonitrile solvent
molecule and the selenium atom is also shown.

213

Figure 6.14. Crystal packing diagram of [Cu2(μ-mbis)2(dmise)2][2BF4] (7)
showing 50% probability density ellipsoids and H-Se short-contact interactions
along the a-axis. The counterions are omitted for clarity.
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Figure 6.15. Crystal packing diagram of [Cu2(μ-mbis)2(dmit)2][2BF4] (8)
showing 50% probability density ellipsoids and the H-F and H-Se shortcontact interactions along the a-axis.
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Figure 6.16. Crystal packing diagram of [Cu2(ebit)3][2BF4] (6)
showing 50% probability density ellipsoids and the H-F short contact
interactions along the a-axis.
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Figure 6.17. Crystal packing diagram of [Cu(mbit)(μ-dmit)]n[BF4]n (10)
showing 50% probability density ellipsoids and the H-F short-contact
interactions along the a-axis.
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